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Summary 
 
The greatest scientific challenge of the 20th century has been the characterization of the 
genetic makeup of an organism, sequencing its genome and studying the function of its genes.  
The first sequence of an eukaryotic genome, Saccharomyces cerevisiae, in 1996 paved the 
way to the sequence of the human genome. The functional characterization of our genes has kept 
scientists busy for the last 10 years. Yet the sequence of the dark side of the genome, the 
metagenome is now revealing the centrality for human health of an harmonious interaction between 
the organismal functions and the activity of the microorganisms colonizing our body. 
Aim of our work is to use the best characterized microorganism S. cerevisiae to understand 
the mechanism governing a fruitful interaction between microbes and the human system.  
Candida albicans and S. cerevisiae are ubiquitous fungal organism that often colonize the 
skin and the mucosal surfaces of normal individuals, without causing disease. However, when the 
normal host defence mechanisms are impaired (for example, in patients who are undergoing 
chemotherapy for malignancies, receiving immunosuppressants after an organ transplant, or 
patients with AIDS), they can become pathogenic.  
Only in the past decade it has become clear that the innate immune system not only specifically 
recognizes various classes of microorganisms, but also initiates and modulates the subsequent 
adaptive responses that are delivered by T cells and B cells through their interactions with antigen- 
presenting cells, especially dendritic cells (DCs). The tasks of recognizing an invading pathogen 
and activating the host response are accomplished by pattern-recognition receptors (PRRs), which 
recognize conserved microbial components called pathogen-associated molecular patterns 
(PAMPs). 
An association between morphogenesis and virulence has long been presumed for 
dimorphic fungi that are pathogenic to humans, as one morphotype exists in the environment or 
during commensalism, and another within the host during the disease process. For C. albicans, 
putative virulence factors include the ability to switch between saprophytic yeast and pathogenic, 
filamentous forms of the fungus. DCs sense either form in a specific way, resulting in distinct, T-
helper (Th)-cell-dependent protective and non-protective immunities. Recent evidence suggests 
that the use of distinct recognition receptors contributes to the disparate patterns of reactivity 
observed locally in response to challenge with C. albicans.  
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The interaction between S. cerevisiae and human societies is so generally recognized to 
hypothesize domestication of strains of this species. Of the multitude of fungal species known, only 
a few can be considered truly pathogenic in healthy individuals. Successful resolution of 
pathogenic fungal disease depends on proper coordination of multiple components of the host 
immune response. The balance between pro- and anti-inflammatory signalling is a prerequisite for 
proper host-fungal interactions. Although inflammation is an essential component of the protective 
response to fungi, its deregulation may significantly worsen fungal diseases and limit protective 
antifungal immune responses.  
Host/fungal interactions have so far been studied only for pathogenic fungi such as C. 
albicans, but it is not known what determines the commensalism of harmless fungi. Understanding 
the mechanisms of cohabitation between humans and non-pathogenic fungi is a prerequisite for 
controlling fungal infections. The decision on how to respond to a microorganisms, be it a 
pathogen or a commensal, is still primarily determined by the interaction between cell wall 
component and cells of the innate immune system. We investigated the rules of host-fungal 
cohabitation and dissected the mechanisms responsible for the differential recognition 
demonstrating that the skewing in the use of pathogen recognition receptors by differences in cell 
wall composition is a requirement for pathogenicity.  
To unravel the rules of the recognition game, we used a systems biology approach to 
understand how different life stages of the harmless and commensal S. cerevisiae interact with our 
immune system, comparing the results to those obtained upon exposure to pathogenic 
microorganisms. In particular we investigated the rules of host-fungal cohabitation using human 
monocyte-derived DCs (moDCs) exposed to cells and spores of the yeast S. cerevisiae as a toolbox 
to dissect the role cell wall component in determining commensalism or pathogenicity traits. 
Combining transcriptional analysis with receptor-specific blocking and cytokine production assays, 
we determined that DCs respond differently to C. albicans and S. cerevisiae and in the latter case, 
the interplay between spores and yeasts is crucial for the commensalism of S. cerevisiae. We 
demonstrated that the differential recognition of specific mannan structures is the master regulator 
of the discrimination between harmful and harmless fungi. Our findings elucidate the mechanisms 
of commensalism, demonstrating the importance of exposing S. cerevisiae mannans to suppress 
pro-inflammatory responses.  
To contrast fungal infection, augmenting the ability of the immune system to eliminate a 
pathogen requires a sophisticated understanding of the molecular mechanisms that are involved in 
pathogen recognition and in the host immune response. Widespread use of microarrays has 
generated large amounts of data, the interrogation of the public microarray repositories, identifying 
similarities between microarray experiments is now one of the major challenges. We developed a 
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novel method to compare microarray experiments at the pathway level, this method consists of two 
steps: first, generate pathway signatures, a set of descriptors recapitulating the biologically 
meaningful pathways related to some clinical/biological variable of interest, second, use these 
signatures to interrogate microarray databases. Using this approach it is possible to retrieve data 
from public microarray databases and perform comparisons at the pathway level using the newly 
structured pathways we curated in the DC-ATLAS initiative. When performing this exercise on 
microarray data derived from pure agonist and stimulation with the entire microorganism we were 
able to dissect the several components of the transcriptional response to the fungus. We also 
demonstrated how our approach improves the power of pathway analysis to dissect the response to 
different fungi. This approach proved very useful to extract from transcriptional data the regulator 
programs discriminating the response elicited from a pathogen and from an harmless 
microorganism. 
 
The integration of a System Biology approach to functional data offers new interpretive 
clues to the mechanisms of fungal virulence: rather than dimorphism per se, the engagement of 
different recognition receptors on DCs might select the mode of fungal internalization and antigen 
presentation, condition the nature of the T-helper response and, ultimately, favor saprophytism or 
infection.
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1 
Introduction 
 
 
The mammalian immune system consists of two different arms – innate and acquired 
immunity - and cooperative interaction of these two branches is required for elimination of 
infective pathogens with the highest possible efficiency. The innate immune system is an 
evolutionarily conserved system that provides the first line of protection against invading microbial 
pathogens and is mediated by phagocytes such as macrophages and dendritic cells (DCs; Hoffmann 
et al., 2003; Akira et al., 2006; Beutler et al., 2007; Medzhitov et al., 2007).  
Within minutes of the invasion of the host by a pathogenic microrganism, the innate immune 
system is activated and coordinates the host defence during the intial hours and days of infection.  
The ability of the host to discriminate self from potentially harmful non-self, and act appropriately 
is a central feature of immune defence. Although the innate immune system is very effective in 
dealing with the vast majority of invading pathogens, it has been believed for many years to be 
non-specific and non-selective, with specificity being conferred only by the secondary activation of 
acquired immunity mediated by T- and B-lymphocytes.  
The initial detection of pathogens is governed by the innate immune system, which is 
composed of cellular and humoral components with common ability to bind conserved features 
present on pathogenic surfaces. These pathogen associated molecular patterns (PAMPs) are the 
‘Achilles heel’ of the microbial world as they are critical to microbial viability and therefore they 
are conserved from an evolutive point of view. 
The dogma of the non-selective nature of the innate immune response and, in particular, 
the presumed non-specific recognition of microrganisms by phagocytic cells, has been challenged 
by the recent discovery of classes of receptors called pathogen recognition receptors (PRRs) which 
specifically recognize PAMPs and deliver appropriate signals to cells of the innate immune system 
(Janeway, 1989). The manner in which antigen presenting cells (APCs) such as macrophages and 
DCs recognize foreign structures and internalize them for presentation to cells of the adaptive
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immune system will determine the overall quality and effectiveness of immune responses. 
Recognition of pathogens by PRRs leads to release of pro-inflammatory cytokines and activation of 
anti-bacterial mechanisms, and modulates the initiation of acquired immunity by activation of DCs. 
 
 
1.1 Dendritic cells: control of immunity and tolerance 
 
Dendritic cells (DCs), originally identified by Steinman and his colleagues (1973) 
represent the pacemakers of the immune response. DCs are professional APCs that are seeded 
throughout peripheral tissues to act as sentinels that process and present antigen to mount 
adequate immune responses. Depending on the type of antigen and the tissue localization, the 
immune response is suppressed or activated (Bancherau et al., 1998; Steinman et al., 2003).  
DCs differentiate from bone marrow stem cells and migrate as precursor DCs into the 
blood. Immature DCs populate all body tissues where they sample either self or non-self 
antigens. Self antigens can be derived from their innocuous environment, such as necrotic and 
apoptotic cells that need to be scavenged before they disintegrate. Alternatively, non-self 
antigens are foreign products from invading pathogens that need to be eliminated. The main 
function of DCs is to capture antigen for processing and presentation as antigenic fragments on 
major histocompatibility complex (MHC) class I or II molecules to naïve T cells (Bancherau et 
al., 1998).  
In a steady-state situation, prior to acute infection and inflammation, DCs are in an 
immature state and are not fully differentiated to carry out their known roles as inducers of 
immunity. It does not mean they are unrensponsive: they actively circulate through tissues and 
into lymphoid organs, capturing self-antigens as well as innocuous environmental proteins. In a 
state of alarm such as a microbial invasion, or massive cell death, immature DCs receive 
simultaneous activation signals through the binding of conserved molecular motifs by pattern 
recognition receptors, such as Toll-like receptors (TLRs) or specific TNF family members 
(Bancherau et al, 1998, Metzinger, 2002). This result in DC maturation and migration to 
secondary lymphoid organs, where DCs present the processed antigens to naïve T cells and 
induce antigen-specific immune responses. 
Certain chemokines, adhesion molecules, and co-stimulatory molecules carefully 
orchestrate the maturation and migration of DCs. These factors control the differentiation 
stages of the DC and direct the migration of the various DC subtypes (Sallusto and 
Lanzavecchia, 1999). Chemokines generated within the lymph nodes attract naïve T cells 
toward the DC, enabling maximal exposure of MHC-peptide complexes to naïve T cells. Also, 
Adhesion molecules are crucial for the cellular interactions that DCs undergo during their 
journey from bone marrow through blood into peripheral organs and subsequently lymphoid 
tissues, where they enable DC–T cell interactions necessary for T cell activation. 
Recently, many novel cell-surface molecules have been identified that are involved in 
antigen capture by DCs. In particular, DCs display a large diversity of C-type lectin receptors 
(CLRs) that are involved in the recognition of a wide range of carbohydrate structures on 
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antigens (Figdor et al., 2002, Drickamer, 1999). Especially the resident immature tissue DCs 
express a wide variety of C-type lectins that seem to be involved in the specific recognition of 
both self-antigens and pathogens.  
One of the major enigmas in immunology concerns those regulatory mechanisms that 
maintain the unresponsiveness of self-reactive T cells in the normal repertoire to self-antigens 
while at the same time allowing effective immune reactions to foreign antigens to be mounted.  
The ability of DCs to immune modulate a proper recognition suggests that DCs fulfill 
the requirements for a cell uniquely capable of discriminating between the different forms of a 
fungus in terms of the elicited immune response. Most pathogens express different PAMPs and 
trigger several classes of PRRs on a single cells simultaneously. As a result, the ultimate 
expression of response genes induced by a pathogen depends on the integration of these 
different signalling pathways. Cross talk between or even within groups of PRRs is crucial in 
balancing immune response through collaborative induction of positive or negative feedback 
mechanisms (Lee and Kim, 2007). 
 
 
1.2 PRRs in antifungal immunity 
 
Humans are continuously exposed to fungi, yet they rarely develop fungal diseases. 
Infections caused by fungal pathogens represent a serious health problem for immunocompromised 
patients (cancer, transplantation and primary immunodeficiency patients; Sternberg, 1994). Host 
defences against fungi are numerous and range from relatively, constitutively expressed non-
specific defences to sophisticated adaptive responses that are specifically induced during infection 
and disease (Romani et al., 1998; Romani, 2002). 
Key sensors in anti-fungal defence are fungal PRRs expressed by phagocytes and APC. 
Fungal PRRs can be divided in two groups that have either intrinsic microbial recognition or 
indirectly facilitate host-pathogen recognition (opsonic receptors). Fungal PRRs with intrinsic 
microbial recognition comprises members of the C-type lectin receptor (CLR) family, Toll like 
receptor (TLR) family, scavenger receptor (SR) family and certain integrins. Fungal PRRs can 
induce fungal phagocytosis, killing and/or initiate signalling leading to cytokine responses 
(Underhill and Ozinsky, 2002; Thoma-Uszynski et al., 2001; Weia et al., 1998). 
 
1.2.1 Toll like receptors 
TLRs are pathogen recognition receptors (Janeway and Medzhitov, 2002) that 
recognize a wide variety of microbial structures, including lipopolysaccharide (LPS) of Gram-
negative bacteria (TLR4), lipoteichoic acid and lipoproteins of Gram-positive bacteria (TLR2), 
bacterial DNA (TLR9), and viral RNA (TLR3, TLR7 and TLR8) (Figure 1.1) as well as factors 
secreted upon tissue damage such as heat shock proteins (Hsp 70; Akira and Hemmi, 2003; 
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Hemmi et al., 2000, Medzithov et al., 2001). The recognition by TLRs triggers intracellular 
signalling cascades that result in DC maturation and the induction of inflammatory cytokines, 
ultimately leading to T cell activation (Underhill and Ozinsky, 2002; Janeway and Medzhitov, 
2002).  
 
 
 
Figure 1.1. Toll-like receptors (TLRs) recognize a variety of pathogen-associated molecular patterns 
(PAMPs). Recognition of lipopolysaccharide (LPS) by TLR4 is aided by two accessory proteins: CD14 and 
MD2. TLR2 recognizes a broad range of structurally unrelated ligands and functions in combination with 
several (but not all) other TLRs, including TLR1 and TLR6. TLR3 is involved in recognition of double-
stranded (dsRNA). TLR5 is specific for bacterial flagellin, whereas TLR9 is a receptor for unmethylated CpG 
motifs, which are abundant in bacterial DNA. G+, Gram-positive; G–, Gram negative; GPI, 
glycophosphoinositol; RSV, respiratory syncytial virus. Adapted from Medzithov, 2001 
 
 
The TLR family of proteins, first described in Drosophila, possess extracellular leucine-
rich repeat region, which are involved in microbial recognition, and an intracellular Toll/interleukin 
(IL)-1 receptor (R) (TIR) domain, which is necessary for signalling. Ligand recognition by TLR 
homo- or hetero-dimers, induces signalling cascade mediated through intracellular adaptors, 
including myeloid differentiation primary response gene 88 (MyD88) and TIR-domain-containing 
adaptor-inducing interferon-β (TRIF), which result in the activation of several transcription factors, 
such as NF-kB and interferon-regulatory factor 3 (IRF3). Ultimately this induces TLR-specific 
pattern of gene expression and the production of various cytokines and chemokines (Akira et al., 
2006). Of the TLRs identified, fungal recognition appears to occur primarily through TLR2, TLR4 
and TLR9 (reviewed in Netea et al., 2006). Deletion of the intracellular adaptor MyD88 renders 
mice highly susceptible to infections with fungi, including Candida albicans, Aspergillus 
fumigatus and Criptococcus neoformans, although the role of the individual TLRs has not been 
established firmly in all the diseases and is often controversial. Several research groups have 
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demonstrated divergent role for TLR2 and TLR4 and their importance in the control of C. albicans 
and C. neoformans infections, for example, is still unclear (Netea et al., 2006; Nakamura et al., 
2006; Biondo et al., 2005). Thus, the TLRs undoubtedly have an important function in immunity to 
these pathogens, although the role of the individual receptors still remains to be completely 
elucidated. 
 
1.2.2 C-type lectins 
In contrast to TLRs, CLRs recognize specific carbohydrate structures on self antigens 
or cell wall components of pathogens. Their main function is to internalize antigens for 
degradation in lysosomal compartments to enhance antigen processing and presentation by 
DCs (Figdor et al., 2002; Engering et al., 2002). To date, several CLRs have been found to 
function as pathogen recognition receptors, whereas only a few have been shown to recognize 
self-antigens. 
Within the past few years, various CLRs have been identified on DCs. The pattern of 
CLR expression depends on the DC subset. Whereas CLRs are abundantly expressed by 
immature DCs in peripheral tissues, the expression of most CLRs is rapidly down-regulated 
upon DC maturation. Although CLRs initially were regarded as scavenger receptors, it is now 
clear that they bind a variety of antigens via specific recognition of particular carbohydrate 
patterns with interesting and important consequences. CLR-bound antigens are processed and 
presented to T cells, thus enhancing antigen presentation and immune activation. Strikingly, in 
vivo stimulation of CLRs induces immune suppression, hinting to an important function of 
CLRs in the tolerance toward self-antigen (Steinman et al., 2003). These findings illustrate a 
possible function for CLRs in the recognition of a wide variety of carbohydrate structures on 
self-glycoproteins to allow specific homeostatic control to self antigens and to mediate cellular 
processes such as cell signalling, cell adhesion, and migration (Figdor et al., 2002).  
Specific pathogens target CLRs to circumvent processing and presentation and to 
prevent immune activation. In contrast, specific pathogens benefit from their capacity to target 
host C-type lectins, using the function of the C-type lectins to induce non-responsiveness 
against their processed antigens with the aim to promote their survival by escaping immune 
activation.  
It has been well established that T cells reactive to self-antigen are part of the normal 
immune repertoire of mice, non-human primates, and humans at frequencies comparable to 
patients with autoimmune diseases. The fact that most of us do not develop autoimmune 
diseases shows that the auto-reactive cells are kept at bay by an efficient and tight control 
mechanism. As the majority of self-antigens are glycosylated, it was postulate that tolerance is 
maintained by the interaction with CLRs on DCs. However, when DCs obtain stimuli that result  
in maturation, such as upon pathogen recognition by TLR or CD40 triggering, this signalling 
overrules the tolerizing effects of CLRs.  
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1.2.2.1 Functional characteristics of C-type lectins 
CLRs form a large superfamily of transmembrane and soluble proteins that contain a 
carbohydrate-recognition domain (CRD) important in pathogen binding, uptake and killing. It is 
important to note that not all CLRs are PRRs, in fact many members of the CLR family have 
diverse functions (Zelensky and Gready, 2005). Members of the CLR family involved in anti-
fungal immunity include Dectin-1 (DC-associated C type lectin 1, Clec7a), Dectin-2 (Clec6a), 
macrophage mannose receptor (MR, CD206), dendritic cell-specific ICAM-3-grabbing non-
integrin (DC-SIGN, CD209) and Mincle (Clec4e, Clecsf9; Willment and Brown, 2008). Most 
CLRs on DCs are type II transmembrane proteins, with the exception of the MR and DEC-
205, which are both type I transmembrane proteins (Figdor et al., 2002; Figure 1.2).  
 
                        
 
Figure 1.2. Two types of C-type lectins or lectin-like molecules are produced by dendritic cells and 
Langerhans cells. Type I C-type lectins (MMR and DEC-205) contain an amino-terminal cysteine-rich 
repeat (S–S), a fibronectin type II repeat (FN) and 8–10 carbohydrate recognition domains (CRDs), which 
bind ligand in a Ca2+-dependent manner. MMR binds ligand through CRD4 and CRD5. Type II C-type 
lectins contain only one CRD at their carboxy-terminal extracellular domain. The cytoplasmic domains of the 
C-type lectins are diverse and contain several conserved motifs that are important for antigen uptake: a 
tyrosine-containing coated-pit intracellular targeting motif, a triad of acidic amino acids and a dileucine 
motif. Other type II C- type lectins contain other potential signalling motifs (ITIM, ITAM, proline-rich 
regions (P)). CLEC-1, C-type lectin receptor 1; DCIR, dendritic cell immunoreceptor; DC-SIGN, dendritic-
cell specific ICAM-3 grabbing non-integrin; DLEC, dendritic cell lectin; ITAM, immunoreceptor tyrosine-
based activation motif; ITIM, immunoreceptor tyrosine-based inhibitory motif; MMR, macrophage mannose 
receptor. Adapted from Figdor et al., 2002. 
 
All C-type lectins contain carbohydrate-binding activity based on the presence of at 
least one carbohydrate recognition domain (CRD; Weis et al., 1998). The CRD of the C-type 
lectin DC-SIGN is a globular protein that contains two Ca2+-binding sites, of which one directly 
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coordinates the binding specificity of the carbohydrate structures (Feinburg et al., 2001). 
Calcium binding is essential for the function of CLRs because mutation of either Ca2+-binding 
site in DC-SIGN leads to the loss of ligand binding (Geijtenbeek et al., 2002). Depending on the 
amino acid sequence, the CRD bears specificity for mannose, galactose, or fucose structures. 
However, binding of these carbohydrate structures to the different CLRs is also dependent on 
carbohydrate branching, spacing, and multivalency.  
The involvement of specific C-type lectins in ligand binding is often demonstrated by 
the ability of specific carbohydrate components, such as mannan, or a calcium chelator to 
block the interaction. However, co-expression of several CLRs — with the same carbohydrate 
specificity and calcium-dependency — on one DC subset makes it essential to use CLR specific 
blocking antibodies to demonstrate specific CLR functions. 
 
1.2.3. TLRs and CLRs cross-talk and effect on immune response 
There are several indications that TLRs and CLRs communicate with each other, and it 
is proposed that the cross talk between TLRs and CLRs may fine-tune the balance between 
immune activation and tolerance (Kaufmann and Schaible, 2003; Geijtenbeek et al., 2003; 
Gantner et al., 2003; Brown et al., 2003). Recognition of self-antigen by CLRs alone will favor 
immune suppression, whereas pathogen recognition or self-recognition in a situation of danger 
where both TLRs and CLRs are triggered induces immune activation. 
Thus, in a steady-state situation, antigens are captured by CLRs to maintain tolerance, whereas 
in a dangerous situation, CLR binding to the same antigen occurs in the presence of TLR 
triggering, and the immunostimulatory function of TLRs overrules the tolerizing function of 
CLRs, resulting in immune activation (Ichikawa et al., 2002). 
Depending on their tissue localization and differentiation state, DCs express unique sets of 
TLRs and CLRs. Reflecting the large variety of CLRs on DC subsets, a large diversity of TLRs 
are also expressed by these DC subsets (Jarrossay et al., 2001). These distinct DC subsets carry 
different sets of TLRs and CLRs raises the possibility that subsets of DCs recognize distinct 
classes of self- and nonself-antigens to induce tolerance or activate immunity. 
Intriguingly, specific pathogens target CLRs to escape immunosurveillance and to 
promote their survival by sequestration in DCs and by reducing their powerful antigen-
presenting capacities. The intriguing question arises of whether oligosaccharides bound to 
specific cell structures allow DC migration to specific sites as well as DC interactions with 
specific T cell subsets. 
Future research addressing carbohydrate-recognition profiles by C-type lectins and the 
regulation of glycosylation on its cellular counter-structures by post-translational modification 
will provide insight as to how these cell-surface receptors mediate cellular interactions and 
regulate DC function. Also, understanding the carbohydrate-recognition element present on 
self-antigens or pathogens that regulate the interaction with a specific CLR may have 
consequences for how the pathogen or antigen is processed by DC. 
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1.2.4. Pro- and anti-inflammatory signal during infection 
Following activation of the innate immune system, strong pro-inflammatory signals are 
generated, inducing inflammation and activation of host defence. After elimination of the invading 
microorganisms, subsequent anti-inflammatory signals are responsible for the resolution of the 
inflammation. These signals are crucial, not only for the return of the immune system to 
homeostatic balance, but also for the protection of the host against the deleterious effects of 
overhelming inflammation and for subsequent tissue repair.  
TLR-signals are involved in both the primary induction of inflammation and the secondary 
activation of anti-inflammatory mechanisms. TLRs are known to induce the release of anti-
inflammatory cytokines (e.g. interleukin (IL)-10, IL-4, IL-5 and IL-13). TLR2 and TLR4-mediated 
signals have been shown to mediate generation of down-modulating T-regulatory cells. The 
human body uses regulatory T cells (Tregs) to control unwanted immune reactivity (Blustone 
and Abbas, 2003). Natural Tregs are localized in the thymus and inhibit T cell activation 
primarily via cell-cell contact, whereas inducible Tregs are distributed over the lymphoid 
organs and exert their suppressive activity via secretion of cytokines. In line with this, the 
ablation of TLR2 or TLR4 signalling results in increased mortality following overwhelming 
inflammation in certain experimental models.  
However, whilst TLR-mediated anti-inflammatory signals are beneficial following the 
elimination of the pathogens, they can induce dangerous immuno-suppressive mechanisms if 
activated too early during a severe infection. 
 
 
1.3. Fungal cell wall component recognition 
 
Several classes of recognition receptors mediate recognition of fungal pathogens mainly by 
recognition of fungal cell wall components.  
 
1.3.1 The fungal cell wall 
The fungal cell wall is an essential organelle that maintains the viability of fungal cells. To 
be strong, yet plastic, fungal cell walls combine skeletal and matrix components in a way that 
resembles the engineering principles that are involved in constructing elaborate structures, such as 
reinforced concrete buildings, that are made of mesh and mortar.  
The cells of the innate immune system recognize elements of both the skeletal and matrix 
components of the fungal cell wall. 
The skeletal component of the cell wall of the majority of fungal pathogens, including C. 
albicans, is based on a core structure of β-(1,3)-glucan covalently linked to β-(1,6)-glucan and 
chitin (a β-(1,4)-linked polymer of N-acetylglucosamine (GlcNAc; Figure 1.3). These polymers 
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form hydrogen bonds between adjacent polysaccharide chains to form a tough three-dimensional 
network of microfibrils. Most models suggest that the skeletal components of the cell wall are 
found close to the cell membrane in an inner layer, although some chitin and glucan can be present 
throughout the thickness of the wall.  
In budding yeast cells, a scar is left on the mother cell after separation of the bud, and at 
this site the components of the inner layers of the cell wall, such as chitin and β-(1,3)-glucan, can 
become exposed at the surface (Gantner et al., 2005). In addition to the glucan and chitin skeleton, 
the fungal cell wall contains a matrix that mainly comprises glycosylated proteins. The 
glycosylphosphatidylinositol (GPI)-anchor-dependent cell wall proteins (GPI-CWPs), are normally 
highly glycosylated with mannose-containing polysaccharides (called mannan), and carbohydrates 
can account for up to 90% of their molecular mass. Many CWPs have a lollipop structure with a 
globular domain that is presented to the outside of the cell and a Ser/Thr-rich polypeptide stem-like 
domain that is stabilized in the cell wall by O-linked mannan side chains. These ether-linked O-
mannans are relatively short, linear polysaccharides that, in C. albicans, consist of one to five 
mannose (Man) sugars that are almost exclusively β-(1,2)-linked (Figure 1.3). 
N-mannan consists of a core Man8GlcNAc2 triantennary complex to which a highly branched 
structure is attached, comprising up to 150 mannose sugars arranged as an β-(1,6)-linked backbone 
with side chains mannose and phosphomannan (Cutler, 2001; Figure 1.3). 
 
 
   
 
Figure 1.3. Schematic structure of C. albicans cell wall. Modified from Netea et al., 2008 
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1.3.2 Fungal cell wall recognition 
Owing to the localization of mannoproteins and mannans in the outermost part of the cell 
wall, mannan detection would be expected to be one of the first steps in the recognition of C. 
albicans by the host innate immune system. However, the presence of β-glucans and chitin, 
especially at the level of the bud scar, is also likely to influence the recognition of C. albicans by 
leukocytes. 
DCs, which are crucial for antigen processing and presentation, also express most of the 
PRRs that are important for the recognition of fungal pathogens (Figure 1.4).  
The mosaic of PRRs that is expressed by the different immune cells ultimately determines the type 
of response that is initiated following recognition of C. albicans. 
 
  
 
Figure 1.4. Fungal pattern recognition receptors present on DC cell surface. DC presents on cell surface 
several receptors specific in fungal recognition. MR; mannose receptor, CR, complement receptor, TLR, Toll 
like receptor. Figure modified from Netea et al., 2008 
  
 
1.3.2.1 Mannans and mannoproteins 
Both mannans and mannoproteins from the C. albicans cell wall have important 
immunostimulatory activities, ranging from stimulation of cytokine production to induction of DC 
maturation (Petrella et al., 2006) and T-cell immunity (Gomez et al., 1996; Gomez et al., 2000). 
Mannoproteins induce mainly T helper 1 (Th1)-type cytokine profiles, which have protective 
effects against disseminated C. albicans infection (Mencacci et al., 1994). 
The first receptor on the surface of macrophages to be described as a mannan receptor was 
the C-type-lectin mannose receptor (MR) (Wileman et al., 1986; Stephenson and Shepherd, 1987). 
The MR recognizes oligosaccharides which terminate in mannose, fucose and GlcNAc (Stahl et al., 
2006), and this binding is mediated by carbohydrate-recognition domains (CRDs) 4 to 8 in the 
extracellular region of the receptor (Linehan et al., 2000). MR preferentially recognizes β-linked 
oligomannoses with branched, rather than linear, structures (Kery et al., 1992). By contrast, 
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recognition of the shorter linear structures of O-bound mannan is performed by TLR4 (Netea et al., 
2006), and results in cytokine production (Tada et al., 2002). Interestingly, TLR4 stimulation is lost 
during the germination of yeast into hyphae, which leads to a loss of interferon-γ (IFNγ) production 
capacity (van der Graaf et al., 2005).  
On DCs, however, the binding of mannans is mediated through the MR and DC-SIGN. 
DC-SIGN is a receptor that is specifically expressed on the cell membrane of DCs; (Cambi et al., 
2003) and recognizes carbohydrates, such as high-mannose structures, in a Ca2+-dependent fashion 
with specificity being achieved through unique interactions with its ligands and tetramerization of 
the receptors (Koppe et al., 2005). Similar to the MR, DC-SIGN recognizes several endogenous 
ligands as well as several microbial pahogens. including C. albicans. A. fumigatus conidia and 
Chrysosporium tropicum (Cambi et al., 2003; Serrano-Gomez et al., 2004; Serrano-Gomez et al, 
2005). 
A recent study has shown that Galectin-3 on the surface of murine macrophages can 
discriminate between pathogenic C. albicans and non-pathogenic Saccharomyces cerevisiae, and 
that an association between Galectin-3 and TLR2 is involved in this process (Jouault et al., 2003). 
Another lectin family member, Dectin-2, has also been described to function as a receptor 
for mannans of hyphal C. albicans (Ariizumi et al., 2000). Owing to its short intracytoplasmic tail, 
dectin-2 must interact with the FcγR to induce intracellular signals and, interestingly, seems to be 
mainly involved in the recognition of C. albicans hyphae (Sato et al., 2006; Robinson et al., 2009). 
 
1.3.2.2. β-glucans 
The fungal cell wall consists of approximately 60% β-glucan (Klis et al., 2001). Although 
initially thought to be buried beneath the mannoprotein layer, recent evidence suggests that β-
glucans are exposed on the cell surface (Torosantucci et al., 2005), although possibly restricted to 
specific regions, such as bud scars.  
The recognition of β-glucans has primarily been ascribed to two receptors, CR3 and, more 
recently, Dectin-1. Although other β-glucan receptors have been described, including 
lactosylceramide and scavenger receptors, the physiological role of these receptors is still unclear. 
CR3 is a widely expressed β2-integrin that recognizes several endogenous and exogenous ligands, 
pathogens that have been opsonized by iC3b (the inactivated form of complement component C3b) 
and carbohydrates, including β-glucans. Carbohydrate recognition is mediated by a lectin domain 
(Thornton et al., 1996; Diamond et al., 1993), which is distinct from the normal ligand-binding site 
(the I domain) of CR3 (Diamond et al., 1993). The lectin domain mediates recognition of both the 
yeast and hyphal forms of C. albicans (Forsyth and Mathews, 2002; Forsyth et al., 1998), as well 
as several other fungi.  
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Dectin-1 is a myeloid-expressed transmembrane receptor and possesses a single 
extracellular, nonclassical C-type-lectin-like domain that specifically recognizes β1,3-glucans. 
Dectin-1 can recognize several fungi, including C. albicans yeast, although it does not appear to 
recognize C. albicans hyphae (Brown and Gordon, 2003). The cytoplasmic tail of dectin-1 contains 
an immunoreceptor tyrosine-based activation-like motif (ITAM), which can mediate various 
protective responses through spleen tyrosine kinase and caspase recruitment domain protein 9 
(Syk–CARD9)-dependent pathways, such as the stimulation of interleukin 2 (IL-2) and IL-10 
(Rogers et al., 2005), IL-6 (Gow et al., 2008), and IL-17 production (LeibundGut-Landmann et al., 
2007). Although Syk dependent signalling from Dectin-1 is sufficient for these responses, 
stimulation of the mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-kB pathways, 
with subsequent production of pro-inflammatory cytokines, such as tumour necrosis factor (TNF), 
requires collaborative signalling with the TLR2 receptor (Brown et al., 2003; Gantner et al., 2003). 
 
 
1.4 Fungal receptor and immune evasion: a host perspective of fungal 
virulence  
 
Recent studies of PRR biology have shown that, while innate recognition is crucial for an 
efficient immune response, certain pathogens use PRR-based strategies to evade host defences.  
Fungi are not merely passive participants in the infectious process, and a hypothetical set of 
virulence factors has been attributed to them (Cutler, 1991; Hogan et al., 1996; Calderone and 
Fonzi, 2001). Additionally, the interaction between fungi and the environment is profoundly 
affected by antigenic variability, phenotypic switching and dimorphic transition (Mitchell, 1998; 
Woods, 2002; Soll, 2002). It has been argued that all the traits required to establish disease should 
be considered fungal virulence traits (Calderone and Fonzi, 2001; Odds et al., 2001; Casadewall et 
al., 1999). However, as fungal virulence is only expressed in susceptible hosts, it cannot be 
considered an independent microbial variable (Casadewall et al., 1999; Casadewall et al., 2001; 
Casadewall et al., 2002). 
An association between morphogenesis and virulence has long been presumed for 
dimorphic fungi that are pathogenic to humans, as one morphotype exists in the environment or 
during commensalism, and another within the host during the disease process. For C. albicans, 
putative virulence factors include the ability to switch between saprophytic yeast and pathogenic, 
filamentous forms of the fungus (Mitchell, 1998; Roney et al., 2002). DCs sense either form in a 
specific way, resulting in distinct, T-helper-cell-dependent protective and non-protective 
immunities. The transition to different fungal morphotypes is detected by the host immune system 
in a morphotype-specific fashion (Romani et al., 1998; Roney et al., 2002; Romani et al., 2002). 
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DCs are uniquely able to decode fungus-associated information, resulting in qualitatively 
different adaptive T-helper cell (Th) immune responses, both in vitro and in vivo (Fe-d’Ostiani et 
al., 2000; Bauman et al., 2000; Newman and Holly, 2001; Gildea et al., 2001; Richards et al., 2001; 
Grazziutti et al., 2001; Montagnoli et al., 2002; Bozza et al., 2002; Bacci et al., 2002). As DCs 
efficiently phagocytose fungi at sites of infection (Bozza et al., 2001), it follows that they are 
unique sensors of fungi, being able to internalize different morphotypes and either kill fungal cells 
or favor parasitism and/or infection. This requires DCs to be able to activate the corresponding 
adaptive immune response at the sites of colonization and/or infection.  
 
1.4.1 Fungi recognition: commensalism and pathogenicity 
The engagement of distinct receptors by Candida yeasts and hyphae translates into 
downstream signalling events, ultimately regulating cytokine production and co-stimulation.  
TLR2 ligation can induce pro-inflammatory cytokine, but that this effect is weaker than 
that mediated by TLR4 (Hirschfeld et al., 2001). In contrast, TLR2 signals are strong mediators of 
anti-inflammatory effects. The TLR2-induced immune-suppression is either an exageration or a 
premature activation of the normal anti-inflammatory effects of TLRs stimulation, necessary 
during the recovery phase of the infection for reversing inflammation. In addition to the induction 
of anti-inflammatory signals through TLRs, certain fungi have developed strategies to either block 
or avoid their recognition by TLRs and subsequent activation of the innate defence. Thus, 
Aspergillus fumigatus evades immune recognition by germination into hyphae, with subsequent 
loss of TLR4 recognition, while the TLR2-mediated IL-10 pathways remain intact thus shifting the 
balance towards a permissive Th2-type profile (Netea et al., 2003).  
A similar evasion of TLR4 recognition was documented for C. albicans hyphae, which 
stimulate mainly anti-inflammatory cytokines through TLR2 (van der Graaf et al., 2005), but which 
are unable to be recognized by TLR4 and thereby stimulate IL-12 or IFNγ synthesis (d’Ostiani et 
al., 2000; van der Graaf et al., 2005). 
TLR4 is not the only PRR targeted during fungal germination. Gantner et al. (2006) 
demonstrated that dectin-1 recognizes the b-glucans at the level of budding scars in the yeast form, 
but can not recognize the β-glucans in the hyphal form, where they are shielded by a layer of 
mannans. In this way two major recognition system (TLR’s and dectin-1) are unable to recognize 
Candida hypahe, shifting the balance towards an anti-inflammatory response.  
Furthermore, the entry of yeasts signals through MR results in the production of 
proinflammatory cytokines, including IL-12, fungal degradation, up-regulation of co-stimulatory 
molecules and increased expression of MHC class II molecules. These events are all suppressed 
upon entry through CR3. By contrast, co-ligation of CR3 with FcγR, as in the phagocytosis of 
hyphae, results in upregulation of co-stimulatory molecules and the presentation of antigens by 
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MHC class II molecules, and the production of IL-4 and/or IL-10 (Montagnoli et al., 2002). In vivo 
studies confirmed that the opsonic dependent phagocytosis of fungi was responsible for type 2 
cytokine production and Th2 cell activation, an activity counteracted by the Th1-promoting activity 
of non-opsonic phagocytosis through MR. That MR appears to be required for the activation of 
antifungal T-cell responses has also recently been demonstrated with the fungus Cryptococcus 
neoformans (Mansour et al., 2002).  
There is compelling evidence that regulatory T cells (Tregs) specialized in attenuating 
immune responses play a crucial role in immune regulation (Roncarolo and Levings, 2000). 
Therefore, in addition to the Th1/Th2 balance, other mechanisms appear to be involved in 
regulating Th1-mediated immunity to C. albicans as the newly described Th17 pathway (see 
below). 
 
 
1.5 Dendritic cell and antifungal T cell response 
 
Immature DCs acquire antigens in peripheral tissues by a variety of mechanisms; they then 
mature and migrate to the T-cell areas of lymphoid organs where they ‘translate’ the tissue-derived 
information into the ‘language’ of Th-cells using different activating signals. In addition to 
initiating immunity, certain sub-populations of DCs can down-regulate immune responses 
(Roncarolo et al., 2001), allowing DCs to act as guardians for the induction and maintenance of 
peripheral T-cell tolerance and the prevention of pathological autoimmune reactions (Mellman and 
Steinman, 2001). 
The T-cell branch of the immune system can respond to a virtually infinite variety of 
exogenous antigens, thus including the possibility of self-antigen recognition and dangerous 
autoimmune reactions. Therefore, regulatory mechanisms operate both during ontogeny within the 
thymus and after birth in the periphery. The control of self-reactive T cells occurs through a 
process of negative selection that results in apoptosis of T cells showing high affinity for self-
peptides expressed at the thymic level by means of promiscuous gene expression. Self-reactive T 
cells escaped to negative selection are controlled in the periphery by other regulatory mechanisms, 
the most important being natural Foxp3 T regulatory (Treg) cells. Regulation is also required to 
control excessive effector T cell responses against exogenous antigens, when they become 
dangerous for the body. Three types of effector T cells have been recognized: (1) T helper 1 (Th1) 
cells, which are protective against intracellular bacteria; (2) Th2 cells, which play some role in the 
protection against nematodes, but are responsible for allergic reactions; (3) Th17 cells, which are 
probably effective in the protection against extracellular bacteria, but also play a role in the 
amplification of autoimmune disorders. Abnormal or excessive Th effector responses are regulated 
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by different mechanisms.  
Redirection or immune deviation of Th1- or Th2-dominated responses is provided by 
cytokines (IFNγ vs. IL-4) produced by the same cell types and by the CXCR3-binding chemokines 
CXCL4 and CXCL10. Moreover, both Th1 and Th2 responses can be suppressed by adaptive Treg 
cells through contact-dependent mechanisms and/or the production of IL-10 and transforming 
growth factor β (TGFβ). 
Finally, TGFβ1 can promote the development of both Th17 effector and adaptive Treg 
cells, while the contemporaneous production of IL-6 contributes to the development of Th17 cells, 
but inhibits Treg cells. The development of Th17 cells is also down-regulated by IL-4 produced by 
Th2 cells and by IFNγ produced by Th1 cells (review in Romagnani, 2006). 
 
1.5.1 Th17 in antifungal host defence 
The Th1-versus-Th2 dichotomy has dominated T cell biology for many years. However, 
the Th17 lineage, has now risen to prominence (Bettelli et al., 2007; Veldhoen et al., 2006; Bettelli 
et al., 2006; Mangan et al., 2006). Th17 cells play important roles in host defence against infection 
with extracellular bacterial and fungal pathogens by recruiting acute inflammatory cells into local 
sites of infection. In addition to host defence, ample experimental evidence supports pathological 
role for Th17 cells during numerous systemic and organ-specific autoimmune disease. These 
diseases probably result from Th17 cells directed against self-antigen. Th17 cell development 
occurs in the presence of transforming growth factor-β (TGF-β) and IL-6 and is opposed by Th1 
cytokines. Th17 cells are maintained in the presence of the IL-12-related cytokine IL-23. Whereas 
IL-1β alone is capable of inducing IL-17 secretion on human central memory T cells (Acosta-
Rodriguez et al., 2007a), IL-21 and TGFβ seem to be needed for driving differentiation of naive T 
cells (Yang et al., 2008). IL-17 induces chemokine production at sites of infection and causes 
recruitment of neutrophils. Because of this unique activity, Th17 cells are important in defence 
against extracellular pathogens (Bettelli et al., 2007; Mangan et al., 2006). Accordingly, strong 
Th17 responses are induced after infection with extracellular bacteria (Mangan et al., 2006).  
Especially intriguing is the demonstration that while Th17 cells represent a separate and 
distinct T-cell lineage, pathogen-specific Th17 cells can play cooperative roles with pahogen-
specific Th1 cells in host defence during some infections. Moreover, accumulating evidence 
demonstrates that Th17 cells can also provide protective effects during infection with more 
traditional pathogens. This is of paramount interest because most studies in vitro indicate that 
cytokines that promote CD4 T-cell differentiation into each lineage not only strongly reinforce 
other cells to differentiate into the same lineage but also potently inhibit differentiation into other T 
cell lineages.  
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Table 1.1 Overview on the possible activities of different CD4+ T cell population. From Romagnani, 
2006. 
 
 
These results suggest that additional signals with the capacity to override lineage-
differentiating signals are triggered during in vivo infection to allow the immune system to ‘fine-
tune’ the kinetics and balance the relative degree of T cell differentiation into multiple effector 
lineages during infection (see Curtis and Way, 2009). 
Both Th1 (Acosta-Rodriguez et al., 2007) and Th17 (Huang et al., 2004; Milner et al. 2008; 
Conti et al., 2009) cells have been proposed to mediate protection against pathogenic fungi and in 
particular against C. albicans. C. albicans can switch from being an intracellular form, the yeast, 
that can be efficiently destroyed by macrophages with the help of Th1 cells, to being an 
extracellular form, the hyphae, that is better controlled by neutrophils (Urban et al., 2008) recruited 
by Th17 cells. 
 
1.5.1.1 PRRs and Th17 priming 
Which are the receptor pathways that direct the immune response toward a Th17 profile is 
a matter of debate, with each of the TLRs (Evans et al., 2007), Dectin-1 (LeibunGut-Landmann et 
al., 2007) and NOD2 (van Beelen et al., 2007) pathways individually being implicated in the 
induction of Th17 cells. 
Dectin-1-mediated fungal recognition ‘preferentially’ induces IL-17–producing Th17 cells 
in both humans and mice. LeibundGut-Landmann et al. (2007) show that recognition of a fungal 
cell wall component by Dectin-1 is sufficient for adaptive immune activation and the induction of 
Th17 cell differentiation in mice. In a complementary study, Acosta-Rodriguez et al. (2007) show 
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that C. albicans–specific memory T cells in humans have a Th17 phenotype and a chemokine 
receptor expression pattern indicative of mucosal homing. It was found that the production of IL-12 
and IL-23 was dissociated during fungal recognition (Acosta-Rodriguez et al., 2007). C. albicans is 
dimorphic and switches between yeast and hyphal forms, both of which are required for 
pathogenicity. In an in vitro T helper cell priming assay, yeast induced more IL-12 than IL-23 and 
a strong Th1 response, whereas hyphae induced only IL-23 and a strong Th17 response. Yeast 
stimulates both Dectins and TLRs, whereas hyphae stimulate mainly Dectin-2 (Sato et al., 2006). 
Thus, C. albicans yeast and hyphae can be distinguished by pattern recognition and induce tailored 
adaptive responses (Figure 1.5).  
 
 
 
 
Figure 1.5. Dectins and TLRs induce distinct T helper cells in response to fungi. Adapted from Palm and 
Medzithov, 2007. 
 
 
 
Recently, MR was described as the main pathway through which live C. albicans induces 
the Th17 response in human primary cells.  
Other pathogens with multiple forms, either in response to environmental cues or as part of 
their life cycle, may also induce distinct T helper cell responses ‘tuned’ to elimination of the form 
that is detected. 
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1.6 Dendritic cell and discrimination of pathogenicity 
 
Recent evidence suggests that the use of distinct recognition receptors contributes to the 
disparate patterns of reactivity observed locally in response to challenge with C. albicans. These 
findings offer new interpretive clues to the mechanisms of fungal virulence: rather than 
dimorphism per se, the engagement of different recognition receptors on dendritic cells might 
select the mode of fungal internalization and antigen presentation, condition the nature of the Th 
response and, ultimately, favor saprophytism or infection. 
Incidence of fungal disease has been rising dramatically in the past several decades. 
Successful resolution of pathogenic fungal disease depends on proper coordination of multiple 
components of the host immune response. The innate immune system is crucial in forming the 
antifungal response, initiated with the processing and presentation of antigens by DCs. The balance 
between pro- and anti-inflammatory signalling is a prerequisite for successful host-fungal 
interactions (Richardson, 2005). Though much progress has been made in the study of the immune 
system under challenge from fungal pathogens, there remain numerous aspects of the tolerogenic 
response in fungi normally under control that are poorly understood. Understanding the 
mechanisms of cohabitation between humans and non-pathogenic fungi is a prerequisite for 
controlling fungal infections.  
The best studied fungal microorganism is Saccharomyces cerevisiae, an ubiquitous yeast 
used in the production of food, wines and beer (Cavalieri et al., 2003). For the past 5 millennia 
human societies have coevolved with the yeast S. cerevisiae, a common colonizer of mucosal 
surfaces and part of the normal flora (Salonen et al., 2000). In addition to C. albicans, several 
strains of the S. cerevisiae species have been isolated from immuno-compromised individuals, 
such as cystic fibrosis or AIDS patients (Munoz et al., 2005; Sethi and Mandell, 1998). These 
findings are not in conflict with the concept that S. cerevisiae is ‘generally recognized as safe’, but 
are rather in agreement with the idea that pathogenicity results from an alteration in the equilibrium 
between microorganisms and host.  
The decision on how to respond to a microorganisms, be it a pathogen or a commensal, is 
primarily determined by the interaction between microorganism and cells of the innate immune 
system. The importance of cell wall recognition in pathogenesis has been recently investigated in 
C. albicans. C-type lectins, such as Dectin-1, DC-SIGN and MR specifically mediate C. albicans 
binding and internalization by DCs (Hernanz-Falcón, et al., 2009; Newman and Holly, 2001; 
Cambi et al., 2008). Moreover, upon C. albicans stimulation, the direct recognition through the MR 
is sufficient for inducing a T helper (Th) 17 response in peripheral blood mononuclear cells 
(PBMC; van der Veerdonk et al., 2009). Mannan from this pathogen is the component capable to 
inducing IL-17 secretion. Interestingly, the dectin-1/TLR2 pathway synergizes with the MR-
induced IL-17 secretion, revealing an interaction between C-type lectin receptors and TLRs (van de 
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Veerdonk et al., 2009). The IL-17 production in response to C. albicans corresponded with the 
appearance of a subset of CD4 T cells that contained cells capable of producing IL-17 or both IFNγ 
and IL-17. 
The S. cerevisiae cell wall is almost exclusively composed by glycans. The interaction 
between the various Saccharomyces cell wall-associated structures with their counter-receptors, 
and the implications to DC function remain unknown. The only indirect evidence available 
indicates that C. albicans mannan (CA-mannan) but not S. cerevisiae-derived mannan (SC-
mannan) is able to induce IL-17 production (van der Veerdonk et al., 2009). The differential 
recognition of mannans from C. albicans and S. cerevisiae is mostly likely due to the different 
branching of these structures: while Candida (CA)-derived mannan has a highly branched 
structure, Saccharomyces (SC)-derived mannan mainly contains short linear chains of mannose 
polymers (Cambi et al., 2008). Thus, MR is able to coordinate different responses to fungal 
pathogens, particularly regarding the Th17 response.  
Dimorphic switch in Candida and germination of Aspergillus spores are two examples of 
the importance of different life stages in determining pathogenicity, possibly by exposing different 
cell wall components (d’Ostiani et al., 2000; Gantner et al., 2005). S. cerevisiae cell wall 
composition radically changes in different life stages and life forms, such as ascospores. Unlike C. 
albicans, S. cerevisiae life cycle alternates haploid and diploid state. Haploid cells mate and 
produce diploid cells. Diploid cells can divide by mitosis and grow and upon stressing conditions 
sporulate and undergo meiosis. Sporulation is a phenomenon that involved conformational changes 
in yeast cells and the final product is an ascus (that maintain the characteristic of the residual yeast 
cell wall) that encloses four spore (tetrad). The S. cerevisiae spores inside the ascus are 
characterized by a totally different cell wall composition with respect to cells. In particular, mature 
spore wall shows 4 distinct layers from innermost to outermost: a layer of mannoproteins (mannan 
layers), one of β-1,3 linked glucose residues (glucan layer), a chitosan layer (α−1,4 linked 
glucosammine residues) and a layer of spourios structure whose major constituent is cross-linked 
tyrosine dimers (dityrosine layer). Even if glucan content is higher than in yeast cell wall, in this 
one they are presumably more exposed. Mannans and glucans, the common fungal PAMPs mainly 
recognized by chitosan and dityrosine, undefined tyrosine dimers that represent the outermost layer 
of spore wall (Kreger-Van Rij, 1978; Figure 1.6).  
 
 
 
Figure 1.6. Schematic representation of components on cell and spore wall. 
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1.7 The complexity of immune system and System Biology approach 
 
Interest in the innate immune response, has exploded in recent years, leading to an 
increased understanding of its importance in protection against and susceptibility to a range of 
infectious agents, in addition to the discovery of the complex communication between the innate 
and adaptive immune systems. This heightened focus has enabled not only an increasingly detailed 
dissection of many of the key signalling pathways involved (Akira, 2006; Kanneganti et al., 2007; 
Thompson and Locarnini, 2007) but also the realization that the innate immune response is much 
more complex than previously imagined (Smith and Bolouri, 2005).  
Innate immunity has not to be thought as a set of discrete signalling pathways activated by 
a pathogen binding to a receptor; it is a complex network of interconnected pathways with 
activities dependent on many factors (Figure 1.7). It is now clear that single ligands can trigger 
multiple signal transduction pathways, although it is rare that a single stimulus would be involved 
in an infection.  
More commonly, multiple ligands simultaneously stimulate linear signalling pathways; 
rather it is comprised of a complex set of integrated responses arising from a dynamic network of 
thousands of molecules subject to a range of receptors, which in turn activate several signalling 
pathways (Brikos and O’Neill, 2008). These pathways often show cross-talk, complex feedback or 
feed-forward loops (Hu et al., 2008) and diverse mechanisms of regulation. Considerable overlap 
with adaptive immunity makes many of these resources relevant to both arms of the immune 
response. Downstream of the pathways, specific subsets of transcription factors (TFs) are activated 
to initiate the appropriate gene expression response to a given stimulus (Walhout, 2006).  
The immune response is also not simply a function of the host; the pathogen itself and 
regulated variations in its virulence along with complex interplay with the rest of the microbiome 
can all lead to variation in the innate immune response. Yet another layer of complexity is 
introduced when the cell-type and species specificity of the innate immune response are 
considered. Certain receptors and signalling pathways are only observed in specific cell-types, and 
there can be marked differences depending on the species.  
The innate immune response is executed at the molecular level by a complex series of 
signalling pathways. In this context, pathways may be defined as a network of directional 
interactions between the components of a cell, which orchestrate an appropriate shift in cellular 
activity in response to a specific biological input or event. 
A system as intricate as innate immunity necessitates the detailed level of investigation 
provided by systems biology approaches. 
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Figure 1.7. Traditional views of innate immune signalling fail to capture its full complexity. (a) 
Illustration of a canonical view of mammalian TLR4 signalling via NFkB, in which the process is 
represented as a simple linear pathway. (b) Demonstration that this simple pathway is under multiple levels 
of control using selected examples. (c) Illustrates a more accurate depiction of the complexity of the system. 
Adapted from Gardy et al., 2009. 
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1.7.1 System Biology 
Systems biology represents a powerful and comprehensive paradigm for biology that 
stands in contrast to the reductionist approach that has tended to dominate. In the reductionist 
approach, researchers attempted to understand a complex entity (e.g. a cell, an organ or a disease) 
by breaking it down into smaller, more tractable units for study, such as genes, complexes or 
pathways. 
The systems biology approach regards a system as more than the sum of its parts – its behavior 
arises not from simply the presence of its building blocks but through the complex relationships 
among them. Indeed, systems display what are termed emergent properties, which are behaviors 
made possible only through the interaction of a system’s components, and which cannot be 
predicted by looking at a single component alone. Understanding of a biological system, its 
components and its emergent properties benefits from harnessing as many data types as possible, 
including database of genes, proteins, RNAs, small molecules and cells and their interactions, 
which have come out of the ‘omics’ era (‘omics’ being a catch-all phrase describing high-
throughput approaches to analysing biological systems, including genomics, transcriptomics, 
proteomics, metabolomics and pharmacogenomics). These resources have permitted the 
development of new approaches, such as the use of genome-wide association studies to identify 
new susceptibility genes or the use of interaction data to identify more accurate biomarkers for 
disease progression or outcome. 
 
1.7.2 Microarrays and transcriptional profiling  
Since its first inception in 1995 (Schena et al., 1995), microarray use has increased 
dramatically over the years. A microarray is a made up by a solid surface (which can be a glass 
slide, a nylon membrane, or a silicon chip) on which thousands of DNA molecules are immobilized 
(‘spotted’) in an orderly pattern of rows and columns. Each of these molecules (named ‘probes’) 
represents a single gene. The surface with its associated probes is then hybridised with free nucleic 
acids (‘targets’, usually RNA) extracted from the sample of interest (for example a tumor tissue or 
a cell line) and labeled with a fluorescent dye. The target will bind with its complementary probe, 
and after washing under stringent conditions (to remove non specific binding) the surface is 
scanned using a confocal laser scanner and the fluorescent signals are quantified by specific 
analysis software. Every probe will have an associated expression value, making possible for a 
researcher to study the expression profile of thousands of genes at once.  
The probes used in microarray experiments can be of different nature. A rather common 
approach is to use cDNA molecules, from 0.6 Kb to 2.4 Kb, containing the genes of interest and 
produced by PCR, which are then spotted on the array. A second approach made possible by 
technological advances is to use single-stranded oligonucleotides, with lengths ranging from 20 to 
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100 bases. Oligo-probes are designed on the basis of their thermodynamic properties and their 
hybridization specificity, and offer advantages over the use of cDNA probes, such as higher 
specificity and the fact that sequence information is the only requirement to generate them.  
A number of microarray platforms exist, which differ by the way the probes are spotted on 
the surface. Array experiments can be designed using two different approaches, namely two-color 
and single-color. The two-color approach is the most common for spotted arrays, and enables the 
direct comparisons of two samples (e.g., two sample conditions) on a single array. RNA from the 
sample and its reference are labeled with two distinct fluorophores (usually cyanin-3 and cyanin-5, 
respectively) and then during scanning the fluorescence of both dyes is assessed separately. Then 
the measurements of the two fluorescent intensities are used to determine the Cy3/Cy5 ratio, often 
expressed in logarithmic form (log2 ratio). This is used to assess the relative expression of the 
sample with respect to the reference. The single-color approach is used almost exclusively on 
oligonucleotide arrays from Affymetrix and Illumina. After hybridization and scanning, the 
intensity of each probe represents the absolute expression level for its corresponding gene. In order 
to make comparisons between expression levels, multiple arrays with different samples need to be 
prepared.  
A typical microarray profiling experiment usually involves either the comparison of a 
specific sample condition with a known reference (e.g., disease state against healthy) or how the 
gene expression profile changes over a series of time points (time-course experiment). As the 
number of genes screened is very high, careful consideration must be put into the design of 
experiment in order to minimize false positives and false negatives.  
Due to the ability to assess expression levels of a very large number of genes simultaneously, 
microarrays have become a very attractive platform to study complex phenotypes, be they either 
physiological or pathological. 
 
1.7.2.1 Microarray data analysis  
Data analysis is a key factor for a microarray experiment. The number of genes on a 
microarray is painstakingly large, therefore techniques must be employed to discard data that has 
no relevance to the experimental design and to assist the interpretation of the results, in order to 
obtain biologically relevant information. As the technology improves and the resolution increases, 
the number of problems associated with data analysis increase as well, prompting the creation of 
new techniques or improvements of the existing ones.  
Nevertheless, the analysis procedure in gene expression is more or less standardized and is 
conducted in several steps (Figure 1.8)  
Analysis of a microarray experiment is a key element in obtaining reproducible data with a 
biological correspondence (see Verducci et al., 2006 for an overview of the challenges in data 
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analysis). It has been demonstrated that the analysis method can have a significant influence on the 
results (Allison et al., 2006), therefore a careful design of the analysis workflow is recommended. 
For example, signal quantification methods can influence the identification of weakly expressed 
(i.e., with low signal) transcripts (Irizarry et al., 2003). A poorly designed analysis method can lead 
to inconsistent or not reproducible results.  
 
                                                    
 
Figure 1.8: A typical analysis workflow for a microarray experiment. Adapted from Verducci et al., 
2006. 
 
1.7.2.2 Limitations of current approaches  
Although the application of the microarray technology to the study of different biological 
process generated a large interest in the scientific community, most of the studies did not account 
adequately for the limitations of the platform (large number of genes evaluated, small number of 
samples) and especially of the analysis methods. Allison et al. (2006) have discussed the impact of 
microarray data analysis on the results. They pointed out that although some consensus has 
emerged in many areas, there are still some key questions that need to be answered regarding many 
steps of the analysis process. Among the issues still at hand, there are some related to the data 
validation and the need for a thorough evaluation of data analysis techniques. The choice and 
validation of the analysis method is especially important when published findings are compared by 
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independent researchers on other data sets, as a wrong choice of method may cause inconsistent 
results.  
Usually the most common problem encountered when comparing different array data is the 
issue of poor overlaps, that is when lists of genes published in one study have little or no genes in 
common with other studies. Sample size is also a source of potential problems when evaluating 
predictors. When a number of candidate genes is too large when compared to the number of 
samples the statistical methods will suffer from overfitting, that is the prediction model will fit too 
tightly to the data it was derived from (training set) and therefore its accuracy will be sub-optimal 
when applied to independent data sets.  
 
1.7.3 Pathway analysis and System Biology approach 
Since their first inception a decade ago, microarray studies have become widely used in the 
research community, thanks to theirability to assess the expression of thousands of genes in a 
single laboratory event. The belief that such wealth of genomic information the community could 
not afford to lose has led to the development of microarray standards (Brazma et al., 2001; Ball et 
al., 2002) and databases including two major public microarray repositories, Gene Expression 
Omnibus (GEO; Edgar et al., 2002) and ArrayExpress (AE, Brazma et al., 2003), in the hope of 
enabling mining and exploration of newly acquired data space. 
Identifying biologically meaningful information in relatively noisy data represents a 
significant tasks and so far breakthrough have been few and far between. Comparisons made on the 
level of gene lists obtained by different statistical methods or from different datasets hardly 
converge (Ein-Dor et al., 2005). As a consequence, the usefulness of the vast amounts of data 
stored in public repositories is subject to debate. At the same time, it is becoming important to use 
more than a single data set when analyzing microarray data (Xu et al., 2008) and gather hundreds 
or thousands of samples to develop prognostic markers (Ein-Dor et al., 2006). Reaching such a 
goal is difficult when information obtained from different experiments do not overlap. This is 
mainly because the data often has been generated with different microarray platforms, 
hybridization protocols, and the authors use different methods and different thresholds to calculate 
differentially expressed genes (DEGs; Allison et al., 2006). Finding ways to reliably compare 
different microarray data sets is therefore important to obtain biologically sound and reproducible 
information from different datasets. 
In the past years collections of all the differentially expressed genes in a given condition 
that exclusively characterize that condition, have been proposed as ‘‘gene signatures’’ for a 
condition (Van’t Veer et al., 2002; Rosenwald et al., 2002; Yu et al., 2007). However, the 
reliability and reproducibility of such signatures has been questioned (Ranshoff, 2004; Simon et al., 
2003), because of the influence of the statistical assumptions used, or errors in the methodology. 
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The number of inconsistencies and discrepancies when microarray data sets are compared 
are often reduced when approaches that take into account biologically related sets of genes, rather 
than single entities, are used (Manoli et al., 2006). The first methods developed with this approach 
aimed at identifying significantly under- or overrepresented terms in the Gene Ontology (Khatri et 
al., 2002). A second approach instead focuses in identifying significantly expressed gene sets 
(sometimes incorrectly referred as pathways or cellular networks) in a given condition using 
different statistical measurements: (1) Z-score (Doniger et al., 2003), (2) Gene Set Enrichment 
Analysis Subramanian et al., 2005), (3) signed Fisher Exact Test (Grosu et al., 2002), (4) Global 
test (Goeman et al., 2003) and (5) impact analysis (Draghici et al., 2007). 
Recently Cavalieri’s group in Florence developed a bioinformatic environment called 
Eu.Gene (Cavalieri et al., 2007) containing a repository of all the freely available biological 
pathways and different statistical methods dedicated to analyze expression datasets and assess for 
enrichment in biological pathways. Eu.Gene relies on 2 components, (1) a database of consistently 
annotated pathways collected from a number of state of the art pathway resources and (2) a module 
of computation implementing an array of tailored heuristics and statistical methods. 
We developed a method allowing to assess similarity of samples in microarray databases. To this 
aim we used Eu.Gene to generate ‘Pathway Signatures’, recapitulating the biologically meaningful 
pathways related to some clinical/biological variable of interest, and used them in an analysis 
workflow to compare different microarray experiments. 
 
1.7.4 Pathway and immune response 
Research has made great strides towards of the goal of understanding biological processes. 
However, despite the recent advancements, dissecting precisely the sequence of causal and 
temporal effects is still a daunting task. High throughput technology such as microarrays or 
massive sequencing has in part exposed the problem more, as the vast amounts of data generated 
need to be fit in the biological landscape.  
One of the ways that can be used to simplify the interpretation of said data is to associate 
them with a biological function or process, using the Gene Ontology (GO; Ashburner et al., 2000) 
or using biological pathways. For such an approach to work, the definition of what constitutes a 
pathway, be it a metabolic pathway or a signalling network, is essential. Unfortunately, the 
knowledge available on the most known pathway databases, KEGG and Reactome suffers from a 
series of problems that limit its usefulness.  
Traditionally, representation of molecular pathways have been produced ad hoc and 
frequently included in reviews and original papers. Whilst they are clearly useful aids to understand 
biological cellular events, they are not sufficient by themselves, relying on extensive textual 
descriptions to explain what is shown pictorially. Recent years have seen considerable growth in 
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the availability of public and commercial databases offering searchable access to pathways and 
interaction derived from a combination of manual and automated (text mining) extraction of 
primary literature, reviews and large-scale molecular interaction studies. Using these tools it is 
possible to view a range of canonical pathway views of generate networks of interactions based on 
a given query.  
To date, many studies have focused on either protein–protein networks or gene regulatory 
networks and these two types of networks are rarely combined into a single comprehensive view.  
All of these efforts are let down by one or a number or key factors. The notation used in 
diagrams to depict one molecule’s interaction with another is varied, often ambiguos and therefore 
limited in its ability to depict the exact nature of the relantionship between components of a 
pathway. There is often a lack of direct access to the experimental evidence relating to the 
interactions depicted or to a dataset as a whole. Similarly, labelling of the pathway components 
often uses non-standard nomenclature or mixes protein names form one species with that of 
another, such that again the reader is left uncertain as to what exactly is being shown. Finally, 
pathway diagrams usually focus only on a small part of biological sytem and one which often 
reflects the curatr’s bias, such that the ‘same’ pathway described by different individuals may share 
little in common.  
Whatever the source of these pathways and networks they generally suffer from 
graphically poor representation with ambiguity around the precise identity of what is being shown 
and the exact nature of their interaction. In order to address these issue different initiative started to 
define pathway notation and representation, from MIM (Molecular Interaction Map) notation 
(Kohn et al., 2006) to PDN (Process Description Notation, Kitano et al., 2005). The Edinburgh 
pathway notation (EPN, Moodie et al., 2006) uses a logical state-transition representation to 
describe biological pathways, similar to PDN. Recently, an initiative aimed to describe the 
signalling pathway important to macrophage activation (Raza et al., 2008) taking into account 
either the EPN notation either the developing international SBGN standard (System Biology 
Graphical Notation; Le Novére et al., 2009). The notation provides a logical context for 
interactions between components in the pathway; it can display the temporal order of reactions and 
can be mapped to the machine-readable SBML (System Biology Markup Language; Hucka et al., 
2003). This scheme and the SBGN desire to develop pathways map ‘readable’ by a biologist. 
While the attempt to represent events in a detailed, accurate and logical fashion, the interpretation 
of the available literature useful for the reconstraction of the individual events is a unavoidably 
flawed process. Determining what constitutes good evidence for an interaction and what does not, 
is often difficult to judge for those who is not an expertise in the field. 
 A possible solution lies in the expert curation of pathways specific for the biological 
system that is being studied. As part of this effort, we recently proposed the DC-ATLAS initiative 
(Cavalieri et al., submitted) as a curated, highly specific pathway database for the DCs. 
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The thousand pink flowers of peach blossom bloom in spring. But its color is One.  
Keizan Zenji 
 
 
 
Aim of the study 
 
The sequence of the dark side of the genome, the metagenome is now revealing the 
centrality for human health of an harmonious interaction between the organismal functions and the 
activity of the microorganisms colonizing our body. 
We propose that the best characterized bakers yeast Saccharomyces cerevisiae can play a 
fundamental role in unraveling the rules of the interaction between the genome and the meta 
genome. 
This work focused on the use of S. cerevisiae to understand the mechanism governing a 
fruitful interaction between microbes and the human system by dissecting the dendritic cell 
immune response to foodborne yeast and pathogenic fungi. 
We pursued different strategies to understand the mechanisms of fungal recognition: 
• By using the existing expression profiling, to allow integration between ‘–omics’ data, we 
developed an algorithm to assign ‘pathway signatures’ to different dataset making them 
comparable.  
• To understand the temporal signalling and the single pattern recognition receptor contribution 
to fungi recognition we contributed to the reconstruction of DC signalling pathways in the 
initiative DC-ATLAS. 
• In order to dissect the signalling due to the single fungal cell wall recognition with respect to 
the complexity represented by the entire yeast we performed a traditional expression profiling 
analysis to identify the differentially expressed genes, their function and the pathway 
signatures associated to the single signal.  
• By integrating microarray data with functional data we investigated the immune response of 
DCs to harmless and opportunistic pathogenic fungi, comparing S. cerevisiae cells, spores and 
C. albicans hyphae. 
This work had two main goals: first, the implementation of an analytical approach that 
would facilitate the interpretation of the ‘-omics’ results and increase the comparability between 
different data sets, lessening the problems associated with the use of different types of data and 
array platforms; and the development of new pathway structure to allow temporal dissection of the 
immune response associated to the pattern recognition receptor sensing; secondly, by integration of 
different results, to investigate the immune response that discriminates between friends or foes.
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The important thing is not to stop questioning  
Albert Einstein 
 
 
 
 
 
2 
Experimental Procedures 
 
 
2.1 Yeast culture and preparation 
 
2.1.1 Saccharomyces cerevisiae cell stimuli 
Saccharomyces cerevisiae strain SK1 (MATa/α HO gal2 cupS can1R BIO, Kane SM and 
Roth J. 1974 Bacteriol. 118: 8-14) was cultured in complete medium (YPD, 2% yeast extract, 1% 
peptone, 2% glucose) for 18 hours, then collected, washed twice with sterile water and resuspended 
at 108 cells/ml.  
S. cerevisiae strains BY4741 (genotype, Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) and 
BY4741 och1 (Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 OCH1::kanMX4) were cultured in complete 
medium till exponentially phase and treated as before. 
 
2.1.2 Spore stimuli 
In order to test homogeneous yeast populations, pure spore cultures were obtained by using 
this strain whose sporulation efficiency is 100%. To prepare spores, cells were grown on YPD 
plates, replicated on SPOIV medium (2% potassium acetate, 0.25% yeast extract, 0,1% glucose) 
and sporulation was assessed by optical microscopy. Zymolyase (2 mg/ml) was used to digest 
ascum and liberate spores. We initially performed experiments to evaluate zymoliase sensitivity of 
asci for this specific strain and we assessed that 15 minutes incubation was the minimum time 
needed to damage the ascus, without touching the spore cell wall. Zymoliase was inactivated by 
heat (65°C for 2 minutes) and washed away carefully together with the remainings of the empty 
ascus, by resuspending twice the spore culture in 500 µl of distilled water centrifuging and 
discarding the supernatant; the spores were then resuspended to a concentration of 108 cells/ml. In 
order to exclude damage on the spore cell wall or effects on spore viability 100 µl of a culture of 
1000 spores per ml was plated on YPD in triplicate, the spores showed 100% viability. The 
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procedure used allows exposing DCs to the pure spore culture and to analyze the response to the 
spores alone, eliminating confounding effects of the presence of the ascus. Although from a 
mycological point of view the term ascospores might seem more appropriate than spores, we will 
use the term spores to specifically indicate that the effects we are observing are only due to the 
spores and not to the ascus.  
We observed that after 24 hours of culture in RPMI 1640 (GIBCO-BRL), spores were 
germinating and the exponentially growing cells were starting to divide. Therefore any analyses 
performed at later time points would be affected by this altered state, while no interference should 
be present until 24 hours.  
 
2.1.3 Candida albicans hyphae stimuli 
Serotype A C. albicans strain SC5314 was cultured overnight in Saboraud medium at 28°C 
and then shifted to RPMI medium for 18 hours at 37°C to allow hyphal growth. The culture was 
treated as for yeast cells. After microscopical inspection of the purity of hyphal culture, this was 
treated as for yeast cells. It should be noted that in all the experiments performed in this study live 
microrganisms were used. 
 
 
2.2 Microrganism survival following uptake by DCs 
After 6 hour of stimulation, DCs were collected, washed 3 times with PBS, treated with zymolyase, 
washed twice and cells, lysated with a hypotonic solution (KCl 0.05%), were plated on YPD. 
Survival of yeast cells, spores or hyphae after uptake was reported as percentage of colony forming 
units after 3 days relative to the total number of cells growing in the absence of DCs exposure. To 
assess the importance of ROS production in DC killing ability, DPI (10 µM) was added 30 minutes 
before stimulation and survival of microorganisms was assessed using the same method. When 
evaluating survival after exposure, the possible effect of DMSO and DPI on the stimuli was taken 
into account. 
 
 
2.3 Dendritic cell preparation and stimulation 
 
2.3.1 Monocyte isolation 
Peripheral Blood Mononucleated Cells (PBMCs) were isolated from buffy coat blood 
sample from healthy volunteers by Ficoll-Hypaque density gradient centrifugation (Biochrom AG). 
Monocytes were isolated from low density PBMCs by magnetic enrichment with anti-CD14 beads 
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(Miltenyi Biotec). MACS® Technology took place within MACS Columns. When a MACS 
Column is placed in a MACS Separator, a strong permanent magnet, a high-gradient magnetic field 
is induced on the column matrix. Unlabeled cells passed through and they were collected; labeled 
cells were released after removal of the column from the magnet. For isolation of monocytes, a 
positive selection was used. Positive selection means that the desired target cells are magnetically 
labeled and isolated as the magnetically retained cell fraction. Both fractions, labeled and 
unlabeled, were recovered and used.  
 
2.3.2 Dendritic cell differentiation 
After isolation, monocytes were cultured in RPMI 1640 (GIBCO-BRL) supplemented with 
glutamine (Sigma), penicillin and streptomycin (GIBCO-BRL), and 10% heat-inactivated fetal calf 
serum (Hyclone) in the presence of GM-CSF (800 U/ml, Gentaur) and recombinant IL-4 (1000 
U/ml, Gentaur) for 6 days to allow DC differentiation (Sallusto e Lanzavecchia, 1994). 
 
2.3.3 Dendritic cell stimulation  
DC activation was induced by yeast in the different life stages. The control stimuli used 
were lipopolysaccharide (LPS 1 µg/ml), Curdlan (100 µg/ml), Zymosan (100 µg/ml, Sigma-
Aldrich). Depending on the experiments, moDCs were added at different concentrations. Serial 
dilution of yeast preparations was added to the moDCs at different stimuli:DC ratios. 
 
2.4 Isolation and priming of T cells 
 
2.4.1 CD4+ purification  
Total CD4+ T cells were obtained from PBMC by negative isolation with a combination of 
magnetic sorting (Miltenyi Biotec). Untouched isolation was performed by depletion of undesired 
cells. Non-target cells were magnetically labeled and eliminated from the cell mixture. The non-
magnetic, untouched cell fraction contained the target cells.  
 
2.4.2 CD4+ T cell priming 
moDCs were stimulated for 12 hours with spores/yeast, washed and plated with autologous CD4+ T 
cells at a ratio of 1:20. For RT-PCR cells were collected after 24, 48 and 72 hours or 5 days of co-
culture. Supernatants were collected after 5 days of co-culture for cytokine detection. 
 
        
2. Experimental procedures 
 
32 
2.5 Cytokine production 
After the times indicated, supernatants were collected and cytokine detection was 
performed. MesoScale Assay 7-spot (Meso Scale Discovery) or Luminex® Assay (Invitrogen) 
were used for detection of IL-1β, IL-8, IL-6, TNFα, IL-10, IL-12p70, IFNγ and IL-17A according 
to the manufacturer’s instructions.  
These procedures allowed simultaneously measurement of different cytokines in the same 
supernatants. The multiplex assay format differs from conventional ELISA in one significant way: 
the multiplex capture antibody is attached to a polystyrene bead whereas the ELISA capture 
antibody is attached to the microplate well. The use of the suspension bead-based technology 
enables multiplexing. Microspheres are internally dyed with red and infrared fluorophores of 
differing intensities. Each bead is given a unique number, or bead region, allowing differentiation 
of one bead from another. Beads covalently bound to different antibodies can be mixed in the same 
assay, utilizing a 96-well microplate format. 
At the completion of the sandwich immunoassay, beads were read, using the Bioplex® 
200™ detection system, in single-file by dual lasers for classification and quantification of each 
analyte.  
Alternatively, ELISA assay was performed according to the manufacturer’s instructions. 
ELISA kits were from Biosource rather than ELISA for IL-12p70 that was from R&D System and 
IL-17 from e-Bioscience. 
In blocking experiment, after 2 hors of exposure with the inhibitor, supernatants were 
collected after 8 or 24 hours or for T cell cytokine detection, 5 days of incubation. 
 
2.6 Quantitative real time polimerase chain reaction (PCR)  
Total RNA was extracted with the Rneasy Mini Kit (Qiagen). Random hexamer and 
reverse transcriptase kit (SuperScript II, Invitrogen) were used for cDNA synthesis. Quantitative 
real-time PCR for FOXP3 gene expression was performed using primer pairs and SYBR Green 
PCR Master Mix (Applied Biosystem). Transcripts for IL-6, IL-17A, and IFNγ were quantified with 
Applied Biosystems predesigned TaqMan Gene Expression Assays and reagents according to the 
manufacturer’s instructions. Quantification of the PCR signals was performed by comparing the 
cycle threshold (Ct) value of the gene of interest with the Ct value of the reference gene GAPDH. 
Values are expressed as fold increase of mRNA relative to that in unstimulated cells. 
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2.7 IL-12p70 blocking assay 
 
2.7.1 IL-12p70 inhibition by cytochalasin D 
DCs were exposed to cytochalasin D (10 µg/ml, TebuBio) for 30 minutes at 4°C. After 
washing with cold PBS, DCs were stimulated with S. cerevisiae yeast cells or spores at a 
DC:stimuli ratio of 4:1 for 24 hours. IL-12p70 production was assessed by ELISA. 
 
2.7.2 IL-12p70 blocking assay 
In order to assess the importance of IL-12p70 in balancing Th1/Th17 response two different 
experiments were performed. 
In one case, DCs were stimulated for 8 hours with live spores of S. cerevisiae and C. 
albicans hyphae at a stimuli:DC ratio of 4:1 in the presence of different concentration of human 
recombinant IL12p70 (0, 1, 10 and 100 ng/ml). 
In the second experiment, DCs were pre-incubated with different concentrations (0, 0.1, 1, 
10, 100 µg/ml) of a monoclonal anti-human IL-12 antibody for 2 hours, then stimulated for 8 hours 
with live S. cerevisiae cells in a stimuli:DC ratio of 4:1.  
The ability of these stimulated DCs to drive CD4+ T cells polarization towards a Th1 
response was assessed by measuring of IFNγ and IL-17 in T cells 5-day culture supernatants. 
 
 
2.8 ROS production 
To determine ROS production we used the modified version by Choi et al. (2006) of the 
microscopic Nitroblue tetrazolium (NBT, Sigma-Aldrich) assay. Briefly, DCs were stimulated with 
spores or yeasts, washed, supplemented with 0.1 mg/ml of NBT, which allows the precipitation of 
formazan particles in presence of ROS. Blue formazan particles were dissolved using 2M KOH and 
DMSO and its absorbance was measured using a microplate reader at 620 nm. The absorbance of 
dissolved NBT increased in proportion to cell number, incubation time, and stimulus concentration. 
 
 
2.9 Internalization assay 
 
2.9.1 Phagocytosis assay 
Yeasts/spores were biotinylated using 10 mg/ml sulfo-NHS-LC-biotin (Sigma-Aldrich) in 
50 mM NaHCO3 pH 8.5 for 2 hours at 4°C. The remaining reactive biotin molecules were 
inactivated by incubation in 100 mM Tris-HCl pH 8.0 for 40 minutes at 4°C. DCs were then 
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treated with biotinylated spores/yeasts. After 1 hour, cells were permeabilized and labeled with 
aHLA-DR-FITC. After zymolyase treatment, intracellular yeasts/spores were detected using APC-
labeled streptavidin and analyzed by flow cytometry. 
 
2.9.2 Receptor mediated-internalization assay 
Immature DCs were allowed to adhere onto fibronectin and subsequently incubated with 
FITC-labeled yeast or spores for 5, 15, 30 minutes at 37°C. At the end of the incubation period, the 
samples were fixed in 4% PFA, permeabilized in Methanol, and labeled for DC-SIGN and/or MR 
using specific mAb and isotype-specific fluorescent secondary Abs. Samples were analyzed using a 
Zeiss LSM 510 confocal microscope. Alexa647-conjugated goat-anti-mouse IgG, and Alexa568 
goat-anti-mouse IgG2b were from Molecular Probes.  
 
 
2.10 Receptor involvement assay 
 
2.10.1 Competition assay  
DCs were exposed to laminarin (500 µg/ml, Sigma-Aldrich), mannan (500 µg/ml, Sigma-
Aldrich) and chitin (500 µg/ml, Sigma-Aldrich) for 30 minutes at 37°C. After washing with PBS, 
DCs were exposed to yeast cells or spores at a concentration of 4:1 for 6 hours. Inhibition ability of 
TNFα production was assessed by ELISA. 
 
2.10.2 Binding assay 
Labeling of S. cerevisiae cells or spores was performed as previoulsy described (Cambi et 
al., 2003). The binding of DCs or CHO-DC-SIGN to S. cerevisiae yeast cells or spores was 
measured by flow cytometry using the FACS Calibur (BD Biosciences) and performed as already 
described. To test the effects of various reagents on ligand binding the following concentrations 
were used: different carbohydrates 150 µg/ml, mannose (100 µM), Isotype control, AZN-D1, 
AZN-D2, AZN-D3 anti-DC-SIGN, anti-MMR, and anti-β2-integrin (30 µg/ml), EGTA and EDTA 
2 mM. Incubation was performed in 20 mM Tris, pH 8.0, 150 mM NaCl, 1 mM CaCl2, 2 mM 
MgCl2 and 1% bovine serum albumin. FITC-labeled yeast cells or spores were added in a 
stimuli:DC ratio of 10:1. After 30 minutes of incubation at 37°C, cell-S. cerevisiae conjugates were 
analyzed by flow cytometry., DCs were labeled with anti-CD45-APC and CHO-DC-SIGN with 
PKH26 (Sigma-Aldrich) to discriminate cells binding FITC-labeled yeast/spores particles from 
yeast/spores aggregates.  
Mannan derived from C. albicans (CA-mannan) and glucan were a kind gift of Prof. David 
Williams and were previously isolated (Chorvatovicová et al., 1999; Lowman et al., 2003). The 
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following Abs were used: mAb AZN-D1, AZN-D2 and AZN-D3 anti-DC-SIGN (Geijtenbeek et 
al., 2000), NKI-L19, anti-b2-integrins. mAb anti-MMR and mAb DCN46 anti-DC-SIGN from BD 
Pharmingen, APC-conjugated mAb anti-CD45RO from Becton Dickinson. Alexa647-conjugated 
goat-anti-mouse IgG, and Alexa568 goat-anti-mouse IgG2b were from Molecular Probes.  
 
 
2.11 In vivo survival assay 
To evaluate spores survival during gastrointestinal transit, one-month old rats were fed for 
4 weeks on a daily basis with water containing 1X107 yeast SK1 spores (n=3) or cells (n=3). A 
group of rats (n=3) was fed with water containing any stimuli as control. From 1 to 4 weeks, faecal 
samples were collected and after serial dilution were plated on YPD medium with chloramphenicol 
(100 ng/ml, Sigma-Aldrich) to allow growth of CFU. After three days, CFU were counted. 
Survival of spores was referred to the number of CFU grown after 3 days.  
 
 
2.12 DC transcriptional analysis 
 
2.12.1 Hybridization protocol 
To obtain the experiments useful for the development of the algorithm, 3X106 DCs 
were either not stimulated or stimulated with yeast grown in exponential phase. Cells were 
harvested after 4 hours of stimulation. RNA extraction was done with TRIzol reagent 
(Invitrogen). Sample pre-processing and biotin labeling were performed using the Affymetrix 
GeneChipH cDNA Synthesis Kit and IVT Labeling Kit (Affymetrix) according to the 
manufacturer’s protocols. Microarray were then hybridized on Affymetrix GeneChipH HG-
U133A 2.0 microarrays, and scanned according to the manufacturer’s instructions on a 
GeneChipH Scanner 3000 (Affymetrix). Extraction, hybridization and scanning were 
performed by the Genopolis consortium (University of Milano-Bicocca, Italy). Microarray 
data have been submitted to GEO (accession number GSE13901). 
To obtain a detailed picture of DC maturation process after yeast and spores 
internalization, 2x106 DCs were cultivated with cells of S. cerevisiae cells, spores, hyphae of C. 
albicans or without any stimuli in a ratio of 4:1. After 4 hours, cells were collected. RNA 
preparation, labeling, hybridization on a HT12 array (Illumina), and scanning were performed 
according to Illumina instructions by Genomics Lab, Wellcome Trust Centre for Human Genetics 
(Univeristy of Oxford). Microarray data have been submitted to Array Express (accession number 
E-MTAB-135). To unravel the specific contribution of cell wall components on fungi recognition, 
2x106 DCs were cultivated with S. cerevisiae cells, spores in a ratio of 4:1 or mannan, curdlan and 
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zymosan (100 µg/ml) or without any stimuli. After 4 hours, cells were collected. RNA preparation, 
labeling, hybridization on a HT12 array (Illumina), and scanning were performed according to the 
Illumina reference protocols by Genomics Lab, Wellcome Trust Centre for Human Genetics 
(Univeristy of Oxford).  The analysis was performed on four different donors. 
 
2.12.2 Array pre-processing 
Affymetrix array data files (CEL files) were pre-processed and normalized using the 
Robust Multichip Average procedure (RMA). Annotations were updated following a procedure 
devised by Dai and co-workers (Dai et al., 2005). Computation was performed with the 
RMAExpress program (http://rmaexpress.bmbolstad.com)  
Bead-summary data saved from Illumina BeadStudio was pre-processed in several steps. 
Firstly, the background signal was assessed and corrected using the intensity signal from the 
control probes present on the array, then quantile normalization was performed. In addition to 
background correction, Illumina probe identifiers were converted to nucleotide universal 
IDentifiers (nuIDs) (Du et al., 2007) specific for the nucleotide sequence of each probe. The 
computation was performed using the lumi package (Du et al., 2008), written in the R 
programming language. 
 
2.12.3 Differential expression and annotation 
Differential expression analysis was carried out using the Rank Product algorithm (Hong et 
al., 2006), taking into account the differences between donors. p-values estimating differential 
expression were corrected for multiple testing (FDR) and genes with a corrected p-value <= 0.05 
were selected. 
Differentially expressed gene lists from the various data sets were uploaded in the Database 
for Annotation, Visualization and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov)) to 
perform functional annotation. The up-regulated and down-regulated gene lists were annotated 
separately.  
 
2.12.4 Pathway analysis 
Pathway analysis was performed with Eu.Gene (Cavalieri et al., 2005), over a set of 80 
pathways selected by the DC-THERA consortium or the new pathway set DC-ATLAS, developed 
during this period and collecting several manullay curated DC-specific pathway (see dedicated 
section).  
Eu.Gene identifies biological pathways, which are enriched in up-regulated or down-
regulated genes (therefore determining if the pathways themselves are up or down-regulated) using 
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a statistical method, the Fisher’s Exact Test (FET; Grosu et al., 2002). Also, it provides two 
measures to assess if a pathway is significantly deregulated:  
 
-  a p-value (result of the statistical analysis)  
-  the ‘Coverage’ parameter. The latter is defined as the number of genes in the data set present 
in the pathway versus the total genes of the pathway.  
 
Pathways with a low coverage may be false positives, because despite being significant, the 
number of genes represented in the pathway itself is little.  
 
2.12.4.1 Fisher Exact Test 
Prior to analysis, the transcriptional data was converted into log2 ratios using the following 
procedure. For each data set, treated and untreated sample data were separated, and the expression 
level of each gene in each treated sample was divided by the expression level of the same gene in 
the corresponding paired untreated sample, and the resulting ratio was log2 transformed, obtaining 
a list of log2 ratios for each gene in each treated sample. The transformed expression data were 
then used for Fisher’s Exact Test (FET). Then, in an effort to reduce inter donor variability, the 
mean of the ratios for all replicates in a specific condition was calculated. The resulting ratios were 
used to perform pathway analysis using the FET.  
The upper and lower cut-offs for FET were determined from the 2s interval of the binomial 
distribution of expression values (Segota et al., 2008). The algorithm was then run using the 
hypergeometric distribution without approximation. Each pathway was associated to a signed p-
value and a matrix of signed p-values for all samples was obtained for each data set. In order to 
provide a correction for multiple testing, p-values were adjusted following the procedure by 
Benjamini et al. (2001). Resulting p-values from the FET analysis were then transformed prior to 
clustering (see below). 
 
2.12.4.2 p-value transformation (FET) 
The FET p-value tables from Eu.Gene were transformed in order to be used for hierarchical 
clustering. Two approaches were used: 
 
- Pathway Enrichment Factor (PEF): p-values were transformed into PEF as follows: 
±log2(1/pvalue) 
where the sign is determined by the Sign of the p-value obtained from the FET analysis in 
Eu.Gene. 
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- signed Binary Enrichment Factors (sBEFs): p-value were transformed in sBEF as: 
±1 if p-value ≤ 0.05 depending on Sign 
0 if p-value < 0 or Sign is not defined   
In the case of sBEFs, after transformation they were filtered to exclude non-significant 
pathways in all the samples (i.e., rows containing only zeroes in all samples). 
 
2.12.4.3 Clustering 
Hierarchical clustering was performed with the TIGR Multiexperiment Viewer (TMeV), 
version 4.1.1 (Saeed et al., 2003). Specifically, we used standard hierarchical clustering and 
clustering with support trees: in the latter case pathways and samples were bootstrapped over 100 
and 1000 iterations. Euclidean distance was used as distance metrics, with average linkage 
clustering.  
 
 
2.13 Statistics 
Student's t-test was used to evaluate the statistical significance of the results, by 
comparison between spores and yeast or between control and blocking condition. Results were 
classified as non significant (p > 0.05), significant (p < 0.05) and highly significant (p < 0.01).
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 3 
1 
Not all who wander are lost 
J.R.R. Tolkien 
 
 
 
 
 
3 
Pathway signatures generation 
 
 
3.1 Background 
Since their first inception a decade ago, microarray studies have become widely used in the 
research community, thanks to their ability to assess the expression of thousands of genes in a 
single laboratory event. 
The number of inconsistencies and discrepancies when microarray data sets are compared are often 
reduced when approaches that take into account biologically related sets of genes, rather than 
single entities, are used (Manoli et al., 2006). 
We developed a method allowing to assess similarity of samples in microarray databases. To this 
aim we used Eu.Gene to generate ‘Pathway Signatures’, recapitulating the biologically meaningful 
pathways related to some clinical/biological variable of interest, and used them in an analysis 
workflow to compare different microarray experiments. 
 
3.2 Data set selection 
In particular, we decided to use as reference experiments a data sets composed of 106 
experiments (grouped in 7 sets) focused on the exposure of Homo sapiens dendritic cells (DCs) to 
different stimuli (Table 3.1). 
Following up the data set collection, data were pre-processed and subject to pathway 
analysis (see Methods). Then, we formulated a prediction basing on biological evidence against 
which the method would be tested. We performed a wet lab experiments stimulating DCs with cells 
of the yeast Saccharomyces cerevisiae in exponential growth phase (analyzed in the same manner 
as the public data) and we predicted that this experiment would show similarity with the samples 
from GEO data set GSE6965 (gene expression profile of monocyte-derived DCs stimulated for 6 
hours with germinating germ tubes of Aspergillus fumigatus). 
Isolation of human monocytes and differentiation on dendritic cells (DC) were performed
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 as described in the Experimental procedures section.  
 
 
Table 3.1. Data set summary. Dendritic cells data sets obtained from GEO 
 
GEO ID Description Type Sample no. Reference Year 
GSE8658 
PPARγ regulated gene 
expression in human 
DCs 
Ligand 
response 
63 
Szatmari et al., 
2007 
2007 
GSE7247 
DCs Compare the 
Similarity of 
Endogenous and 
Exogenous Antigens 
Loading 
methodology 
comparison 
10 
Decker et al., 
2006 
2006 
GSE4984 moDCs Maturation 
Dendritic cell 
maturation 
12 
Fulcher et al., 
2006 
2006 
GSE6090 
DC-SIGN initiates an 
immature DCs 
phenotype triggering 
Rho activation that is 
used by HIV-1 
Receptor 
signalling 
6 
Hodges et al., 
2007 
2007 
GSE6965 
Gene expression 
profiling of human 
DCs after infection 
with A. fumigatus 
Dendritic cell 
activation 
4 
Mezger et al., 
2008 
2008 
GSE5679 
Comparative gene 
expression profile of 
PPARγ and RARa 
ligand treated human 
dendritic cells 
Ligand 
response 
11 
Szatmari et al., 
2006 
2008 
 
3.3 Selection of the pathway set 
To identify biologically meaningful changes in our data sets, we assembled a dedicated 
pathway set. The pathway database present in Eu.Gene was searched for pathways involved in 
immune response and signal transduction by key transcription factors involved in immune 
response. All pathways were defined as gene lists (containing genes associated with the pathway). 
The set was prepared excluding pathways containing less than three elements. Out of the remaining 
pathways, we built a selection where pathways were classified by their level of immunological 
relevance. Out of the 1038 human pathways available, 80 were selected to be part of the set. 
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3.4 Preprocessing and pathway analysis 
Prior to the analysis, microarray raw data were transformed into absolute-scale values and 
processed following the procedure outlined by Beltrame et al. (2009): firstly, ratios between each 
treated condition and the unstimulated controls were calculated.. The resulting ratios were used to 
perform pathway analysis using the Fisher’s Exact Test (FET).  
With the aim of selecting the most representative FET threshold, FET thresholds were selected 
from the 2s interval of the binomial distribution of the expression values.  
When using FET, we addressed the question of how to use the collection of p-values for a defined 
set of pathways to generate a pathway signature with the aim of comparing different microarray 
experiments. 
Firstly, we corrected the p-values for multiple testing as described in the Experimental procedures 
section then our first attempt was to transform the p-values into a measure whose magnitude would 
express the degree of significance, and to that purpose, we transformed p-values into Pathway 
Enrichment Factors (PEFs). 
Secondly, we transformed p-values in signed binary enrichment factors (sBEFs) (see 
Experimental procedures section): these factors categorized p-values into three classes: 
 
1. significantly up-regulated,  
2. significantly down-regulated, and  
3. not significantly affected. 
 
We then evaluated the performance of these metric, as expressed in the ability of 
assessing similarity according to the expectation that biologically similar experiments should 
show identical or similar pathway profiles (defined as collections of PEFs or sBEFs used for 
testing). 
 
3.5 Validation of the method  
The clustering of signed pathway enrichment factors (sPEFs) gave results that were 
agreeing with our prediction, as wet lab experiments (analyzed in the same manner as the public 
data) show similarity with the samples from GEO data set GSE6965. The Pathway Signatures of 
ad-hoc sample produced stimulating DCs with cells of the yeast S. cerevisiae in exponential growth 
phase, clustered together with profile of moDCs stimulated for 6 hours with germinating germ 
tubes of A. fumigatus (Figure 3.1).  
In detail, the two samples belonged to the same sub-cluster and were the most closely 
associated. Pathways which shared a similar profile among the two samples included the Toll-like 
receptor signalling pathway, JAK-STAT signalling, and cytokine-cytokine receptor interaction 
(Figure 3.2).  
3. Pathway signatures generation 
 
42 
Since we expect the two stimuli to elicit signalling from the same pathogen associated 
molecular patterns (PAMPs) these experiments were in principle the nearest stimulations to the 
yeast one, among those present in the selected dataset. The results therefore show that pathway-
level signatures identify samples with similar biological characteristics and totally confirmed the 
expectation. These findings show that FET pathway based metrics are a powerful tool to identify 
similarity between experiments. 
 
 
 
 
 
 
Figure 3.1. Sample clustering of Fisher’s Exact Test samples on dendritic cell data. Sample tree 
originated from the clustering of FET signed Binary Enrichment Factors (sBEFs) values with Euclidean 
distance. 
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Figure 3.2. Clustering of signed Binary Enrichment Factors (sBEFs) obtained from the FET analysis 
on dendritic cell samples. Colored spots indicate significant (p#0.05) up- (red) or down- (green) regulation. 
The colors of the dendrogram indicate the percentages of the tree support (significance), from 50% (pink) to 
100% (black). The inset shows the clustering of sample GSM160356 from data set GSE6965 with the in-
house dendritic cell experiment 
 
 
3.6 Discussion 
With the aim to propose a novel method to compare microarray experiments at the pathway 
level, our work addressed three major tasks:  
 
1. defined a metric measuring the probability of a set of pathways to be related to some 
clinical/biological variable of interest and the relative importance of that set in the context 
of the biological problem;  
2. proposed a method using these pathway signatures to assess relative similarity of the 
experiments;  
3. proved the validity of this method applying it to two different well defined biological 
problems on two independent collections of microarray experiments.  
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As a proof of concept we decided to use data sets from Homo sapiens because the majority 
of the experiments stored in GEO and ArrayExpress are from human samples. We chose 
transcriptomic datasets from DCs as they have some clear advantages respect to other fields. 
Firstly, the cell type is well-defined, which enables the study of the alterations in gene expression 
following stimulation. Secondly, there is the possibility to perform prediction and hypothesis-
driven functional genomics studies aiming at the reconstruction of the networks of molecular 
interactions characterizing specific DC differentiation programs. 
The aim of the work was to propose a procedure to assess similarity between microarray 
experiments at the pathway level generating ‘Pathway signatures’ (PS) for a set of experiments and 
use these signatures to interrogate microarray databases.  
The need for better methods to identify similarities in microarray data sets arises from the fact that 
although the analysis techniques have constantly improved over the past years, one of the biggest 
hurdles remains the comparability among distinct data sets produced by different researchers and 
laboratories, resulting in lists of genes which do not overlap, or overlap in a very limited fashion.  
The improvements observed when comparing different experiments at the pathway level 
(Manoli et al., 2006) is coherent with the assumption that genes never act alone in a biological 
system, but participate in a cascade of networks, an approach overlooked by gene-based analyses. 
The selection of the statistical method used to measure enrichment is central to our 
approach. Different metrics have been proposed to integrate the probability of alteration of a sector 
of the cellular network (pathway) and the relative importance of that pathway in the context of the 
biological problem, such as the probability vector (Grosu et al., 2002), the impact factor (IF; 
Draghici et al., 2007). Other methods have been devised for the identification of regulatory 
modules and their regulation program by integrating genome-wide location and expression data 
(Tavazoie et al., 1999; Segal et al., 2003; Segal et al., 2004; Segal et al., 2005).  
However, to our knowledge, these methods have not been employed to compare a large 
number of experiments assembled from different microarray data sets. To make more immediate 
FET p-values had to be transformed to improve interpretation: p-values express a probability, and 
the smaller they are the more significant the result is; while from a point of view it is better to 
express pathway enrichment as a number that it is either categorical or the more significant the 
greater it is. That is the reason we first used the logarithm of reciprocal of the p-value (the Pathway 
Enrichment Factor), to express the measure in a scale that would avoid interpretation problems, the 
PEF was finally obtained multiplying the value for a sign representing the ‘direction’ of a pathway, 
with the same approach described in (Grosu et al., 2002). Our results showed that clustering PEFs 
grouped samples according to their biological similarity.  
Biclustering of PEFs on the DC data sets gave concordant and biologically relevant results, 
the responses elicited by stimulation with S. cerevisiae follow the same downstream signalling as 
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the ones in response to the fungus A. fumigatus (Buentke e Scheynius et al., 2003; van de Veerdonk 
et al., 2008; Roeder et al., 2004; Tada et al., 2002).  
The observation that sBEFs, PEFs and PSs, identify similarity between samples that are 
biologically meaningful, indicates that the categorical transformation of the p-values does not 
affect the observed result, concluding that the observed similarity has a biological meaning rather 
than resulting from a manipulation of the data. 
We can conclude that the ability to investigate at the single sample makes the Fisher’s Exact Test 
conceptually appropriate to search for similarities among experiments in a microarray database, 
that contains a number of hybridizations that should be interrogated without necessarily specifying 
the membership to a data set or another.  
Our results show that using pathway signatures in conjunction with hierarchical clustering 
with support trees is a powerful and useful technique to compare experiments produced by 
different people and laboratories with greater power than with the traditional analysis techniques. 
The results are also easier to interpret and discover biologically meaningful implications, making 
this approach an ideal candidate to analyze data from different sources. PS generated using sBEFs 
can be useful as ‘‘barcodes’’ to classify experiments in microarray databases and clustering of 
sBEFs can be a useful way to query experiments in databases according to their similarity at a 
pathway level. Thus, we propose to store PSs as an additional experimental annotation in the 
microarray databases and implement methods using pathway signatures to query experiments in 
public databases and concurrent analyses of subsets of experiments. 
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1 
If people never did silly things nothing intelligent would ever get done 
Ludwig Wittgenstein 
 
 
  
 
 
4 
DC ATLAS: towards the reconstruction of the pathway of the 
dendritic cells 
 
 
4.1 Background 
Research has made great strides towards of the goal of understanding biological processes. 
However, despite the recent advancements, dissecting precisely the sequence of causal and 
temporal effects is still a daunting task. The description of the causal inferences between a set of 
proteins or genes is usually described as a pathway. Pathways are currently generic in terms of cell 
type and topography, and a possible solution lies in the expert curation of pathways specific for the 
biological system that is being studied. The results presented in this chapter are part of a larger 
effort, in the context of the consortium DC-THERA, the DC-ATLAS initiative (Cavalieri et al., 
submitted).  
Exposure of DCs to various stimuli leads to profound changes in their phenotypic and 
functional properties, a process commonly referred to as activation or maturation. Depending on 
the nature of the stimuli, and their interactions with specific cell-surface or intracellular receptors, 
the signals are translated by the fundamental machinery of the cell into appropriate cellular 
responses (Huang et al., 2001).  
DC-ATLAS provides an integrated description of the interactions operating in DCs.  
This initiative aims at establishing a complete ‘road-map’ of intracellular signalling pathways and 
regulatory networks by defining the methodological bases, and proposing a computational 
infrastructure, suitable for the investigation of the networks of molecular interactions 
characterizing activation programs of DCs.  
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4.2 Goals and organization of the DC-ATLAS initiative 
The overarching goals of DC-ATLAS are to define the structure, interconnection, and 
regulation of signalling pathways in DCs, to create a consensus description of these pathways using 
a language amenable to modelling and statistical analysis, and to foster a systems biology approach 
for understanding the biology of this immunologically central cell type. The DC-ATLAS initiative 
aimed to establish both the methodological basis and computational infrastructure required for 
investigating the networks characterizing the activation programs of DCs. The methodological 
aims were to develop a model describing the molecular interactions occurring in DCs, and to define 
the appropriate ontological terms describing these interactions. The interactions were annotated 
precisely with information on the cell type and organism in which supportive evidence has been 
obtained, and the reasons for which the process as a whole can be considered to be operative in 
DCs. The pathways were curated manually and constructed using controlled vocabularies and 
hierarchies. 
Strategically, the project relied on close collaboration between members of an 
interdisciplinary research group, the DC-ATLAS curation team, which integrated the biological, 
bioinformatic and statistical expertise required to ensure the development of a systemic approach to 
the analysis of a complex biological system. 
 
4.3 Pathway structure in DC-ATLAS 
Interactions were organized in functional coherent modules: a set of modules, describing 
the transfer of the signal from the receptor to the outcome, defines a pathway. The selected 
pathways have been used to populate the DC-PATH pathway repository, created by using a SBGN 
compliant data model and dedicated controlled vocabularies.  
Pathways were constructed according to a DC-ATLAS specific data model.  
The data model was built to unambiguously describe pathways, their genes and proteins, 
and their interactions. Pathways are shown as sets of nodes (genes, small molecules, etc.) 
connected by lines that represent interactions. Genes have been identified using the official symbol 
provided by HUGO Gene Nomenclature Committee (HGNC, www.genenames.org, Bruford et al. 
2008) symbol and their Entrez Gene ID (www.ncbi.nlm.nih.gov/Entrez; Maglott et al., 2005; 
2007). 
 We reached a consensus on the structure, interconnection, and regulation of signalling 
pathways using an ontological language amenable to modeling and statistical analysis. Specifically, 
controlled vocabularies were built to clearly annotate the components, their interactions and their 
location. These vocabularies were created by integrating with DC-specific terms the Open 
Biomedical Ontologies, and allowed to reduce to a widely accepted representation the complexity 
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of molecular interactions, such as complex formation, nuclear translocation and post-translational 
modifications.  
The graphical representations of the pathways were performed with the tool DC-PathEDIT, 
allowing the design of the pathways in which proteins (Nodes) react (Edges) with each other. DC-
PathEDIT permits the selective visualization of reactions that have been proven to occur in 
dendritic cells, those that have only been documented in other cell types, and hypothetical reactions 
that remain to be formally established.  
The data model divided pathways into 3 different modules: 
 
1- the portion of the pathway implicated in sensing the stimulus (receptor/sensing 
module);  
2- the principal signal transduction modules situated downstream of the receptor 
(transduction modules);  
3- the biological outcome, such as cytokine or chemokine production, apoptosis, 
migration and differentiation (outcome modules). 
 
The pathways were curated by creating a gene list, a graphical representation and a text 
file, containing a controlled vocabulary compliant detailed description of the pathway itself. 
Pathways have been curated on the basis of information available in existing databases and 
literature, as well as of experimental evidence generated in the laboratories of the researchers 
involved in the DC-ATLAS project. The curation process led to the definition of pathways not yet 
present in any other databases, which exclusively describe interactions proven in DCs  
In the case of pathways already described in public databases, disproven interactions were 
eliminated and significant newly established connections were added. In particular, the Outcome 
modules included a major amount of novel information derived from functional genomics data 
combined with physiological information.  
 
4.4 Curation ex novo of Dectin-1 
Many pathways, as Dectin-1 or DC-SIGN, are novel in that they are currently not available 
in other systematic pathway collections (Kanehisa, M. et al. 2008; Vastrik, I. et al 2007). The 
intracellular signalling pathways induced by these C-type lectins modulate the responses of other 
PRRs such as TLRs, but also exert functions independent from other PRRs (vonVliet et al., 2007) 
Dectin-1 was originally cloned as a dendritic cell surface molecule capable of delivering 
co-stimulatory signals to T cells (Ariizumi et al, 2000). It was subsequently shown to be expressed 
more widely on myeloid cells including macrophages, dendritic cells and neutrophils (Robinson et 
al, 2006; Taylor et al, 2002) and identified as a receptor for β-glucans (Brown and Gordon 2001). 
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Dectin-1 specifically recognizes soluble or particulate β-1,3- and/or β-1,6-glucans, which are found 
primarily in the cells walls of fungi but also plants and some bacteria (fungi and micobacteria, 
Yadav and Schorey, 2006).  
Dectin-1-deficiency is associated with impaired recruitment of inflammatory leukocytes 
and inflammatory mediator production at the site of infection. Myeloid cell activation by dectin-1 
is controlled by inherent cellular programming, with distinct macrophage and dendritic cell 
populations responding differentially to the engagement of this receptor. The inflammatory 
response is further modulated by the progression of the phagocytosis, with ‘frustrated 
phagocytosis’ resulting in dramatically augmented inflammatory responses. Dectin-1 in isolation is 
sufficient to drive a potent inflammatory response in a context-dependent manner. This has 
implications for the mechanism by which myeloid cells are activated during fungal infections and 
the processes involved in the therapeutic manipulation of the immune system via exogenous dectin-
1 stimulation or blockade. 
Trough this novel pathway, Dectin-1 also collaborates with the TLRs to induce pro-
inflammatory responses, such as TNFα (Brown et al, 2006). The first evidence for collaboration 
between TLR2 and Dectin-1 in coordinating inflammatory gene induction came from studies with 
zymosan (Gantner et al, 2003; Brown et al, 2003). Dectin-1 and TLR2 signals have also been 
reported to contribute to cytokine induction by A. fumigatus conidia (Hohl et al, 2005; Steele et al, 
2005; Gersuk et al, 2006). How this collaboration takes place is unknown, as the read out is largely 
cytokine production as Dectin-1 and the TLR synergise/collaborate but it seems that it is not at 
signalling level. 
Despite the information collected in years to understand the molecular mechanisms that 
underlie Dectin-1 function, a complete picture of the intracellular signalling lacks. 
In the DC-ATLAS initiative, we used the literature information available to reconstruct the 
intracellular signalling leading from initial recognition to DC maturation, describing the pathway as 
an assembly of modules, sensing, signal transduction and outcome (Figure 4.1, for legend, Figure 
4.2) and as a description of the reaction (Appendix A and B) and a list of genes (Appendix C). 
 
4.5 Discussion 
DC-ATLAS represents a major advance relative to other existing databases with respect to 
eight key aspects:  
1- it is focused on DCs signalling pathways being thus cell type specific;  
2- it is the first immunological and bioinformatics integrated project that will allow the 
analysis of high throughput data in a DC-specific manner;  
3- it contains many pathways that are not currently available in other pathway collections;  
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4- it contains pathways that have been curated manually by prominent experts in the field, 
and have been in certain cases validated with laboratory experiments;  
5- it contains pathways that have been constructed using controlled vocabularies and 
hierarchies, allowing automatic processing of the data for various applications, including 
pathway analysis; 
6- it adopted a data model composed of interconnected modules that provide a structural 
overview of the mechanisms, from receptors via signal mediators to effectors. The 
modules allow to appreciate the time in which the signal take place overcoming the issues 
of the current generic pathway structure that masks specific events in a plethora of generic 
interactions; 
7- DC-ATLAS is one of the first pathways databases SBGN compliant and  
8- it represents a consensus established by a large number of scientists, comprising 
essentially the entire European scientific community with expertise in DCs. 
 
The division of pathways into different modules will be critical for the statistics of pathway 
analysis. Furthermore, the modules can be used to define or reconstruct general signal transduction 
pathways in immunology.  
The possibility of verifying key biological information relevant to the DC-specific 
modules, including data from patients, will permit an improved description of the hallmarks of DC 
maturation. The latter can not be achieved with the current generic pathway structure, which masks 
specific events in a plethora of generic interactions. 
Our data model allows the dissection of signal transduction pathways involved in DC 
activation by means of a Systems Biology approach. Expert curated DC-ATLAS pathways 
represents a valuable tool to emphasize established facts as well as highlight the limits of our 
knowledge with respect to the hierarchy of events leading to effective immune responses. The 
appropriate application of computational methods will contribute to fill current gaps in the 
bioinformatics analysis of genomic data, in which the integration of different types of information 
remains a major, and partially unresolved, computational issue. Furthermore, the ability of DC-
ATLAS to identify gaps in our current knowledge will help to focus future research efforts, and 
lead to the design of specific experiments aimed at reconciling interactions and findings 
documented in human and mouse DCs, and at establishing relationships between pathways 
operating in DCs and other cell types. 
Finally, DC-ATLAS will provide a knowledge base on DC biology that will prove to be 
valuable for rationalizing information present in the literature. The ability of DC-ATLAS to 
identify gaps in our current knowledge will help to focus future research efforts, and will lead to 
the design of specific experiments aimed at reconciling interactions and findings documented in 
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human and mouse DCs, and at establishing relationships between pathways operating in DCs and 
other cell types. 
 
 
 
 
 
 
Figure 4.1. Graphical representation of Dectin-1 with DC-PathEDIT. 
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Figure 4.2. Legend of symbols used to represent the different reaction/interaction in the pathway using 
DC-PathEDIT. 
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Differential immune response to pathogenic and 
harmless fungi 
 
 
5.1 Background 
The decision on how to respond to a microorganisms, be it a pathogen or a commensal, is 
primarily determined by the interaction between microorganism and cells of the innate immune 
system.  
Host/fungal interactions have so far been studied only for pathogenic fungi such as C. 
albicans, but it is not known what determines the commensalism of harmless fungi. In particular, 
the rules governing the interaction of S. cerevisiae and our immune system are almost completely 
unknown. Following this observation, we attempted to understand the mechanism by which the 
host immune system discriminates friends from foes in the interplay with microorganisms.  
 
5.2 Pathway analysis allows distinguishing different DC response to fungi 
In order to dissect the response of DCs to fungi at the pathway level, we performed a 
pathway analysis on 7 microarray data sets, which included dendritic cells stimulated with the 
supposed harmless S. cerevisiae, in form of cells and spores, and the two opportunistic pathogen, 
C. albicans and A. fumigatus (Table 5.1), using the DC-ATLAS pathway set (see Chapter 4). The 
analysis results were then converted to pathway signatures (see Experimental Procedures) and 
clustered (Figure 5.1 and 5.2). We observed that the Saccharomyces yeast cell samples formed a 
separate cluster, indicating a peculiar DCs response to distinguish between pathogenic and non-
pathogenic fungi. Interestingly, the two yeast spores data sets grouped closely to the C. albicans 
samples (see separate section for discussion).  
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Table 5.1. Selection of microarray experiments challenged with fungi 
 
 
In general terms, we observed a strong inter-donor variability, exhibited by the fact that single 
replicates of the same experiment did not show a consistent grouping when clustered. Also, we 
noticed a very marked ‘platform effect’ in the clusters, that is samples from the same microarray 
platform had the tendency of grouping together, regardless of the stimulus. 
In an effort to improve the specificity of the analysis and to reduce the platform and donor 
variability effects, we ran the same analysis on the mean expression ratios for each data set (Figur 
5.2). The cluster showed a clear reduction of the platform effect, as the various stimuli grouped 
together. In particular, yeast spores formed a close cluster along with A. fumigatus, with C. 
albicans and Saccharomyces yeast samples being more distant in the cluster tree. Interestingly, 
heat-killed Candida samples formed a separate cluster as compared with the stimulation with live 
C. albicans. This is probably due to the several changes in exposure of cell wall components 
consequent to heat killing.  
The activation states of the various pathway modules showed a number of consistent 
features across all data sets. These consistent features are in general describing the common 
response to fungi, irrespectively of the fact if these are pathogenic or not. Globally the expression 
dataset shows significant enrichment in genes of the pathways specifically involved in fungi 
recognition such as the C-type lectins, DC-SIGN and Dectin-1, signalling or Toll like receptor 
(TLR) 2/6 signalling.   
dataset origin stimulation platform 
hmoDC – S. cerevisiae yeast cells Our lab 4 hours Affymetrix 
hmoDC – S. cerevisiae spores Our lab 4 hours Affymetrix 
hmoDC – S. cerevisiae yeast cells Our lab 4 hours Illumina 
hmoDC – S. cerevisiae yeast cells Our lab 4 hours Illumina 
hmoDC – live C. albicans hyphae Our lab 4 hours Illumina 
hmoDC – heat killed C. albicans hyphae G. Shuler lab 3 hours Illumina 
hmoDC – A. fumigatus conidiae GSE6965 6 hours Affymetrix 
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Figure 5.1. Clustering of signed Binary Enrichment Factors (sBEFs) obtained from the FET analysis 
on dendritic cell samples. Colored spots indicate significant (p#0.05) up- (red) or down- (green) regulation. 
The colors of the dendrogram indicate the percentages of the tree support (significance), from 50% (pink) to 
100% (black). The inset shows the clustering of S. cerevisiae cells stimulated DCs. 
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Figure 5.2. Clustering of Pathway Enrichment Factor (PEF) obtained from the FET analysis on 
dendritic cell samples. Colored spots indicate significant (p#0.05) up- (red) or down- (green) regulation. 
The colors of the dendrogram indicate the percentages of the tree support (significance), from 50% (pink) to 
100% (black). The inset shows the cluster tree. 
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Upon stimulation with non-pathogenic yeasts or yeast forms the receptor/sensing modules of 
Dectin-1, or TLR 2/6 pathways were mostly down-regulated, and part of the transduction modules 
for these pathways was either down-regulated as well, or only weakly activated. DC-SIGN 
receptor/sensing module was down-regulated for all the data sets. This underlines the importance 
of C-type lectins, such as Dectin-1, DC-SIGN and the macrophage mannose receptor (MR) to 
specifically mediate fungal recognition (Hernanz-Falcón et al., 2009; Newman and Holly, 2001; 
Cambi et al., 2008). This is a very important finding; so far it was unclear what happened to gene 
expression of the genes producing the mRNAs of the proteins responsible of the first initial 
interaction between the dendritic cell and the fungi. 
We clearly observed that these genes were switched off at 3-4 hours after the exposure to the 
microorganism. This result is therefore consistent with the fact that the experiments in the dataset 
analyzed were performed at 3-4 hours. It is reasonable to think that this down-regulation means 
that the cell is priming its response towards to fungi. The observation we made can be compared to 
a ‘snapshot’, a view of the state of DCs in a specific moment of their maturation process, a period 
where DCs are already matured and ready to prime differential Th responses. In this scenario the 
cell's fate has been decided it does not make sense in the cell economy to continue maintaining the 
molecular repertoire dedicated to sensing. The significant downregulation we report is in 
agreement with the observation that the expression of C-type lectins is very sensitive to maturation 
stimuli, leading to down-regulation as DCs mature (van Kooyk, 2008). 
 
5.2.1 Differential involvement of Dectin-1 in fungi recognition 
The Dectin-1 receptor/sensing module exhibited different regulation between C. albicans 
and the rest of the samples: the former was not significantly active, while for the other samples it 
showed clear down-regulation. The datasets we compared derived from DCs stimulated with C. 
albicans hyphae and are consistent with previous observations that Dectin-1 recognized yeast form 
and not filaments of C. albicans (Gantner et al., 2005).  
The genes present in the Dectin-1 receptor/sensing module were expressed consistently 
with the global direction of expression of the module (Figure 5.3) confirming the validity of our 
enrichment method.  
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Figure 5.3. Dectin-1 modular structures. In yellow, the differences at the sensing level, between C. 
albicans hyphae and S. cerevisiae stimulation were underlined and the differential gene expressions were 
reported in the table. 
 
 
0.38 CLEC7A Candida hyphae 
stimulation 
-1.3 SYK Saccharomyces cells 
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As we hypothesize that the down-regulation of the receptor/sensing module observed at 3-4 
hours is a time dependent phenomenon, we investigated the behavior of these genes with a time 
course experiment spanning several time points, using real-time PCR. We stimulated DCs from 3 
donors with S. cerevisiae cells and hyphae of C. albicans and we performed a RT-PCR after 1, 2, 4, 
8 and 12 hours (Figure 5.4). As predicted, the mRNA levels of Dectin-1 (CLEC7A) and of its 
adaptor SYK markedly increased at early time points with respect to the immature DCs (up to two 
hours following stimulation with S. cerevisiae). The expression then decreased over time indicating 
a consequent lack of persistent stimulation.  
 
    
 
Figure 5.4. DECTIN-1 and SYK gene expression on DCs upon challenge with C. albicans and S. 
cerevisiae. Gene expression was assessed in real-time PCR on DCs stimulated with S. cerevisiae cells and 
hyphae of C. albicans for 1, 2, 4, 8 and 12 hours (N=3). 
 
 
RT-PCR spanning several time points also confirmed the down-regulation of CARD9 
(Figure 5.5) that we had observed with microarray analysis. Interestingly, the C. albicans-
stimulated samples showed a sustained expression of CLEC7A and SYK even after 4 hours.   
 
                                   
 
Figure 5.5. CARD9 gene expression on DCs upon challenge with S. cerevisiae. Gene expression was 
assessed in real-time PCR on DCs stimulated with S. cerevisiae cells 1, 2, 4, 8 and 12 hours. (N=3) 
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With regards to the transduction modules of Dectin-1, they were down-regulated in all 
samples, with the exception of the transduction module leading to NFkB, which was up-regulated. 
This suggests a role for NFkB signalling in the regulation of the temporal events related to fungal 
immune responses. 
Interestingly, considering the transduction that lead to Calcium dependent activation of the 
transcription factor NFAT, genes coding for the calcium channel (ORA1) and its adaptors STIM1 
and STIM2 were found downregulated upon A. fumigatus and S. cerevisiae stimulation, and the 
gene NFATC1 result differentially upregulated with respect to Candida. The upregulation of STIM2 
is essential if Ca2+ signalling is present (Lioudyno et al., 2008).  
The outcome modules are significantly up-regulated, indicating that a large part of the 
transduction signal has already reached the later part of the pathways. In addition to the results we 
found regarding Dectin-1, our findings indicate that the genes present in the outcome modules of 
DC-SIGN exert an important role in the recognition of fungi, as previously reported at the protein 
level (Serrano-Gomez et al., 2005, Cambi et al., 2005). 
In general terms, our results show that the signal travels through the network starting very 
early following stimulation, prompting a rapid commitment of the affected DCs. 
 
5.3 Dissection of the pathway response for cell wall components 
Fungal recognition is not the result of one microbial component interaction with a single 
recognition receptor, but a complex network of interacting receptors and ligands. Depending on the 
type of receptors involved and also the organization of the receptors at the cell surface, the outcome 
can be completely different. It can result in simple resolution of pathogen but also lead to a 
vigorous adaptive immune response or lead to tolerance induction. 
To determine the role of the single components in the fungal cell wall as opposed to the 
multiple receptor stimulation by whole organisms, we carried out additional experiments, 
stimulating DCs with components of the fungal cell wall. In particular, we focused on the various 
components of the S.cerevisiae cell wall, a structure whose main components include β-glucans 
and mannan (Figure 5.6).  
We performed a transcriptionl analysis on moDCs stimulated with zymosan A, a cell wall 
extract from S. cerevisiae (containing both β-glucans and mannan and other glycan recognized by 
several receptors, including C-type lectins such as Dectin-1, MR and DC-SIGN and TLRs, such as 
TLR2 and 4), curdlan, a β-glucan preparation, mannan derived from S. cerevisiae and the whole 
fungus, represented by S. cerevisiae cells. Cells were collected after 4 hours of stimulation. 
Pathway analysis was carried out using Eu.Gene (Cavalieri et al., 2007), and PEFs were clustered 
against the whole organisms (Figure 5.7).  
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Figure 5.6. S. cerevisiae cell wall and components. Yeast cell wall is a dinamic structure which main 
components are mannan and β-glucan. 
 
 
DCs stimulated with mannan (thus without β-glucan) showed a completely different 
pathway profile than the rest of the samples, which were groped together. Curdlan stimulated DCs 
were closely associated with Saccharomyces spores, while zymosan, curdlan, S. cerevisiae, and C. 
albicans formed separate, distinct groups.  
As represented in Figure 5.7, all the outcome modules, which overlap to some degree, were 
activated. Mannan signalling resulted in repression of the genes for the receptor module of DC-
SIGN, curdlan specifically down regulated Dectin-1 sensing module, Zymosan downegulated DC-
SIGN and Dectin-1 sensing modules while activating TLR2 and TLR4 pathway. 
A number of other receptor pathways resulted regulated in different way across the stimuli. Several 
of the TLR pathways show overlap in the elements that contribute to the signalling but this does 
not necessarily means that they are specifically involved in the signalling. Moreover, we identified  
‘key players’ in the recognition game: the differential regulation of the signalling which leads to 
AP-1 transcription factor activation is likely a factor which differentiates the response to β-glucan 
containing stimulation with respect to mannan. Lastly, the endosomal pathways were differentially 
regulated among RNA presenting stimuli with respect to single cell wall component. These 
observations need further investigation. 
We did not obtain the same results when using publicly available pathways, as the 
differences between stimuli were not discernible (Figure 5.8). We could assess differences at the 
cluster level but we could not infer any indication about the signalling itself. 
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Figure 5.7. Clustering of Pathwat Enrichment Factors (PEFs) obtained from the FET analysis on 
dendritic cell samples challenged with cell wall components. Colored spots indicate significant (p#0.05) 
up- (red) or down- (green) regulation. The colors of the dendrogram indicate the percentages of the tree 
support (significance), from 50% (pink) to 100% (black). The inset shows the cluster tree. 
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Figure 5.8. Clustering of Pathway Enrichment Factors (PEFs) obtained from the FET analysis on 
dendritic cell samples challenged with cell wall components using public pathways. Colored spots 
indicate significant (p#0.05) up- (red) or down- (green) regulation. The colors of the dendrogram indicate the 
percentages of the tree support (significance), from 50% (pink) to 100% (black). The inset shows the cluster 
tree. 
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The affected pathways represent all the genes involved in the complete process, without 
any indication of the temporal recruitment of the molecules: we observed a general activation of 
the immune response pathway in all conditions. In particular we observed the activation of 
pathways such as Toll Like Receptor signalling pathway, JAK-STAT signalling, COX reaction and 
cytokine-cytokine receptor interaction. T cell receptor signalling pathway and apoptotic pathway 
were also significantly activated. 
In contrast with the DC-ATLAS data, it was not possible to identify the state of the signal 
in a specific part of the pathway. The Toll-like signalling pathway, from KEGG, shows a general 
up-regulation in all the conditions but it includes information derived from signalling of all TLRs, 
without distinction. On the other hand, the Reactome-curated pathways attempt to describe the 
contribution of each TLR: nevertheless, it was still difficult to determine which pathway 
discriminated the response to the various stimuli. Furthermore, the traditional, publicly available 
pathways were not able to show the integration of signals derived from the interaction between 
DCs and a complex stimulus. For example, mannan showed a TLR activation pattern similar to the 
one of the entire fungus. 
 
5.3.1 From whole genome picture to genes: the harmless S. cerevisiae 
In order to obtain a detailed description of immune response activated by the different 
PAMPs we performed a comparative analyis on differential expressed genes (DEG). 
The analysis between the single cell wall components indicated clearly that DCs stimulated with 
curdlan and mannan shared less responsive elements and as expected zymosan, that contains both 
curdlan and mannan, induced a complex level of higher gene activation (Figure 5.9). The genes 
activated in response to the three stimulation conditions showed a common proinflammatory 
response indicated by upregulation of genes coding for cytokines (IL1A, ILB, IL6, IL8, TNFA), 
chemokines (CXCL1, CXCL2, CCL20). In addition prostaglandin related gene (PTGS), cell 
adhesion molecules and matrix-metallo proteinases (MMP10) were found differently regulated 
(Figure 5.9C).  
The comparative analysis of zymosan-stimulated DCs and curdlan-stimulated DCs showed 
that zymosan but not curdlan is able to activate the expression of some genes involved in Th1 
response such as IL-12A and IL-12B genes, prompted the parallel stimulation of TLR2. This 
difference in IL12 genes expression was not found in mannan stimulation comparison. Zymosan-
stimulated DCs showed expression of CCR7 gene known to be involved in the maturation process 
and in the migration process to lymphnodes and of RND1 gene that regulates the organization of 
active cytoskeleton in response to extracellular facto (Nobes et al 2008).  
However, although the strong activation of Th1 polarizing factor (Figure 5.10) balancing 
the Th17 factor, zymosan-stimulated DCs activated several genes, such as IL-10 and its receptor 
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IL-10R, that mediate immunosuppressive signals of IL-10 inhibiting proinflammatory signals and 
SOCS2, a member of a family genes associated with the suppression of cytokine production (Figure 
5.10). We also found upregulated TRAF3 gene, responsible for stress activated kinase response and 
DUSP genes (DUSP10 and DUSP2), a family genes involved in counter-mechanism to limit innate 
immune response and TLR signalling acting on different MAPKs (Konstantin and Tamas, 2007). 
These observations configure a self-regulated activation process by activation of negative-feedback 
mechanisms, which can restrain and terminate the innate immune response. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9. Immune response (IR) genes activated different cell wall components in moDCs. 
Transcriptional analysis was performed on moDCs after 4 hours of stimulation with curdlan, zymosan, 
mannan or without any stimuli. (A) and (B) Venn diagram of upregulated and downregulated DEGs, 
respectively. (C) IR differentially regulated genes (p <= 0.05) commonly expressed among the three 
stimulation condition. 
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Figure 5.10. Immune response (IR) genes activated by Zymosan in moDCs. IR differentially regulated 
genes (p <= 0.05) uniquely expressed in Zymosan-stimulated DCs compared to Curdlan-stimulated DCs. 
 
 
The comparative analysis among the different stimulation condition showed, in the four stimulation 
conditions, 21 genes commonly activated (Figure 5.11). Among these, genes coding for cytokines, 
chemokines and immune receptors, were up-regulated compared to the unstimulated control.  
The Gene Ontology analysis of differentially expressed genes showing for all the stimulation condition a 
marked representation of biological process involved in immune response and recognition of external stimuli 
(Figure 5.12). 
                   
Figure 5.11. Immune response (IR) genes activated by different cell wall components and 
Saccharomyces cerevisiae in moDCs. Transcriptional analysis was performed on moDCs after 4 hours of 
stimulation with curdlan, zymosan, mannan and S. cerevisiae or without any stimuli. (A) and (B) Venn 
diagram of upregulated and downregulated DEGs, respectively.  
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5. Differential immune response to pathogenic and non pathogenic fungi 
 
67 
 
 
 
 
 
Figure 5.12. GO_Slim enrichment of DC stimulated with curdlan, mannan, zymosan and S. cerevisiae. 
GO_SLIM was calculated by using the Bingo tools on Cytoscape. 
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The comparison between yeast-stimulated DCs and zymosan-stimulated DCs, showed a 
common marked expression of several pro-inflammatory mediators and factors involved in the 
maturation process of DCs, including a remarkable activation of IL12A and IL12B genes coding for 
the Th1 polarizing factor IL-12p70 (Figure 5.13). They also showed an increased expression of the 
CCR7 and CCL20 genes, known to be involved in the maturation and migration to lymph nodes 
(Hansonn et al, 2006), of the PTX3 gene known to be involved in phagocytosis (Diniz et al., 2004). 
However, the strong induction of pro-inflammatory and Th1 polarizing cytokine gene activation 
induced by yeast was counter-balanced by an increased expression of factors involved in immune 
modulation which limit DC activation as well as T cell effector function such as IL-10, INDO and 
IL2RA (Romani, 2008; Steinman et al., 2003; Romani and Puccetti, 2007). Genes for the Th17 
polarizing factors IL-1β and IL-6 were also found to be expressed showing that the balancing 
among the different Th polarizing cytokine is peculiar to the proper maturation program of 
stimulated DCs.  
 
       
 
Figure 5.13. Compared dendritic cell immune response (IR) to zymosan and S. cerevisiae. IR 
differentially regulated genes (p <= 0.05) commonly expressed among the two stimulation condition, 
 
 
Overall, these core responses suggest that TLR and C-type lectins-cell surface activation, set the 
stage for the more intense TLR-dependent and -independent responses generated by phagocytosed 
yeast cells. 
The key difference between pure stimuli and entire cells could be represented as a precise 
program, involving signalling from cell surface receptors within the first two hours, a proper 
response that requires switching off the response from surface sensors, and a final activation of the 
response prompted by stimuli deriving from the phagosome. Live yeast cells also more intensely or 
exclusively regulated several genes associated with cell damage and repair than zymosan (Figure 
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5.14). This finding could be related to the capacity to initiate programmed cell death responses. 
Gene transcripts within this group included PARP10 (Poly ADP-ribose polymerase10). The 
catalytic activity of PARPs has been shown to be stimulated by DNA strand breaks, which occur 
during programmed cell death. PARP10 has not been previously associated with apoptosis (Kleine 
et al., 2008), suggesting that phagocytosis of S. cerevisiae may initiate novel mechanism of cell 
damage and repair. 
Yeast cells compared to zymosan stimulation are able to induce a differential regulation of 
type I interferons and type I interferon associated genes (IFIH1, IFIT1, IFIT2, IFIT3). These 
responses are of particular relevance given that lipoprotein mediated TLR2-derived signals do not 
induce type I interferons (Toshchakov et al., 2002; Kawai and Akira, 2007). Several other TLRs, 
including TLR7, TLR8 and TLR9, are able to launch distinct signalling pathways from within 
phagosomal vacuoles that differentially regulate type I interferons (Stockinger et al., 2000). 
 
          
Figure 5.14. Dendritic cell immune response (IR) to S. cerevisiae. IR differentially regulated genes (p <= 
0.05 more  expressed upon S. cerevisiae cell stimulation than Zymosan stimulation. 
 
 
Particularly important for the development of phagosomal signalling was the markedly 
enhanced secretion of IL-1β in response to yeast. Unlike other pro-inflammatory cytokines (i.e. 
TNF-α), which are linearly induced by TLR activation, the production of biologically active IL-1β 
requires the integration of NF-κB-mediated transcription of pro-IL-1β followed by activated 
caspase-1 cleavage of the inactive cytokine (Ogura et al., 2006). It requires processing into its 
active form by activated caspase-1. Caspase-1 is activated within a multiprotein complex called the 
inflammasome (Weiss et al., 2007) in response to diverse stimuli. Stimulation of cell surface 
purinergic receptors by exogenous ATP, following human monocyte activation, is a known 
mechanism by which bacterial pathogens can lead to cleavage of caspase-1 (Piccini et al., 2008). 
Released ATP engages the cell's purinergic ion channel receptors (P2XR7) inciting release of 
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intracellular K+ which in turn generates signals that lead to assembly of the inflammasome and 
activation of caspase-1.  
By transcriptional analysis we observed the overexpression of P2XR7 gene and by Elisa 
measurement, presence of active IL-1β only after yeast cells stimulation (Figure 5.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15. Cytokine production after S. cerevisiae and zymosan stimulation. Elisa were performed for 
IL-1β, TNFα, IL-6 and IL-p70 measurement on supernatants of DCs stimulated for 24 hours with S. 
cerevisiae or zymosan. 
 
 
Collectively our results highlight the ability of phagocytosed S. cerevisiae to induce diverse 
and more intense innate immune signals which are mechanistically distinct from those generated 
when different glycan engage cell surface PRRs. 
 
5.3.2 From whole genome picture to genes: the opportunistic pathogen C. albicans 
The ability of phagocytosed yeast to induce a stronger innate immune response with 
respect to single cell component, is evidenced in DC response upon C. albicans stimulation. 
The comparative analysis showed a marked inflammatory response induced by C. albicans, 
represented by the upregulation of mediators and factors involved in the maturation process of DCs 
(Figure 5.16) such as genes coding for co-stimulatory molecules (A), genes coding for cytokines 
and chemokines (B), genes involved in inflammation and apoaptosis (C) and several transcription 
factors (D). The upregulation of genes coding for cytokines is different to what observed after S. 
cerevisiae cells stimulation suggesting a different Th polarizing cytokines production leading to a 
Th17 response instead to a Th1. 
Upon live C. albicans hyphae internalization, the inflammosome is activated as suggested by the 
trascriptional analysis (Figure 5.17) and the clearly upregulation of NLRP3 gene, important for 
inflammosome complex formation and production of the active form of IL-1β (Gross et al., 2009). 
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Figure 5.16. Immune response (IR) genes activated by C. albicans hyphae in moDCs. (A) IR genes 
coding for co-stimulatory molecules (A), genes coding for cytokines and chemokines (B), genes involved in 
inflammation and apoaptosis (C) and several transcription factors (D) differentially regulated genes (p <= 
0.05) in Candida-stimulated DCs.  
 
 
Figure 5.17. Inflammasome-related genes activates in DCs stimulated with live C. albicans hyphae. 
Inflammasome activation related genes differentially regulated (p <= 0.05) in Candida-stimulated DCs  
 
 
It’s worthwile to note that after 4 hours of stimulation, CLEC7A gene, coding for Dectin-1, is still 
upregulated as a lack of involvement, while CLEC4A gene, coding for Dectin-2 is downregulated 
as recently reported in the involvement of C. albicans hyphae recognition (Robinson et al., 2009, 
Figure 5.18) 
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Figure 5.18. Different involvement of Dectin-1 and Dectin-2 recognition of hyphal form of C. albicans. 
CLEC7A and CLEC4A were differently regulated by DCs in response to C. albicans hyphae. 
 
 
 
5.3.3 Pathogenic versus non pathogenic fungi 
The importance of cell wall recognition in pathogenesis has been recently investigated in 
C. albicans. Dimorphic switch in Candida and germination of Aspergillus spores are two examples 
of the importance of different life stages in determining pathogenicity, possibly by exposing 
different cell wall components (d’Ostiani et al., 2000; Gartner et al., 2005). S. cerevisiae cell wall 
composition radically changes in investigated the immune response to S. cerevisiae, in cell form 
and spores, and hyphae of C. albicans.  
Through transcriptional analysis on moDCs exposed to these fungi we obtained lists of 
differentially expressed genes (DEGs) for each stimulation compared to unstimulated controls. 
1179 genes were commonly activated in the three stimulation conditions as indicated by the Venn 
Diagram (Figure 5.19). Differentially expressed gene (DEG) analysis showed an up-regulation of a 
wide range of DEGs involved in immune responses and inflammation, such as genes coding for 
cytokines, chemokines and immune receptors. The regulation of genes coding for the receptors, 
Toll like receptor (TLR) 2 and TLR1 and Dectin-1, the adaptor proteins Syk and Card9, and co-
stimulatory molecules and metalloproteinases. outlined a common maturation process between S. 
cerevisiae and C. albicans stimulation. The Gene Ontology analysis of DEGs showed for all the 
stimulation condition a marked representation of biological process involved in immune response 
and recognition of external stimuli, as represented for spore stimulation in Figure 5.20. 
In addition to the commonly activated genes a set of 174 genes was differentially expressed 
only after S. cerevisiae cells stimulation, while 444 and 507 genes were uniquely differentially 
expressed after C. albicans and S. cerevisiae spores stimulation, respectively. 
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Figure 5.19. Venn diagram of differentially expressed genes (DEGs). Transcriptional analysis was 
performed on moDCs after 4 hours of stimulation with S. cerevisiae spores, exponentially growing yeast 
cells, C. albicans hyphae or without any stimuli. 
 
 
 
                 
 
 
 
Figure 5.20. GO_Slim enrichment of DC stimulated with spores. GO_SLIM was calculated by using the 
Bingo tools on Cytoscape 
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The comparative analysis of Saccharomyces cells-stimulated moDCs and Candida hyphae-
stimulated moDCs, showed a marked expression of several pro-inflammatory mediators and factors 
involved in the DC maturation process, including the activation of IL12A (Figure 5.21A). The 
strong induction of pro-inflammatory and Th1 polarizing cytokine genes induced by S. cerevisiae 
cells was counter-balanced by an increased expression of factors involved in immune modulation 
which limit DC activation as well as T cell effector function as underlined before. 
Compared to S. cerevisiae stimulation, Candida-stimulated moDCs showed an increased 
expression of the CCR7 and CCL20 genes, known to be involved in the maturation and migration 
to lymph nodes (Hansoon et al., 2007). Genes for the Th17 polarizing factors IL-1β and IL-6 were 
also found to be more expressed in Candida-stimulated DCs (Figure 5.21B), showing that different 
fungi induce peculiar maturation program of stimulated DCs.  
 
 
 
  
 
Figure 5.21. Immune response (IR) genes activated by Saccharomyces cerevisiae cells or spores and C. 
albicans hyphae in moDCs. (A) IR differentially regulated genes (p <= 0.05) more expressed in 
Saccharomyces (SC) cells-stimulated DCs compared to Candida-stimulated DCs. (B) IR differentially 
regulated genes (p <= 0.05) more expressed in Candida-stimulated DCs compared to Saccharomyces cells-
stimulated DCs. 
 
 
 
The comparison of S. cerevisiae cells and spores stimulation showed a strong induction of 
pro-inflammatory and Th1 polarizing cytokine gene activation, counter-balanced by an increased 
expression of factors involved in immune modulation (Figure 5.22A). Conversely, genes for the 
Th17 polarizing factors IL-1β and IL-6 were found more expressed in spore-stimulated DCs 
(Figure 5.22B), in a Candida like manner, suggesting that different life stages of S. cerevisiae can 
induce a different maturation program on DCs.  
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Figure 5.22. Immune response (IR) genes activated by Saccharomyces cerevisiae cells or spores and C. 
albicans hyphae in moDCs. (A) IR differentially regulated genes (p <= 0.05) more expressed in 
Saccharomyces cells-stimulated DCs compared to Saccharomyces spores-stimulated DCs. (B) IR 
differentially regulated genes (p <= 0.05) more expressed in Saccharomyces spores-stimulated DCs 
compared to Saccharomyces cells-stimulated DCs  
 
 
To investigate the regulation of pathways and cellular networks in our samples, we 
performed a pathway analysis and clustered the results as signed Binary Enrichment Factors 
(sBEF; Figure 5.23; Beltrame et al., 2009). We observed a general activation of the immune 
response pathway in all conditions. In particular we observed the activation of pathways such as 
Toll Like Receptor signalling pathway, JAK-STAT signalling, COX reaction and cytokine-
cytokine receptor interaction. T cell receptor signalling pathway and apoptotic pathway were also 
significantly activated in all the three stimulation conditions. Furthermore, the clustering analysis 
separated C. albicans and S. cerevisiae in two distinct groups. This finding showed the different 
DCs response to pathogenic and non-pathogenic fungi. Futhermore, the clustering outlined 
different pathway signatures between S. cerevisiae cells and spores.  
These findings indicate that S. cerevisiae spores are ‘teleologically’ similar to Candida 
albicans hyphae in terms of ability to induce a DC response, possibly related to the different cell 
wall component disposition among S. cerevisiae cells and spores. 
 
5.4 Discussion 
Host/fungal interactions have so far been studied only for pathogenic fungi such as C. 
albicans, but it is not known what determines the commensalism of harmless fungi.  
We attempted to address the mechanism by which the host immune system discriminates friends 
from foes in the interplay with microorganisms, by using a pathway analysis approach. This 
approach allows comparison of different microarray experiments in order to obtain a detailed 
photograph of the genomic response at the time of the experiment. During dendritic cell sensing of 
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the microrganism and the maturation program that lead to the proper Th polarization to cope better 
the invading pathogen, several changes either at transcriptional level either at protein level occur. 
Through the comparison of different whole genome transcriptional analysis at the pathway 
level, we confirm the presence of a peculiar transcriptional program governing the recognition of 
fungi, be it a pathogenic or a commensal fungi.  
DC-ATLAS, the collection of pathway for PRR signalling we are curating, allows to 
dissect the temporal events characterizing the signalling cascades leading to initial recognition to 
maturation, describing the pathway as an assembly of modules, sensing, signal transduction and 
outcome. The results of statistical analysis based on DC-ATLAS are much improved respect to the 
results one can obtain from existing pathway databases using the same statistical test. DC-ATLAS 
reduces overlap between pathways and as a consequence improves the capture of specificity of a 
signalling program respect to another. Despite this substantial improvement in many cases 
pathways that are not specifically meant to respond to a stimulus are called as significantly altered. 
The reason for this lack of consistency is that the two selected pathways share a substantial element 
in common that fools the statistical test used, or the approach used for multiple test correction. This 
consideration implies that substantial work needs to be invested in tailoring the multiple test 
correction to the section where the correction wants to be applied. This will require further 
interaction with experts in statistics to improve the statistical applications to specific section of the 
module analysis. 
The overall upregulation of the otucome modules in DC stimulated with various stimuli 
was in principle due to the time the experiments were performed. That is, at that point in time DCs 
are matured and ready to prime differential Th response. Thanks to the division in modules, we 
could assess the temporal signalling of the events, since the sensing and transduction modules were 
downregulated. In particular we can observed differential involvement of receptors due to 
differences in cell wall components disposition (i.e C. albicans hyphae) or distinguish the single 
cell components contribution the response to a whole fungus by discrimination of the preferential 
signal flow of different cell wall components.  
Most studies so far have analyzed DC activation induced by single microbial compounds. 
However, pathogens express several TLR and C-type lectins agonists that may engage different 
receptors at different times and in distinct cellular compartments. By pathway analysis and 
differential transcriptional analysis we observed that cell wall components such as mannan and 
curdlan integrate their stimulation as observed by using zymosan as stimuli. 
Further, after internalization yeast presents other PAMPs to endosomal receptors with 
respect to the single cell wall components. Immune cell activation by yeast has generally been 
ascribed to outer membrane lipoprotein-TLR1/2 and Dectin-1 (Clec7a) mediated inflammatory 
responses. Our study results also make obvious that a far more intense and diversified innate 
immune response coincides transcriptionally of live yeast and maturation of the phagosome. Most 
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prominently, the innate immune signals generated by phagocytosed live S. cerevisiae led to an 
enhanced TLR-mediated pro- and anti-inflammatory cytokine output. TLRs continuously sample 
the extracellular environment and inform the cell to react to PRRs by facilitating cellular responses 
via inflammatory pathways which culminate in cytokine production and cell activation (Lien et al., 
1999; Kaway and Akira, 2007).  
Human DCs, which originate as monocytes in the peripheral blood, express a substantial 
complement of both cell surface as well as endosomal TLRs (Chuang and Ulevitch, 2000). The 
transcriptional responses elicited by both live S. cerevisiae and zymosan, for the most part were 
representative of cell surface TLR1/2 and dectin-1 mediated activation. These responses were 
perhaps best exemplified by the differential regulation of cytokines as well as several other 
chemokines. Surface signals were also capable of up-regulating several genes associated with 
molecules that regulate TLR responses, including SOCS3 (Yasukawa et al., 2003). 
The enhanced TLR-mediated cytokine production could be the result of several nonexclusive 
mechanisms broadly divided into three categories;  
 
1. a more efficient activation of recruited cell surface and endosomal TLR1/2 receptors by 
yeast glycans,  
2. engagement of additional endosomal TLRs by internalized and degraded yeast cells, and  
3. cooperation between multiple TLR receptors from within the phagosomal vacuole.  
 
The transcriptional activation of genes conding for TNF-α, IL-1β, IL-6 and IL-10 in DCs, suggests 
that TLR2 is available for signalling,  
TLR7, TLR8 and TLR9, all of which are known to be expressed in endosomal membranes (Kawai 
and Akira, 2006) may also play an important role in generating the enhanced cytokine responses to 
internalized yeast cells.  
The initial recognition of the cell surface create a temporal window for stimulation of other 
receptors that intensify, complement and sustains the DC activation process. 
The integration of multiple stimuli over a defined temporal window might allow a more effective 
response to invading pathogens than to soluble microbial products. This mechanism substains the 
ability of DCs of integrating signals from pathogens, cytokines and T cells, leading to the 
generation of an adaptive immune response of the appropriate class (Reis e Sousa, 2004) 
Infact, DCs represent a critical source of interleukin 12 (IL-12), a cytokine that is key in innate 
responses and drives T helper type 1 (Th1) polarization (Trinchieri, 2003), but also other cues 
driving T cell differentiation have been described. One such factor is IL-23, which shares the p40 
chain with IL-12 but pairs this with a unique p19 chain. IL-23 drives the differentiation of 
inflammatory T cells capable of secreting large amounts of tumor necrosis factor (TNF) and IL-17, 
which mediate tissue damage in autoimmune diseases (Cuang et al., 2003; Langrish et al., 2004). 
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The transcriptional analysis indicated that, far from being inactive microbes, S. cerevisiae 
yeast cells activate a defined pathway of immune responses in moDCs, balancing each other in 
order to avoid potentially harmful inflammation processes. The DC transcriptional response to 
pathogenic fungi has been previously in part addressed. The transcriptional report of DCs 
stimulated with a C. albicans strain defecting in filamentous development in experimental 
conditions largely superimposable to that used in our paper was reported by Huang et al. (2001). 
The overall response, taking into account the different technology used in that experiment, is more 
closely related to S. cerevisiae cells than to C. albicans hyphae. Infact some of the genes (e.g 
CD83, IL12A, TNFA, IL6, IL1B and more) found differentially regulated by Huang et al., were 
found also differentially regulated in a similar manner in our experiment by using DCs stimulated 
with S. cerevisiae cells. 
Furthermore, the immune response to spores, a peculiar S. cerevisiae life stage, is much 
closer to the response to the well known pathogen C. albicans, indicating that the changes in S. 
cerevisiae cell wall composition during sporulation could influence DC recognition. 
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Figure 5.23. Spores induce a response closed to C. albicans. Clustering of signed Binary Enrichment 
Factors using Euclidean distance using support trees on DC stimulated with S. cerevisiae cells, spores and C. 
albicans. Colored spots indicate significant (p = 0.05) up- (red) or down- (green) regulation. The colors of 
the dendrogram indicate the percentages of the tree support (significance), from 50% (pink) to 100% (black). 
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1 
Nothing in life is to be feared, it is only to be understood 
Marie Curie 
 
 
 
 
 
6 
Differential IL-17 production and mannan recognition 
explain fungal commensalism and the insurance of 
pathogenicity  
 
 
6.1 Background 
Unlike C. albicans, S. cerevisiae life cycle alternates haploid and diploid state. Haploid 
cells mate and produce diploid cells. Diploid cells can divide by mitosis and grow and upon 
nitrogen starvation sporulate and undergo meiosis. Sporulation is a phenomenon that involved 
conformational changes in yeast cells and the final product is an ascus (that maintain the 
characteristic of the residual yeast cell wall) that encloses four spore (tetrad), which wall is 
arranged differently from cell one. In particular, mature spore wall shows 4 distinct layers from 
innermost to outermost: a layer of mannoproteins (mannan layers), one of β-1,3 linked glucose 
residues (glucan layer), a chitosan layer (α-1,4 linked glucosammine residues) and a layer of 
indeterminant structure whose major consistuent is cross-linked tyrosine dimers (dityrosine layer). 
Even if glucan content is higher than in yeast cell wall, in this one they are presumably more 
exposed Mannans and glucans are also found in the vegetative cell wall. Chitosan and dityrosine 
are unique to the spore. (Coluccio et al., 2004).  
The transcriptional results showed that that S. cerevisiae spores are ‘teleologically’ similar 
to Candida albicans hyphae in terms of ability to induce a DC response, possibly related to the 
different cell wall component disposition among S. cerevisiae cells and spores. 
 
6.2 Spores circumvent the DCs activation process 
To assess the cytokine response of moDCs to S. cerevisiae treatment, we exposed moDCs 
to yeast or spores for 24 hours in a concentration (expressed as stimuli:DC ratio) of 10:1. Cytokine 
production in supernatants was evaluated by Mesoscale or Elisa assay. In agreement with the 
microarray data presented in the previous section, yeast cells promoted an increased production of 
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IL-12p70 and IL-10 compared to spores (Figure 6.1). In order to understand if this behaviour 
could be related to pathogenic fungi, DC stimulation with C. albicans hyphae was also performed 
in parallel. 
 
 
 
Figure 6.1 Cytokine profile of spore-stimulated and yeast-stimulated DCs. DCs were stimulated for 24 
hours with spore or yeast of S. cerevisiae and surnatants were analyzed for presence of released cytokines. 
Data are representative of mean±s.d. (N=3), **p<0.01. 
       
 
 
The absence of IL-12p70 induction upon spore stimulation was observed even after 
massive or prolonged stimulation (Figure 6.2A and B). In particular DCs were exposed at different 
concentrations of yeast cells (black squares) or spores (open circles) and IL-12p70 was evaluated 
after 24 hours in culture supernatants. Otherwise, DCs were exposed to spores and yeast cells at 
10:1 ratio and IL12p70 was evaluated after 2 (gray bars), 8 (white bars) and 30 hr (black bars) of 
stimulation. 
To rule out that zymoliase treatment could interfere in DCs recognition of spores, crucial 
experiments such us the IL-12p70 production by DCs were performed in parallel by DC 
stimulation with liberated spores, liberated spores treated with zymoliase for 5 minutes more, and 
untreated asci. Upon asci stimulation, the level of IL-12p70 was comparable to that induced upon 
spores challenge (Figure 6.3). This demonstrated that the 15 minutes zymoliase treatment does not 
affect the spore wall structure in a way to interfere with the immune response. 
 
** 
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A                                                              B 
         
 
Figure 6.2 IL-12 production by spore-stimulated and yeast-stimulated DCs. (A) IL-12p70 was evaluated 
after exposure to different concentration of stimuli (spores, white circles; yeast cells, black squares); (B)) IL-
12p70 was measured after 2 (grey bars), 8 (white bars) and 30 hours (black bars). Data are representative of 
mean±s.d. (A, N=3, B, N=4), **p<0.01.  
 
                      
Figure 6.3. Zymoliase treatment does not influence IL-12p70 production by spores. To rule out that 
zymoliase treatment could interfere in DCs recognition of spores, IL-12p70 production by DCs were 
performed by stimulating DCs with liberated spores (asci treated for 15 minutes), liberated spores treated for 
5 minutes more and asci (without zymoliase treatment) at stimuli: DC ratio of 10:1 for 24 hr, IL-12p70 
production was assessed by ELISA. 
 
IL-12p70 production in the presence of C. albicans depends on internalization of the 
pathogen by DCs (Chiani et al., 2000). By blocking internalization of S. cerevisiae yeasts and 
spores using cytochalasin D (10 µg/ml), an inhibitor of actin polymerization, we showed that IL-
12p70 synthesis induced by the yeast form was strongly suppressed (Figure 6.4A), suggesting that 
cytokine production was dependent upon S. cerevisiae internalization.  
The lack of IL-12p70 production by spore-stimulated DCs could be related to a lower 
phagocytosis rate of spores, thus we evaluated the ability of moDCs to internalize spores. We 
performed confocal fluorescent microscopy and flow cytometry analysis of DCs exposed to yeast 
and spores at stimuli:DC ratio of 4:1. DCs were treated with zymolyase to detect intracellular 
yeasts/spores only, labeled with aHLA-DR-FITC and biotinylated yeasts/spores were labeled with 
streptavidin-APC (SA-APC) (Figure 6.4B and C). 
** 
6. Differential IL-17 production, mannan and fungi recognition 
 
83 
 
 
 
 
 
 
Figure 6.4. Internalization, survival rate of yeast or spore forms of S. cerevisiae and induction of ROS 
production by DCs. (A) DCs pre-treated or not with cytochalasin D (10  g/ml) were stimulated for 24 hr 
with yeast cells or spores. IL-12p70 was measured by ELISA. (B) Confocal fluorescent microscopy and (C) 
flow cytometry of DCs exposed to yeast and spores at stimuli:DC ratio of 4:1. DCs were treated with 
zymolyase to detect intracellular yeasts/spores only, labeled with aHLA-DR-FITC and biotinylated 
yeasts/spores were labeled with streptavidin-APC (SA-APC). (D) S. cerevisiae spores, yeast cells and C. 
albicans hyphae survival after culturing with DCs. Stimuli were cultured alone (black bars) or with DCs (4:1 
ratio). After 6 hr of exposure, DCs were treated (gray bars) or not (white bars) with zymolyase and lysated. 
Data are expressed as percentage of CFU of yeast growing. (E) ROS production by DCs in response to 
stimuli. DCs were stimulated with yeast cells (gray bars), spore (black bars) or without any stimuli (white 
bars) at a 4:1 ratio. NBT assay was performed after the time indicated. (E) NADPH oxidase-induced ROS 
account for the killing of S. cerevisiae cells. Stimuli were cultured alone or with DCs (4:1 ratio) in presence 
of absence of DPI (10 µM). After 6 hr of exposure, DCs were treated with zymolyase (white bars) and 
lysated. DPI did not influence viability of stimuli. Data are expressed as percentage of CFU of yeast growing. 
Data are representative of three separate experiments (mean±s.d, A, B, C, D, E, F). Statistical comparisons 
between samples are represented as horizontal bars, *p<0.05, **p<0.01.  
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We found that spores, as well as yeast cells, similarly interacted with DCs and that spores 
were equally internalized as observed after elimination of surface-bound spores by zymolyase 
treatment (Figure 6.4B and C).  
This indicates that spores and yeast cells are equally taken up by DCs.  
 
6.2.1 Spores could evade degradation process by DCs 
We next investigated the degradation process of S. cerevisiae yeast cells, spores and C. 
albicans hyphae in the phagosome by evaluating the survival following their uptake by moDCs. 
We cultured moDCs in the presence of S. cerevisiae yeast cells or spores and C. albicans, then 
lysated the DCs and plated on yeast growth medium. As shown in Figure 6.4D, significantly more 
colonies were obtained from internalized spores or C. albicans compared to S. cerevisiae yeasts 
after 6 hours of exposure.  
We therefore measured ROS production by DCs cultured with yeast or spores for 8, 24 and 
48 hours (Figure 6.4E) by measures of formazan accumulation after ROS oxidation (see 
Experimental Procedures).  
The reduced production of ROS in the presence of spores together with the intrinsic 
resistance of spore wall structure to acidic pH might account for the increased intracellular survival 
ability of spores compared to the yeast cell.  
ROS production is one of the parameters, that most likely reflects the differences in 
intracellular killing: previous studies demonstrated the important role on NADPH oxidase-induced 
ROS in DC killing of C. albicans. In order to link production of ROS and survival of spores upon 
internalization, we performed survival experiments in the presence of DPI, an inhibitor of 
flavoproteins including the NADPH oxidase. DPI-treated DCs lack ROS production in response to 
PMA (Vulcano et al., 2004), therefore DPI is a useful reagent to investigate NADPH oxidase 
activity in DC. DPI treatment (10 µM) abrogated the ability of DCs to kill S. cerevisiae cells 
without affecting spore survival (Figure 6.4F). These results indicate that ROS produced by 
NADPH oxidase play an important role in DC fungicidal activity and that the observed major 
survival of spore could suggest an escape mechanisms to oxidative damage as reported for C. 
albicans (Donini et al., 2007). We can speculate that the lack of IL-12p70 production and the 
reduced production of ROS might all be mechanisms by which spores circumvent the DC 
activation process.  
To obtain indications on the possible relevance of differential survival in vivo, we 
measured survival of S. cerevisiae cells and spores fed to rats by plating stool samples after 1 to 4 
weeks of treatment. Furthermore, in faecal sample of rats treated with spores we assessed the 
presence of spores. The results indicated that S. cerevisiae spores can survive the passage through 
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the gut, while yeast cells cannot (Table 6.1), but does not allow to conclude anything on the 
mechanism. Further in depth investigations of the molecular mechanisms and on the role of 
different cell types, including the response to Candida hyphae, will be fundamental to clarify the 
role of DCs in determining differential survival. 
 
Table 6.1. Survival of S. cerevisiae through rat intestinal tract.  
TREATMENT 1 week* 2 weeks* 3 weeks* 4 weeks* 
Control 0 CFU/ml 0 CFU/ml 0 CFU/ml 1.2 CFU/ml 
Yeast cells 2±0.5 CFU/ml 3±1 CFU/ml 4±1 CFU/ml 3.5±1 CFU/ml 
Spores 2000±100 
CFU/ml 
2500±100 
CFU/ml 
2500±100 
CFU/ml 
4000±250 
CFU/ml 
*data expressed as colony forming unit (CFU) grown after plating 1 ml of faecal sample 
 
6.3 DCs stimulated by diverse forms of S. cerevisiae prime a different T helper 
response 
Whether Th1 or Th17 responses arise depends on the balance between the Th1 polarizing 
factor IL-12p70 and the Th17 polarizing factors (IL-1, IL-6 and IL-23 in humans) with IL-12p70 
being dominant over Th17 polarizing factors (Bettelli et al., 2008). The evidence that moDCs 
released IL-12p70 in the presence of yeast cell and almost no IL-12p70 in the presence of spores 
prompted us to ask whether moDCs, which were matured in the presence of these two forms of S. 
cerevisiae, differed in their capacity to promote Th1 and Th17 responses. CD4+ cells were co-
cultured in a ratio of 20:1 with autologous moDCs, which matured for 12 hours with S. cerevisiae 
cells or spores. Quantitative real-time PCR assays were performed to assess the expression over 
time of IL-6 and IL-17A genes, encoding for cytokines involved in Th17 polarization, and the 
IFNG gene, encoding for the main cytokine produced by Th1 cells on CD4+ T cells stimulated with 
spore or yeast-stimulated DCs (Figure 6.5A). The analysis showed an increase of IL-17A mRNA 
and of IL-6 mRNA in T cells exposed to spores- and C. albicans-stimulated DCs compared to 
unstimulated DCs just after 24 hours of co-culture. By contrast yeast-stimulated DCs did not 
induce IL-17A gene activation and only slightly increased IL-6 gene activation (Figure 6.5A). The 
INFG gene was activated by all the stimuli (Figure 6.5B). The expression of the FOXP3 gene was 
found to be increased in T cells after 5 days of co-culture with yeast-stimulated DCs only (Figure 
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6.5C) suggesting that yeast cells might induce the differentiation of a Treg population, as also 
supported by microarray data (Figure 5.22A).  
In co-culture experiments with autologous CD4+ T lymphocytes, we used C. albicans hyphae 
stimulation as control stimulus for IL-17 induction. As expected, IL-12 producing yeast-matured 
DCs promoted a pure Th1 response, inducing the release of IFNγ only (Figure 6.6A). In contrast, 
spore-stimulated DCs, such as the pathogenic fungus C. albicans, induced the release of a 
substantial amount of IL-17 together with IFNγ, consistent with the presence of a Th17 response 
(Figure 6.6). Thus, the low levels of IL-12p70 induced by spore stimulation were sufficient to 
induce a Th1 response but they could also allow the effect of Th17 polarizing factors on IL-17 
production by CD4+ T cells. 
 
 
              
 
 
Figure 6.5. Effect of spore-stimulated DCs or yeast-stimulated DCs on CD4+ effector T cell 
differentiation. (A) IL6, IL17A and (B) IFNG gene expression in CD4+ T-cells exposed to spores (white 
circles) or yeast cell (black square) for 24, 48 and 72 hours; (C) FOXP3 gene expression in CD4+ T-cells 
exposed to spores or yeast cell for 5 days. All data are presented as mean±s.d (A, B, N=3).  
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Figure 6.6. Effect of spore-stimulated DCs or yeast-stimulated DCs on cytokine production by CD4+ 
effector T cell. IL-17 and IFNγ measurement in 5-day culture supernatants of CD4+ T cells produced in 
response to yeast- and spore-stimulated DCs 
 
 
6.3.1 IL-12p70 antagonizes Th17 priming 
To assess the importance of IL-12p70 in the balance of Th1/Th17 responses we cultured 
DCs with spores or C. albicans hyphae in the presence of human recombinant IL-12p70. The added 
IL-12p70 during DC stimulation by spores rescued the ability of DCs to polarize a pure Th1 
responses, in a dose dependent fashion as well as antagonized the IL-17 induction by C. albicans 
(Figure 6.7A), indicating that high amount of IL-12 can indeed counteract the effect of the Th17 
polarizing factor. To address this observation in yeast stimulated DCs, we used an antibody against 
IL-12 to block the activity of the cytokine. The block of IL-12 activity favoured Th17 cell 
activation (Figure 6.7B). This demonstrates the important role exerted by IL-12 in balancing the 
fungal immune response. 
 
6.4. S. cerevisiae recognition by DCs: differential involvement of MR and DC-SIGN  
As previously reported in the Introduction, different receptors are responsible of 
recognition and internalization of conserved structure of yeast cell wall. C-type lectins, such as 
Dectin-1, DC-SIGN and the macrophage mannose receptor (MR) specifically mediate C. albicans 
binding and internalization by DCs (Hernanz-Falcón et al., 2009; Newman and Holly, 2001; Cambi 
et al., 2003; Cambi et al., 2008). 
While β-glucan is specifically recognized by Dectin-1 (Reid et al., 2009), N-linked mannan is the 
fungal carbohydrate structure specifically recognized by MR and DC-SIGN directly influencing the 
production of pro-inflammatoy cytokines (Cambi et al., 2008).  
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Figure 6.7. IL-12p70 drives the balancing between Th1 and Th17 response. (A) Human recombinant IL-
12p70 rescue Th1 polarization upon S. cerevisiae spore and C. albicans hypahe stimulation in a dose 
dependent fashion. DCs were treated with spores or C. albicans for 8 hr in presence of hrIL12-p70 and ability 
of DCs to polarize a Th1 or a Th17 response were assessed by IFNγ and IL-17 measurement, respectively, in 
5-day culture supernatants of CD4+ T cells. (B) Blocking IL-12p70 activity by using an antibody specific for 
IL-12 results in a loss of IFNγ production and promotes IL-17 production in 5-day culture supernatants of 
CD4+ T cells in response to yeast- stimulated DCs. Statistical comparisons between samples are represented 
as horizontal bars, *p<0.05, **p<0.01. 
 
 
To identify which receptors are involved in the differential recognition of S. cerevisiae 
spores, we performed experiments with competitive ligands of the structures most commonly 
involved in fungal recognition: laminarin for dectin-1, mannan for mannose receptor and chitin for 
chitin receptors (Netea et al, 2006). Untreated DCs or DCs pre-exposed for 2 hours to the receptor 
agonists, laminarin, mannan and chitin (100 µg/ml. respectively) were incubated with yeasts and 
spores for 6 hours. Blocking each of these receptors resulted in an inhibition of TNFα production 
in DCs stimulated by yeast cells (Figure 6.8A). 
On the contrary, none of the three competitor ligands was able to inhibit TNFα release in 
spore-stimulated DCs, suggesting that the molecular pathways involved in spore recognition could 
be different from those commonly implicated in yeast-DC interaction.  
Human DCs are able to bind C. albicans through MR (Newman and Holly, 2001) and DC-
SIGN (Cambi et al., 2003). In order to assess if these receptors could contribute to the different 
recognition of yeast cells or spores by DCs, we used the transfectant (CHO) cell line stably 
expressing DC-SIGN to investigate the ability of S. cerevisiae cells or spores to bind DC-SIGN in 
the absence of any other known fungal receptors.  
6. Differential IL-17 production, mannan and fungi recognition 
 
89 
PKH206-labeled transfectant (CHO) cells stably expressing DC-SIGN were exposed to 
FITC-labeled yeast (black bars) or spores (white bars). mAbs AZN-D1/D2/D3 and L19 were used 
to block DC-SIGN and β2-integrin, respectively. By flow cytometry we assessed that DC-SIGN 
clearly mediates adhesion to both yeast cells and spores (Figure 6.8B). Blocking-antibodies against 
DC-SIGN significantly inhibited binding of S. cerevisiae by CHO-DC-SIGN. Furthermore, the 
calcium chelator EGTA abrogated binding. This Ca2+ dependence confirms that the C-type lectin 
domain of DC-SIGN mediates binding to yeast cells and spores.  
To get further insight into the specificity of DC-SIGN recognition, we analyzed several 
purified fungal cell wall components for their capacity to inhibit the interaction between DC-SIGN 
and S. cerevisiae. In particular we used SC-mannan, CA-mannan, β-glucan or mannose.  
CA-mannan was the only carbohydrate that inhibited DC-SIGN binding to S. cerevisiae. SC-
mannan was not able to inhibit binding of spores as previously observed for C. albicans (Cambi et 
al., 2003).  
To determine the receptor repertoire involved in the interactions between DCs and S. 
cerevisiae, we performed similar experiments using moDCs and blocking MR and DC-SIGN either  
with purified fungal cell wall glycans (Figure 6.8C) or with antibodies (Figure 6.8D). Blocking of 
β2-integrin receptors was used as negative control. In particular, CD45-APC-labeled DCs were 
incubated with FITC-labeled yeast (black bars) or spores (white bars) in the presence or absence of 
anti-DC-SIGN mAb, a mixture of anti-DC-SIGN Abs, anti-MR mAb, EDTA and anti-β2-integrin 
antibody as control or SC-mannan, CA-mannan, β-glucan or mannose. As before, basal binding 
(TSA) is set as 100%. 
Again, blocking-antibodies against DC-SIGN significantly inhibited binding of spores and 
yeast cells by DCs, suggesting that DC-SIGN plays an important role in S. cerevisiae recognition. 
Interestingly blocking of MR by using antibody or mannose only affected the DC ability to bind 
yeast cells, whereas had no effect in the binding to spores (Figure 6.8).  
To assess if the different recognition of spores and yeast cells by DCs influences the 
internalization we performed a phagocytosis assay, labeling specifically MR and DC-SIGN. By 
confocal microscopy the double labeling or MR and DC-SIGN showed that, after yeast cell 
stimulation, the two receptors co-localized in the same phagocytic vesicle (Figure 6.9).  
This indicates that yeast cells were internalized by DCs in vesicles containing both MR and 
DC-SIGN as well as mutually exclusive vesicles, as previously reported for C. albicans 
internalization (Cambi et al., 2005). In contrast, spores were internalized by DCs in vesicles 
containing DC-SIGN only as shown by the lack of co-localization of the two receptors (Figure 6.9).  
These results clearly demonstrate that DCs use a different PRR repertoire to recognize 
different life stages of the same microorganism. 
 
6. Differential IL-17 production, mannan and fungi recognition 
 
90 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. MR and DC-SIGN involvement in S. cerevisiae recognition. (A) Untreated DCs or DCs pre-
exposed to receptor agonists, laminarin, mannan and chitin were incubated with yeasts and spores for 6 hr. 
TNFα  production was inhibited by receptor agonist treatment only in yeast-stimulated DCs. (B) DC-SIGN 
specifically binds to both S. cerevisiae cells and spores. PKH206-labeled transfectant (CHO) cells stably 
expressing DC-SIGN were exposed to FITC-labeled yeast (black bars) or spores (white bars). mAbs AZN-
D1/D2/D3 and L19 were used to block DC-SIGN and β2-integrin, respectively. Addition of EGTA showed 
that DC-SIGN-mediated binding is Ca2+ dependent. (C) and (D) Immature DCs binds S. cerevisiae trough C-
type lectins. CD45-APC-labeled DCs were incubated with FITC-labeled yeast (black bars) or spores (white 
bars) in the presence or absence of anti-DC-SIGN mAb, a mixture of anti-DC-SIGN Abs, anti-MR mAb, 
EDTA and anti-β2-integrin Ab as control or SC-mannan, CA-mannan, β-glucan or mannose. Basal binding 
(TSA) is set as 100%. All data are presented as mean±s.d (N=3). Statistical comparisons between samples 
are represented as horizontal bars, *p<0.05, **p<0.01. 
 
 
 
 
 
 
 
 
6. Differential IL-17 production, mannan and fungi recognition 
 
91 
 
 
 
 
 
 
Figure 6.9. Differential involvement of MR and DC-SIGN in S. cerevisiae spore and cell recognition. 
Labeling of MR (in red) and DC-SIGN (in green) show considerable colocalization with yeast cells 
(asterisk). Spores are internalized by DC-SIGN-containing vesiscle only. All data are presented as mean±s.d 
(N=3). 
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6.5 Role of exposed mannan in defining immune responses to S. cerevisiae  
It was recently demonstrated that the MR is the main pathway trough which C. albicans 
induces a Th17 response. The interaction between the various Saccharomyces cell wall-associated 
structures with their counter-receptors, and the implications to DC function remain unknown. The 
only indirect evidence available indicates that C. albicans mannan (CA-mannan) but not S. 
cerevisiae-derived mannan (SC-mannan) is able to induce IL-17 production upon PBMC 
stimulation (van der Veerdonk, 2009), implying that the different branches of the two structures 
profoundly influence the recognition of fungi and the subsequent Th response. 
Since SC-mannan itself cannot induce IL-17 production despite interacting with MR 
(Cambi et al., 2008) and spores lack exposed mannan, we further investigated the specific role of 
this branched carbohydrate in stimulating the innate S. cerevisiae immune response. We assessed 
by stimulation of immature DCs with SC-mannan that mannan itself stimulated IL-12p70 
production by DCs (Figure 6.10) indicating that the exposure of SC-mannan could influence the Th 
response priming. Thus, DCs were exposed or not to an excess of SC-mannan (100 mM) for 2 
hours and stimulated with spores for 8 hours. Then the co-colture with CD4+ T cells was 
performed. IL-12p70, IFNγ and IL-17 were measured. The amount of IL-12p70 produced by SC-
mannan was sufficient to inhibit the IL-17 production by T cells induced by spores (Figure 6.10). 
This suggests that the lack of SC-mannan in spore may be responsible for the low IL-12 
production.  
 
 
            
 
Figure 6.10. S. cerevisiae derived-mannan inhibits Th17 response induced by spores. DCs were exposed 
(white bars) or not (black bars) to an excess of SC-mannan (100 mM) for 2 hours and stimulated with spores 
for 8 hours. Thus the co-colture with CD4+ T cells was performed. IL-12p70, IFNγ and IL-17 were 
measured. All data are presented as mean±s.d (N=3). 
 
 
From previous reports it is known that Candida och1 mutant, defective in mannosylation 
process, failed to interact with DCs supporting the important role played by N-linked mannan in 
the binding of C. albicans to DCs (Cambi et al., 2008). In contrast, in S. cerevisiae, OCH1 gene is 
not only required for a proper mannosylation but also for masking the β-glucan and the immune 
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recognition by the Dectin-1 pathway (Wheeler and Fink, 2007) involved in Th17 priming (Acosta-
Rodriguez et al., 2007).  
This prompted us to further investigate the effects of absence of exposed mannan in Th17 
induction by S. cerevisiae spores. DCs were exposed to cells of different S. cerevisiae strains (SK1, 
BY4741 wild type, BY4741 och1 mutant), to C. albicans hyphae and to SK1 spores for 12 hours 
and their capacity to prime Th17 or Th1 polarization of T cells was assessed by IL-12, IL-17 and 
IFNγ measurement by ELISA. Stimulation with S. cerevisiae och1 mutant yeast cells polarized a 
Th1/Th17 population towards the type of responses induced by spores (Figure 6.11).  
 
 
         
 
Figure 6.11. Absence of exposed mannan induces Th17 polarization. DCs were exposed to cells of 
different S. cerevisiae strains (SK1, BY4741 wild type, BY4741 och1 mutant), to C. albicans and to SK1 
spores for 12 hr and their capacity to prime Th17 or Th1 polarization of T cells was assessed by IL-12, IL-17 
and IFNγ measurement by ELISA. All data are presented as mean±s.d (N=3). 
 
 
Stimulation with C. albicans hyphae polarized a Th17 response as previously demonstrated 
(van der Veerdonk et al., 2009). These data demonstrate that the presence of exposed mannan on 
the cell wall influences the immune response mounted by the DCs to properly respond and tolerate 
S. cerevisiae yeast cells, differently to what occur with C. albicans hyphae.  
We demonstrated that spores are recognized by DC-SIGN and not by MR and we know 
that SC-mannan is a ligand for DC-SIGN as well as MR. To understand the relative contribution of 
these two receptors in S. cerevisiae Th response, we exposedDCs to blocking antibodies before 
exposure to spores and yeast cells. The blocking of MR induced the decrease in IL-12p70 
production and an increase of IL-17 induction upon yeast cells stimulation, while blocking of DC-
SIGN showed a slightly effect on IL-17 production (Figure 6.12).  
Thus, we show that in contrast to C. albicans hyphae stimulation, S. cerevisiae cells 
interaction with DCs, exerted by mannan, favours the IL-12/IFNγ axis, while the absence of 
exposed mannan in spores induces a Th17 response.  
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Figure 6.12. Specific role of mannan structures for interaction of host cells with S. cerevisiae. DCs were 
exposed to S. cerevisiae cells, spores and C. albicans (purple bars). mAbs were used to block MR (black 
bars) or DC-SIGN (white bars) or exposure to SC-mannan (light blue bars) were used. After 12 hours, IL-12-
p70 was measured and after 5 days of co-colture IL-17 was assessed on T cells supernatants. All data are 
presented as mean±s.d (N=3). 
 
 
6.6 Discussion 
Our results demonstrate the usefulness of S. cerevisiae as a tool to learn the rules of 
cohabitation between yeast and its host. The relationship between humans and S. cerevisiae is so 
strong that some strains of this species are often referred to as domesticated organisms (Liti et al., 
2009). Our results demonstrate that, in spite of the lack of IL-12p70 production by DCs, spores, a 
peculiar form of S. cerevisiae, induce a Th1/Th17 polarization of CD4 T cell precursors. In contrast 
the activation of suppressive mechanisms, such as the increased expression of the IDO gene in DCs 
and the induction of a CD4+ FOXP3+ Treg population, was observed upon yeast cell stimulation. 
Furthermore, in contrast to what happened with yeast cells, spores seem to interact with 
DC with a reduced activation of the NADPH oxidase and inducing a poor fungicidal activity of 
these cells as previously reported for C. albicans (Donini et al., 2007). Further investigation on the 
nature of this possible oxidative damage escape mechanisms will be carried out in follow-up 
studies. 
We observe that similarly to what reported for C. albicans (Cambi et al., 2008), interaction 
between S. cerevisiae yeast and DCs is mediated by mannan rather than other fungal cell wall 
components. While recognition of mannan and mannose by DC-SIGN and MR plays an important 
role in binding and phagocytosis of S. cerevisiae cells by human DCs, DC-SIGN alone seems to 
have the major role in spore recognition. Our data suggest that the outermost layer of dityrosine 
present on spore wall could hide to DCs important carbohydrates, influencing immune detection by 
eluding important PAMPs.  
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We demonstrate that the interplay between spores and yeasts is crucial for the 
commensalism of S. cerevisiae. The differential induction of a Th1 response versus a Th17 
response is determined by the structure of the cell wall of these two forms of the fungus. Our 
results indicate that SC-mannan could favor a specific individual recognition pathway through 
mannan-recognizing receptors such as MR, DC-SIGN or TLR4 that lead to different cytokine 
release and the polarization of a Th1 response. By contrast, the absence of exposed mannan 
contributes to the Th17 induction by the spores.  
We show that S. cerevisiae och1 mutant, defective in N-mannosylation process, induces a 
Th1/Th17 response comparable to that induced by spores, highlighting the importance of the 
presence of the mannan layer to address the T cell response to better cope with the invading 
pathogen.  
The differential recognition of mannan from C. albicans and S. cerevisiae is most likely 
due to the different branching of these structures. In contrast to SC-mannan, CA-mannan induces 
potent Th17 responses (van der Vendoonk et al., 2009), which suggests that MR is differently used 
by C. albicans and S. cerevisiae to induce an immune response. The relative contribution of DC-
SIGN in Th17 priming is under investigation. 
Our results show that in moDCs S. cerevisiae spores are able to activate different molecular 
pathways with respect to yeast cells.  
The evidence that S. cerevisiae spores do not induce IL-12p70 and are resistant to 
phagocytosis suggests that sporulation may be a mechanism for circumventing adaptive immune 
responses as well as the Th1 responses that protect against intracellular pathogens. Both Th1 
(Acosta-Rodriguez et al., 2007) and Th17 (Huang et al., 2004; Milner et al., 2008; Conti et al., 
2009) cells have been proposed to mediate protection against pathogenic fungi and in particular 
against C. albicans. C. albicans can switch from being an intracellular form, the yeast, that can be 
efficiently destroyed by macrophages with the help of Th1 cells, to being an extracellular form, the 
hyphae, that is better controlled by neutrophils (Urban et al., 2008) recruited by Th17 cells. This is 
consistent with the differential chemokine profile we observed in cells challenged with the yeast or 
the hyphae. Indeed Th1 cells express CXCR3 and migrate towards IFN dependent chemokines, 
such as CXCL10 and CXCL11, which are preferentially induced in response of the yeast. In turn, 
Th17 cells express CCR6 and are recruited in response of CCL20, which is preferentially expressed 
in the presence of the hyphae. The pattern of chemokine expression induced by the spore is similar 
to that induced by the hyphae. This might represent a mechanism to escape the Th1 responses 
mediated by the CXCR3-CXCL10 axis and to favour Th17 responses which might be beneficial for 
the pathogen. Indeed here we show that the enhancement of Th17 responses in presence of S. 
cerevisiae spores, via increased IL-1β and IL-6 release, favours spore expulsion. This finding may 
have relevance for autoimmune diseases such as inflammatory bowel disease (IBD) where S. 
cerevisiae spores could play a role in the inflammation process mediated by a mixed Th1/Th17 
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response. Interestingly, anti-S. cerevisiae antibodies can be detected in a subset of patients with 
Crohn’s disease and are considered to be markers of active disease (Standaert-Vitse et al., 2006). 
The capacity of spores to promote IL-17 release may be a possible link between S. cerevisiae and 
the pathogenesis of this disease and therefore sporulation could be a potential target for therapy.  
It has been recently shown that survival of S. cerevisiae spores in Drosophila 
melanoglaster gut is increased compared to yeast cells (Coluccio et al., 2008) and that spores are 
thus more resistant to innate mechanisms of protection. In this work, we find that spores but not 
cells of S. cerevisiae can be isolated from faecal samples of rats treated with spores or yeasts. This 
result indicates the functional implications of differential immune recognition of spores with 
respect to yeast cells. Reports of spores in mammalian intestine are rare probably due to the habit 
of culturing faecal samples rather than observing them by microscopy. This result opens new 
avenues for further investigation on the in vivo nature of the immune response in animal models 
and IBD’s patients in future studies 
Tolerance requires the ability of the microbe to circumvent inflammatory signals evolved 
as response to potentially pathogenic microorganisms. We demonstrate that the differential 
recognition of specific mannan structures is the master regulator of the discrimination between 
harmful and harmless fungi, outlining the importance to deeper insight on the specific contribution 
of each receptor in fungal recognition.  
The higher capacity of SC-mannan to induce IL-12/Th1 protective response is likely to 
play a major role for the non-pathogenicity of S. cerevisiae and its commensalism in humans. Our 
findings are ecologically important as insects and mammalians that feed on fruits and fermented 
beverages are continuously contaminated with yeasts that can potentially colonize the gut. 
Sporulation may have evolved in yeast to allow host clearance while surviving the immune 
response. This trait may be advantageous and explain the maintenance of the ability to sporulate, as 
indicated by the high sporulation rates of many of the naturally existing strains (Mortimer, 2000). 
The yeast ecological cycle could therefore possibly include mammals as hosts and vectors.
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 D Creativity requires the courage to let get go of certainties. Erich Fromm 
 
 
 
 
 
7 
Discussion 
 
 
Despite life-threatening systemic fungal infections has risen steadily over the past three 
decades, although this increase might now be reaching a plateau. The increased prevalence of fungi 
as agents of disseminated infection has been restricted to patients in whom surgical or 
chemotherapeutic interventions and/or underlying immunological deficiencies have allowed fungi 
to overwhelm the protective host defence mechanisms. In healthy and immunologically normal 
individuals, the innate immune system is an efficient sentinel that provides protection from the 
thousands of fungal species that humans regularly encounter.  
Candida albicans and Saccharomyces cerevisiae are ubiquitous fungal organism that often 
colonizes the skin and the mucosal surfaces of normal individuals, without causing disease. 
However, when the normal host defence mechanisms are impaired they can become a pathogen.  
Until recently, little was known about the ways in which antigen presenting cells, the major players 
in innate immunity, recognized C. albicans as a pathogenic and S. cerevisiae as a harmless 
microorganism, or how the fungal–leukocyte interaction triggers an inflammatory response. The 
dogma that had been blindly accepted over the past 50 years was that although effective, innate 
immunity was non-specific and ‘rather primitive and dumb’. However, this simplistic model, in 
which innate immunity performs only simple ‘ingest and destroy’ tasks, could not explain how 
innate immune cells recognize microbial pathogens as ‘non-self’, or why different responses are 
triggered by different classes of microorganisms, be they pathogenic or commensal. Only in the 
past decade has it become clear that the innate immune system not only specifically recognizes 
various classes of microorganisms, it also initiates and modulates the subsequent adaptive 
responses that are delivered by T and B cells through their interactions with antigen- presenting 
cells, especially dendritic cells (DCs). The tasks of recognizing an invading pathogen and 
activating the host response are accomplished by pattern-recognition receptors (PRRs), which 
recognize conserved microbial chemical signatures called pathogen-associated molecular patterns
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 (PAMPs). 
 
An association between morphogenesis and virulence has long been presumed for dimorphic 
fungi that are pathogenic to humans, as one morphotype exists in the environment or during 
commensalism, and another within the host during the disease process. For C. albicans, putative 
virulence factors include the ability to switch between harmless yeast and pathogenic, filamentous 
forms of the fungus. DCs sense either form in a specific way, resulting in distinct, T helper cell-
dependent protective and non-protective immunities. Recent evidence suggests that the use of 
distinct recognition receptors contributes to the disparate patterns of reactivity observed locally in 
response to challenge with C. albicans. The interaction between S. cerevisiae and human societies 
is so generally recognized to hypothesize domestication of strains of this species.  
Successful resolution of pathogenic fungal disease depends on proper coordination of multiple 
components of the host immune response. The balance between pro- and anti-inflammatory 
signalling is a prerequisite for safe host-fungal interactions. Although inflammation is an essential 
component of the protective response to fungi, its deregulation may significantly worsen fungal 
diseases and limit protective antifungal immune responses.  
Host/fungal interactions have so far been studied only for pathogenic fungi such as C. 
albicans, but it is not known what determines the commensalism of harmless fungi. Understanding 
the mechanisms of cohabitation between humans and non-pathogenic fungi is a prerequisite for 
controlling fungal infections. We investigated the rules of host-fungal cohabitation and dissected 
the mechanisms responsible for the differential recognition demonstrating that the skewing in the 
use of pathogen recognition receptors by differences in cell wall composition is a requirement for 
pathogenicity.  
 
The immune response is a complex entity with many possible inputs, influences and 
outcomes, and systems biology holds the promise of allowing us to both better understand its 
nature, and generate predictions and hypotheses about its behaviour under particular conditions. 
Immunity is not simply the product of a series of discrete linear signalling pathways; rather it is 
comprised of a complex set of integrated responses arising from a dynamic network of thousands 
of molecules subject to multiple influences. Its behavior often cannot be explained or predicted 
solely by examining its components. 
The comparison of the immune response to pure agonists and entire cells clearly illustrated 
how without addressing the complexity of the response to entire fungi it is impossible to model the 
immune response. In particular the exposure to entire living cells highlighted the importance of 
signalling from different cellular compartments dissecting the interplay between outer membrane 
and phagosomal receptors. Our result indicate the importance of the temporal window between the 
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initial recognition of the fungus at the cell surface and the stimulation of the other receptors that 
intensify, complement and sustains the DC activation process. 
The integration of multiple stimuli over a defined temporal window is a requirement for an 
effective response that can be understood only when studying the challenge with pathogenic and 
non-pathogenic microorganisms in addition to soluble microbial products. This mechanism is of 
paramount importance for the generation of an adaptive immune response of the appropriate class. 
Our transcriptional analyses indicated that one of the major differences between stimulation of DCs 
with S. cerevisiae yeast cells and Candida hyphae activate a common defined pathway of immune 
responses, that differs importantly for the differential regulation of sustained transcription of C-
type lectins in Candida hyphae, contrary to repression of sensing proteins genes in DCs treated 
with S. cerevisiae. This evidence supports the observation that the activation of the phagosomal 
pathways is partially or totally missing from the stimulation with Candida hyphae (similarly to S. 
cerevisiae spores) and could be associated with a lack of switch repressing signalling from cell 
membrane an activating signalling from the phagosome, visible in yeast but not in hyphae. This 
temporally restricted switch could be crucial in moDCs, balancing tolerogenic and inflammatory 
responses, in order to guarantee microbial recognition and avoid potentially harmful sustained 
inflammation processes. 
The transcriptional analysis indicated that, far from being inactive microbes, S. cerevisiae 
yeast cells activate a defined pathway of immune responses in moDCs, balancing each other in 
order to avoid potentially harmful inflammation processes.  
 
The type of immune response mounted is primarily determined by the initial interaction 
between the pathogen and the cells of innate immune system. The ability to eradicate fungal 
infection has been associated to Th1 response. Conversely, a Th17 polarization has been described 
in several pathological conditions and is activated in response to pathogenic fungi. 
It was previously shown that the important differences in the structure of Saccharomyces-derived 
mannan and Candida-mannan determine differential responses. In contrast to Saccharomyces 
mannan, Candida-mannan induces potent Th17 response, which suggests that MR is differently 
used by C. albicans and S. cerevisiae to induce an immune response. We used human monocyte-
derived dendritic cells exposed to cells and spores of the yeast S. cerevisiae as well as C. albicans 
hyphae, as a toolbox to dissect the role of surface mannans which are central for pattern 
recognition.  
Combining transcriptional analysis with receptor-specific blocking and cytokine production 
assays, we determined that DCs respond differently to C. albicans and S. cerevisiae and in the 
latter case, the interplay between spores and yeasts is crucial for the commensalism of S. 
cerevisiae. In contrast with the yeast cell wall, mannan are present only in the innermost layer of 
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the spore wall preventing mannan recognition. We identified that, while yeast cells are recognized 
either by MR and DC-SIGN, spores are recognized by DC-SIGN only, suggesting that not only 
MR acts differently in response to pathogenic and non-pathogenic fungi but also in response to 
different form of the same microorganism.  
 
Our results indicate that S. cerevisiae mannan favor a specific individual recognition 
pathway through mannan-recognizing receptors, leading to different cytokine release and the 
polarization of a Th1 response. In contrast, the absence of exposed mannan on the spore surface 
contributes to the Th17 induction by the spores. We demonstrated that the differential recognition 
of specific mannan structures is the master regulator of the discrimination between harmful and 
harmless fungi. The higher capacity of Saccharomyces-mannan to induce IL-12/Th1 protective 
response is likely to play a major role for the non-pathogenicity of Saccharomyces and its 
commensalism in humans, in contrast with Candida mannan-Th17 induced response.  
We demonstrate that the spores are able to elicit a Th17 response, hypothesizing this as a 
mechanism of escaping host clearance that ultimately may favour yeast dissemination. Thus, we 
investigated the potential of yeast spores to survive passage through the human host and be 
disseminated in new environments.  
 
Our results bear importantly on the ecological significance of sporulation and on the central 
role of fungal cell wall recognition in discrimination between friends and foes. 
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Conclusion 
 
The research presented here aimed at using a Systems Biology approach to dissect the 
response of dendritic cells to fungi. Systems Biology requires the acquisition of information on the 
different levels of regulation of a biological system and its integration in the development of 
models, that could predict the outcome of stimuli and changes in variables controlling the dynamic 
nature of the system. This work combined traditional wet-lab work and genome wide analyses of 
transcription and gene regulation, with computational and bioinformatic methods to dissect the 
response of dendritic cells to fungi, in particular to the harmless Saccharomyces cerevisiae. 
Dissecting the poorly characterized immune response to this non-pathogenic yeast is of paramount 
importance to identify the thin line that render a saprophytic fungus an opportunistic pathogen one. 
Extending our studies to different forms of clinical isolates of S. cerevisiae will be crucial 
to fully understand the rules of proper recognition of fungi and might lead to development of new 
drugs to treat fungal infections or Immune Bowel Disease.  
From an ecological perspective the observation that spores evolved strategies to survive 
better than yeast cells in mammalian viscera, and spore-mediated Th17 response could suggest 
spores as a mean to circumvent host clearance, that ultimately may favor the use of mammals as a 
vectors for yeast dissemination. The evidence that S. cerevisiae cells induce a tolerogenic response 
explains its description as non pathogenic microorganism. The finding that only spores are capable 
of inducing IL-17-mediated inflammatory response might provide the missing link between the 
presence of anti-S. cerevisiae antibody and inflammatory bowel diseases, and sporulation, a 
potential target for therapy.  
Understanding the molecular mechanisms governing immune response discrimination of 
pathogenic and non pathogenic microorganisms is the only way to the understanding of aberrant 
immune phenomena such as autoimmunity and chronic inflammatory diseases as well as informing 
the design of vaccine, immune-modulatory drugs and novel antifungal drugs. 
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Appendix A 
 
The following is the text of the short description of the reaction involved in Dectin-1 signalling. 
 
DECTIN-1 SIGNALLING 
 
SENSING MODULE – SYK  
• The 1,3-β-glucan particles binds to the C-type lectin Dectin-1 in glucan containing 
phagosome.  
• The adaptor Dectin-1 dimerizes and becomes tyrosine phosphorilated.  
• Syk binds to dectin-1 dimer and autophosphorilates.  
 
TRANSDUCTION MODULE – NFkB - RELA 
• Syk autophosphorilates and phosphorilates the transmembrane adaptor CARD9 
• The effector molecule BLC10 binds to MALT1 by PLCG2 activity. 
• After a conformational change CARD9 binds to the complex BLC10:MALT1. 
• The complex binds to TRAF6. 
• The protein TRAF6 binds to the serine/threonine kinases TAK1, TAB1, TAB2 
(TRAF6:TAK1:TAB1:TAB2). 
• The complex of the serine/threonine kinases TAB1-TAB2 phosphorylated-TAK1 
phosphorylated and the protein TRAF6 (TAB1:TAB2-p:TAK1-p:TRAF6) translocates from 
the cytoplasmic membrane to the cytosol. 
• The complex of the serine/threonine kinases TAB1-TAB2 phosphorylated-TAK1 
phosphorylated and the protein TRAF6 (TAB1:TAB2-p:TAK1-p:TRAF6) binds the E2 
ubiquitin ligases Uev1A and Ubc13 and the protein TRAF6 is ubiquitinated. 
• The protein TRAF6 ubiquitinated controls the unknown process that leads to the 
activation of the serine/threonine kinaseTAK1 phosphorylated. 
• The serine/threonine kinase TAK1-phosporilated phosphorilates the serine/threonine 
kinases IKK-alpha and IKK-beta of the complex IKK (IKK-alpha-IKK-beta-IKK-gamma) 
• The phosphorylation of the transcriptional regulator IkB-alpha by the IKK complex 
phosphorylated leads the translocation of the general transcription factor NFkB p65 
complexed with c-Rel into the nucleus. 
• The transcriptional regulator IkB-alpha is ubiquitinated and degraded in the 
proteosome. 
 
OUTCOME NFkB - RELA 
• The transcription factor NFkB translocates in the nucleus. 
• The transcription factor NFkB binds DNA and activates the transcription of the genes: 
IL-23A, IL-6, IL-2, IL-10, TNF-alpha, MIP2. 
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TRANSDUCTION MODULE – NFkB - RELB 
• Syk autophosphorilates and phosphorilates the transmembrane adaptor CARD9 
• The effector molecule BLC10 binds to MALT1 by PLCG2 activity.. 
• After a conformational change CARD9 binds to the complex BLC10:MALT1. 
• The complex binds to TRAF6. 
• The protein TRAF6 binds to the serine/threonine kinases TAK1, TAB1, TAB2 
(TRAF6:TAK1:TAB1:TAB2). 
• The complex of the serine/threonine kinases TAB1-TAB2 phosphorylated-TAK1 
phosphorylated and the protein TRAF6 (TAB1:TAB2-p:TAK1-p:TRAF6) translocates from 
the cytoplasmic membrane to the cytosol. 
• The complex of the serine/threonine kinases TAB1-TAB2 phosphorylated-TAK1 
phosphorylated and the protein TRAF6 (TAB1:TAB2-p:TAK1-p:TRAF6) binds the E2 
ubiquitin ligases Uev1A and Ubc13 and the protein TRAF6 is ubiquitinated. 
• The protein TRAF6 ubiquitinated controls the unknown process that leads to the 
activation of the serine/threonine kinaseTAK1 phosphorylated. 
• The serine/threonine kinase TAK1-phosporilated phosphorilates the serine/threonine 
kinases IKKa and IKKb  of the complex IKK (IKK-alpha:IKK-beta:IKK-gamma) 
• The phosphorylation of the transcriptional regulator IkB-alpha by the IKK complex 
phosphorylated leads the translocation of the general transcription factor NFkB 
complexed with RelB into the nucleus. 
• The transcriptional regulator IkB-alpha is ubiquitinated and degraded in the 
proteosome. 
 
OUTCOME NFkB-RELB 
• The transcription factor NFkB translocates in the nucleus. 
• The transcription factor NFkB complexed with RelB binds DNA and activates the 
transcription of the genes: CCL17, CCL22. 
• The transcription factor NFkB complexed with RelB binds DNA and repress the 
transcription of the genes IL10, IL12A, IL12B, IL6, IL1B 
 
TRANSDUCTION MODULE -ERK 
• Syk autophosphorylates and phosphorylates the complex Grb2/Sos and PLCG 
• The phosphorylated Grb2/Sos:PLCG2 complex phosphorylates the transcription factor 
ERK. 
• The transcription factor ERK translocates into the nucleus. 
 
OUTCOME ERK 
• The  transcription factor ERK translocates in the nucleus. 
• The transcription factor ERK binds to AP1. 
• AP1 binds to DNA and activates the transcription of the genes of the cytokines: IL-10. 
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TRANSDUCTION MODULE NFAT  
• Syk autophosphorylates and phosphorylates PLC-g2. 
• PLCG2 hydrolyzes the membrane phospholipid PIP2 to IP3 and DAG. 
• IP3 opens IP3R which permits Ca
2+ efflux from ER Ca2+ stores.  
• The ER Ca2+ sensor STIM1 and STIM2 sense the resulting reduction of ER Ca2+ stores 
via their paired N-terminal EF hands located in the ER lumen. 
• After Ca2+ dissociation from the EF, STIM proteins aggregate into small cluster in the ER 
membrane and trigger store-operated Ca2+ entry via the CRAC channel, ORAI1. 
• Ca2+ influx elevates intracellular Ca2+ concentration and activates the calcineurin-NFAT 
pathway by dephosphorylation of NFAT. 
• The dephosphorylated transcription factors NFATC1 and NFATC2 translocate into the 
nucleus. 
 
OUTCOME NFAT  
• The dephosphorylated transcription factor NFAT translocates into the nucleus. 
• The transcription factor NFAT binds DNA and activates the transcription of the genes of 
the cytokines: EGR2, EGR3, COX2, IL2, IL10, PGE2, IL12. 
 
TRANSDUCTION MODULE JNK  
• Syk phosphorylates CARD9  
• CARD9 binds BLC10 and MALT1  
• With an unknown process, JNK phosporilates. 
 
TRANSDUCTION MODULE p38  
• Syk phosphorylates CARD9  
• CARD9 binds BLC10 and MALT1  
• With an unknown process, p38 phosporilates 
 
SENSING MODULE – RAF1 
• The 1,3-b-glucan particles binds to the C-type lectin Dectin-1 in glucan containing 
phagosome.  
• The C-type lectin Dectin-1 dimerizes and becomes tyrosine phosphorilated.  
• The C-Type lectin Dectin-1 dimer autophosphorilates. 
• The C-type lectin Dectin-1 phosphorilates the MAP kinase Raf1 through Pac and Src 
kinases. 
 
TRANSDUCTION MODULE - RAF1 
The subunit RelB of the transcription factor NFkB complexes with the subunit RelA of the 
transcription factor NFkB. 
The MAP kinase Raf1 acetylates NFkB RelA by CPB and p300 
The inactive transcription factor NFkB translocates into the nucleus. 
 
OUTCOME MODULE – RAF1 
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The transcription factor NFkB translocates into the nucleus. 
The transcription factor NFkB induces the transcription of the genes IL12A, IL12B, IL1B, IL10, 
IL6 and represses the transcription of the gene IL23A. 
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Appendix B 
 
The following is the text of the long description of the reaction involved in Dectin-1 signalling. 
 
DECTIN-1 
 
Dectin-1 is the archetypal signalling, non-Toll like pattern recognition receptor that play a 
protective role in immune defence to fungi. Dectin-1 was originally cloned as a dendritic cell 
surface molecule capable of delivering co-stimulatory signals to T cells (Ariizumi et al, 2000). It 
was subsequently shown to be expressed more widely on myeloid cells including macrophages, 
dendritic cells and neutrophils (Robinson et al, 2006; Taylor et al, 2002) and identified as a 
receptor for β-glucans (Brown and Gordon 2001). Dectin-1 specifically recognizes soluble or 
particulate β-1,3- and/or β-1,6-glucans, which are found primarily in the cells walls of fungi but 
also plants and some bacteria (fungi and micobacteria, Yadav and Schorey, 2006).  
Dectin-1-deficiency is associated with impaired recruitment of inflammatory leukocytes and 
inflammatory mediator production at the site of infection. Myeloid cell activation by dectin-1 is 
controlled by inherent cellular programming, with distinct macrophage and dendritic cell 
populations responding differentially to the engagement of this receptor. The inflammatory 
response is further modulated by the progression of the phagocytosis, with ‘frustrated 
phagocytosis’ resulting in dramatically augmented inflammatory responses. Dectin-1 in isolation 
is sufficient to drive a potent inflammatory response in a context-dependent manner. This has 
implications for the mechanism by which myeloid cells are activated during fungal infections and 
the processes involved in the therapeutic manipulation of the immune system via exogenous 
dectin-1 stimulation or blockade. 
Trough this novel pathway, dectin-1 also collaborates with the TLRs to induce pro-inflammatory 
responses, such as TNFα (Brown et al, 2006). The first evidence for collaboration between TLR2 
and Dectin-1 in coordinating inflammatory gene induction came from studies with zymosan 
(Gantner et al, 2003; Brown et al, 2003). Dectin-1 and TLR2 signals have also been reported to 
contribute to cytokine induction by A. fumigatus conidia (Hohl et al, 2005; Steele et al, 2005; 
Gersuk et al, 2006). 
Analysis of the transcriptional responses of macrophages and dendritic cells to fungi has 
revealed collaboration between TLR2 and Dectin-1 signalling to amplify the TLR2 response and 
promote the induction of proinflammatory cytokines.  
How this collaboration takes place is unknown, as the read out is largely cytokine production as 
Dectin-1 and the TLR synergise/collaborate but it seems that it is not at signalling level. 
The major work on understanding Dectin-1 recognition was done in mouse myeloid cells, bone 
marrow derived macrophage or bone marrow derived dendritic cells. 
There are some evidences in human DCs. The involvement in this DCs was specified during the 
text. By contrast, if the interaction is proven only in BMDCs, this was not specificated. 
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Dectin-1 signalling 
 
The 1,3-β-glucan particles binds to the C-type lectin Dectin-1. On ligand binding Dectin-1 
dimerizes and becomes tyrosine phosphorylated, presumably by Src kinases and induces an 
intracellular signalling cascade that results in various cell-specific responses.  
Dimerization is not known to be the specific trigger for Dectin-1 activation. In fact crosslinking 
with antibodies and non-particulate β-glucans do not stimulate the receptor (eg laminarin is a 
soluble b-glucan that is used as an antagonist). In short only particulate ligands have been 
shown to trigger Dectin-1. This mechanisms is known as ‘frustrated phagocytosis’ (Rosas et al, 
2008). They propose that β-glucan particles are too big to be phagocytosed and act as Dectin-1 
agonists. This was also shown by Caetano Reis e Sousa’ s group (Hernanz-Falcon et al.,2009). 
In summary clustering of Dectin-1 by particulate β-glucans induces the intracellular signalling 
cascades. A robust cellular activation leading to gene transcription may only be achieved if the 
particle is too large to be phagocytosed.  
Despite requiring only the membrane-proximal tyrosine for signalling, the cytoplasmic tail of 
dectin-1 , the ITAM domain can interact with spleen tyrosine kinase, Syk. The nature of this 
interaction is unknown but it is proposed to occur to the bridging of two dectin-1 molecules 
(Rogers et al., 2005). Whereas interactions with Syk can directly induce cellular responses, such 
as respiratory burst and IL-10 IL-2, TNFα and IL-6 production (Leibundgut-Landmann S 2007). 
Syk contributes to phagocytosis of zymosan particles in DCs.  
Trough this novel pathway, dectin-1 also collaborates with the TLRs to induce pro-inflammatory 
responses, such as TNFα (Brown et al, 2006).  
Besides Syk, Dectin-1 induces a second signalling pathway trough the kinase Raf1 that was 
independent of the Syk pathway but converges at the level of NFkB activationto control adaptive 
immunity to fungi. Moreover, Dectin-1 cross-talk with various TLRs was dependent on Raf-1 
signalling. 
Dectin-1 can induce a robust TNF response in DCs without TLR enagaement (Leibundgut-
Landmann et al, 2007). This underlines a major feature of Dectin-1 signalling in that it differs 
greatly between cell types. Therefore although DCs and macrophages are closely related the 
outcomes of Dectin-1 triggering on these two cell types differs greatly. This is best studied by 
Rosas et al (2008). So one cannot make assumptions from one cell type to another. Goodridge 
et al (2009) have recently expanded on this showing the coupling of Card9 to NFkB is cell type 
dependent. Here they show the split is not Macrophage Vs DC but also between sub-population 
of macrophages and DCs.  
In summary, the ability of Dectin-1 to engage signals that lead to gene transcription (eg TNF) 
varies greatly between different sub-populations of macrophages and DCs. This may be 
governed by the ability of Card9 to induced NFkB. Curdlan stimulation induced also rapid Syk-
dependent phosphorylation of the mitogen-activated protein kinases p38, Erk and Jnk.  
In cells where Dectin-1 does not trigger a robust gene induction, it is still able to potently 
syngerise with TLRs.  
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SENSING MODULE - SYK 
The 1,3-β-glucan particles binds to the C-type lectins Dectin-1 in glucan containing phagosome 
(see frustrated phagocytosis comment above). On ligand binding Dectin-1 dimerizes (see 
dimerisation comment above) and becomes tyrosine phosphoryilated. Syk is recruited by a 
tyrosine phosphorylation in the ITAM portion of receptor (Rogers et al 2005; Gantner et al, 
2006).  
Usually, dually phosphorylated ITAM domains recruit tandem SH2 containing kinase of the Syk 
family (Underhill et al, 2005, Rothfuchs et al, 2007). Although Dectin-1 has a dual tyrosine 
motif, only tyrosine 15 is required. This differs from all other ITAMs (Rogers et al 2005). This 
binding triggers autophosphorylation (Turner et al., 2000). The kinase Syk was recruited. 
 
Ref: Gantner et al, 2006; Rogers et al, 2005; Underhill et al, 2005, Rothfuchs et al, 2007; 
Futterer et al., 1998 
 
TRANSDUCTION MODULE SYK – NFkB-RELA 
Following ligation of Dectin-1, Syk kinase I activated and phosphorylates a number of 
substrates. This leads to recruitment of phospholipase Cγ-2 (PLCγ-2, Xu et, 2009) contributing 
to its activation and production of inositol bisphosphate and diacylglycerol (DAG, Schulze-
Luehrmann et al, 2006). Syk also mediates activation of the PI-3K pathway as measured by 
phosphorylation of protein kinase B, PKB, a downstream substrate of PI-3K (unpublished data, 
Dennehy and Brown, 2007). DAG or PI-3K products contribute to the activation of PKC isoforms.  
Card9 is shown to be important for Dectin-1 signalling and it was further proposed that during 
Dectin-1 signalling, a Card9-Bcl10-Malt1 complex was formed instead to activate NF-κB, (Gross 
et al, 2006; Xu et al, 2009). 
PLCγ-2 signalling might be important to induce the association of Malt1 with Bcl10 but not 
Card9 with Bcl10. Although it’s not known the hierarchy of the interactions of these three 
proteins, there are indications that PLCγ2 signalling is required for the proper stoichiometry and 
stable assembly of Card9-Bcl10-Malt1 complex in Dectin-1 signalling. Thus PLCγ2 plays an 
important role in coupling Dectin-1 recognition of fungal PAMPs to the activation of NF-κB in 
BMDCs via inducing the assembly of the Card9-Bcl10-Malt1 complex and the subsequent 
activation of IKKα/β and degradation of IκB proteins. 
 
In particular, Syk phosphorylates the transmembrane adaptor caspase recruitment domain 9 
CARD9 (Gross et al., 2006). The effector molecule BLC10 binds to the mucosa-associated 
lymphoid tissue 1 (MALT1) through PLCγ-2 activity. After a conformational change, CARD9 binds 
to the complex BCL10:MALT1 (Xu et al 2009). The complex binds the TNF receptor-associated 
factor 6 (TRAF6) (Rawlings et al 2006).  
The TRAF6 complex binds to the IkB kinases leading to phosphorylation and degradation of IkB 
and NFkB activation by formation of the complex RelA-cRel-p52. 
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There are no evidences of TRAF6 engagement downstream of Dectin-1. If this is an extension 
from other cell types it can’t necessarily be applied here. Therefore the gaps could fill to NFkB 
via TRAF6 and the downstream effectors listed below. It’s not known at the moment if there is a 
direct link between TRAF6 and NFkB activation.  
 
Maybe it’s happen as TRAF6 signalling in TLR cascade, where  
the protein TRAF6 binds to the serine/threonine kinases TAK1, TAB1, TAB2 
(TRAF6:TAK1:TAB1:TAB2). 
The complex of the serine/threonine kinases TAB1-TAB2 phosphorylated-TAK1 phosphorylated 
and the protein TRAF6 (TAB1:TAB2-p:TAK1-p:TRAF6) translocates from the cytoplasmic 
membrane to the cytosol. 
The complex of the serine/threonine kinases TAB1-TAB2 phosphorylated-TAK1 phosphorylated 
and the protein TRAF6 (TAB1:TAB2-p:TAK1-p:TRAF6) binds the E2 ubiquitin ligases Uev1A and 
Ubc13 and the protein TRAF6 is ubiquitinated. 
The protein TRAF6 ubiquitinated controls the unknown process that leads to the activation of 
the serine/threonine kinaseTAK1 phosphorylated. 
The serine/threonine kinase TAK1-phosporylated phosphorylates the serine/threonine kinases 
IKKα and IKKβ  of the complex IKK (IKKα-IKKβ-IKKγ) 
The phosphorylation of the transcriptional regulator IκBα by the IKK complex phosphorylated 
leads the translocation of the transcription factor NFκB into the nucleus. 
The transcriptional regulator IκBα is ubiquitinated and degraded in the proteosome. 
The TRAF6 complex binds to the IkB kinases leading to phosphorylation and degradation of IkB 
and NFkB activation 
The phosphorylation of the transcriptional regulator IκBα by the TRAF6 complex leads the 
translocation of the general transcription factor NFκB into the nucleus. 
The transcriptional regulator IκBα is ubiquitinated and degraded in the proteosome. 
 
Ref: Gross et al., 2006; Rawlings et al 2006; Dennehy and Brown 2007, Xu et al, 2009, 
Gringhuis et al., 2009. 
 
OUTCOME NFκB - RELA 
The transcription factor NFκB translocates in the nucleus. 
The transcription factor NFκB binds DNA and activates the transcription of the genes: IL23A, 
IL6, IL2, IL10, TNα, MIP2 . 
The IL-23 production is proven also in moDCs (Gerosa et al, 2008). moDCs in response to β-
glucan produce also IL-10, TNFα, and IL-1β (Carmona et al, 2006)but it is not known the 
involvement of the transcription factor NF-kB. 
Ref: Leibundgut-Landmann S et al, 2007; Gantner et al, 2003; Rogers et al, 2005; Ariizumi et 
al, 2000, Goodridge et al 2009, Gerosa et al, 2008, Carmona et al, 2006. 
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TRANSDUCTION MODULE SYK – NFkB- RELB 
Besides the activation of canonical NFkB subunits p65 (RelA) and c-Rel, dectin-1 induced Syk 
signalling activates the non canonical NFkB subunit RelB, making dectin-1 the only know 
pathogen recognition receptor to induce the non canonical NFkB pathway by mediating the 
association between RelB and p52.  
 
The mechanism under this activation in unknown. Problably the mechanism is similar to the 
classical NFkB activation, where: 
In particular, Syk phosphorylates the transmembrane adaptor caspase recruitment domain 9 
CARD9 (Gross et al., 2006). The effector molecule BLC10 binds to the mucosa-associated 
lymphoid tissue 1 (MALT1) through PLCγ-2 activity. After a conformational change, CARD9 binds 
to the complex BCL10:MALT1 (Xu et al 2009). The complex binds the TNF receptor-associated 
factor 6 (TRAF6) (Rawlings et al 2006).  
The TRAF6 complex binds to the IkB kinases leading to phosphorylation and degradation of IkB 
and NFkB activation by formation of the complex RelB-p52. 
 
There are no evidences of TRAF6 engagement downstream of Dectin-1. If this is an extension 
from other cell types it can’t necessarily be applied here. Therefore the gaps could fill to NFkB 
via TRAF6 and the downstream effectors listed below. It’s not known at the moment if there is a 
direct link between TRAF6 and NFkB activation.  
 
Maybe it’s happen as TRAF6 signalling in TLR cascade, where  
the protein TRAF6 binds to the serine/threonine kinases TAK1, TAB1, TAB2 
(TRAF6:TAK1:TAB1:TAB2). 
The complex of the serine/threonine kinases TAB1-TAB2 phosphorylated-TAK1 phosphorylated 
and the protein TRAF6 (TAB1:TAB2-p:TAK1-p:TRAF6) translocates from the cytoplasmic 
membrane to the cytosol. 
The complex of the serine/threonine kinases TAB1-TAB2 phosphorylated-TAK1 phosphorylated 
and the protein TRAF6 (TAB1:TAB2-p:TAK1-p:TRAF6) binds the E2 ubiquitin ligases Uev1A and 
Ubc13 and the protein TRAF6 is ubiquitinated. 
The protein TRAF6 ubiquitinated controls the unknown process that leads to the activation of 
the serine/threonine kinaseTAK1 phosphorylated. 
The serine/threonine kinase TAK1-phosporylated phosphorylates the serine/threonine kinases 
IKKα and IKKβ of the complex IKK (IKKα-IKKβ-IKKγ). 
The phosphorylation of the transcriptional regulator IκBα by the IKK complex phosphorylated 
leads the translocation of the transcription factor NFκB into the nucleus. 
The transcriptional regulator IκBα is ubiquitinated and degraded in the proteosome. 
The TRAF6 complex binds to the IkB kinases leading to phosphorylation and degradation of IkB 
and NFkB activation 
The phosphorylation of the transcriptional regulator IκBα by the TRAF6 complex leads the 
translocation of the general transcription factor NFκB into the nucleus. 
The transcriptional regulator IκBα is ubiquitinated and degraded in the proteosome. 
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Ref: Hayden et al., 2004, Gringhuis et al., 2009 
 
OUTCOME SYK - NFkB - RELB 
The non canonical NFkB transcription factor acts as a negative regulator of transcription of the 
immune genes, balancing the response and the Th1/Th17 polarizing factor production. 
 
The subunits of the transcription factor NFkB, RelB-p52 translocate into the nucleus. 
The subunits of the transcription factor NFkB, Rel B-p52 induce the transcription of the genes 
CCL17 and CCL22 and represses the transcription of the genes IL12A, IL12B, IL1B, IL10, IL6. 
 
TRANSDUCTION MODULE ERK 
Besides inducing NF-κB, Dectin-1 also activates MAPKs, which are important for signalling the 
production of inflammatory cytokines in BMDCs. 
In TLR signalling, the activation of ERK and JNK can lead to the induction of the transcription 
factor AP-1 that contributes substantially to the production of inflammatory cytokines (Vanden 
Bush et al, 2008: Agrawal et al, 2003). Consistent with this, the engagement of Dectin-1 by 
curdlan could lead to the induction of AP-1 as demonstrated in BMDCs. The signal transduced by 
PLCγ2 is required to activate AP-1 during Dectin-1 signalling (Xu et al, 2009). 
It has been clearly showed that zymosan activation of ERK in DCs is Syk dependent (Slack EC et 
al 2007). The inference of this is that this will also be true of Dectin-1. It was clearly shown that 
this mechanisms is Myd88 and TPL2 independent.   
 
Syk autophosphorylates and phosphorylates the complex Grb2/Sos and PLCγ−2 
The phosphorylation of the Grb2/Sos:PLCγ−2 complex leads to ERK phosphorilation (Xu et al, 
2009 ) and the translocation of the MAPK ERK into the nucleus. 
 
Ref. Vanden Bush et al, 2008; Agrawal et al, 2003; Slack et al 2007; Xu et al., 2009 
 
OUTCOME ERK 
The transcription factor ERK translocates in the nucleus. 
The transcription factor ERK binds to AP1 (Xu et al, 2009) . 
AP1 binds to DNA and activates the transcription of the genes of the cytokines: IL-10.  
ERK is also required to stabilize IL-2 mRNA (Slack et al, 2007). 
 
Ref. Slack EC et al 2007, Xu et al, 2009. 
 
TRANSDUCTION MODULE JNK  
Besides inducing NF-κB, Dectin-1 also activates MAPKs, which are important for signalling the 
production of inflammatory cytokines in BMDCs. 
In TLR signalling, the activation of ERK and JNK can lead to the induction of the transcription 
factor AP-1 that contributes substantially to the production of inflammatory cytokines (34, 35). 
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Consistent with this, the engagement of Dectin-1 by curdlan could also lead to the induction of 
AP- 1 as demonstrated by the robust binding of consensus DNA sequences by nuclear extract 
prepared from wildtype BMDCs. In contrast, the activation of AP-1 was minimal in curdlan 
treated plcγ2-/- BMDCs, suggesting that signal transduced by PLCγ2 is required to activate AP-1 
during Dectin-1 signalling (Xu et al, 2009). 
 
Syk phosphorylates the transmembrane adaptor caspase recruitment domain 9 CARD9 (Gross 
et al., 2006). After a conformational change, CARD9 binds the downstream effector molecule 
BLC10 and the mucosa-associated lymphoid tissue 1 (MALT1) (Ruland, 2008).  
The process leading to JNK phosphorylation is unknown. 
 
Ref. Leibundgut-Landmann S et al, 2007, Xu et al, 2009. 
 
TRANSDUCTION MODULE p38  
CARD9 in macrophages is recruited to phagosomes where it coordinates signalling to p38 MAPK, 
even in the absence of a connection to the NF-kB pathway. It is the same in DCs. 
 
Syk phosphorylates the transmembrane adaptor caspase recruitment domain 9 CARD9 (Gross 
et al., 2006). After a conformational change, CARD9 binds the downstream effector molecule 
BLC10 and the mucosa-associated lymphoid tissue 1 (MALT1) (Ruland, 2008).  
The process leading to p38 phosphorylation is unknown. 
 
Ref. Leibundgut-Landmann et al, 2007 Goodridge et al, 2009 
 
TRANSDUCTION MODULE NFAT  
Zymosan and live C. albicans triggers NFAT activation trough calcineurin pathway such as for 
NFAT activation in lymphocytes (Goodridge et al, 2007). This activation is PLCγ-2 dependent (Xu 
et al, 2009).   
 
Syk autophosphorylates and phosphorylates PLCγ-2 (Xu et al 2009). PLCγ-2 hydrolyzes the 
membrane phospholipids PIP2 to IP3 and DAG. 
IP3 opens IP3R which permits Ca
2+ efflux from ER Ca2+ stores (first evidence of this flux, Xu et 
al, 2009) 
The ER Ca2+ sensor STIM1 and STIM2 sense the resulting reduction of ER Ca2+ stores via their 
paired N-terminal EF hands located in the ER lumen. 
After Ca2+ dissociation from the EF, STIM proteins aggregate into small cluster in the ER 
membrane and trigger store-operated Ca2+ entry via the CRAC channel, ORAI1. 
Ca2+ influx elevates intracellular Ca2+ concentration and activates the calcineurin-NFAT pathway 
by dephosphorylation of NFAT. 
The dephosphorylated transcription factors NFATc1 and NFATc3 translocate into the nucleus. 
 
Ref. Goodridge et al, 2007, Xu et al 2009 
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OUTCOME NFAT  
The dephosphorylated transcription factor NFATc1 and NFATc3  translocate into the nucleus. 
The transcription factor NFATc1 and NFATc3 binds DNA and activates the transcription of the 
genes: EGR2, EGR3, COX2, IL2, IL10, PGE2, IL12. 
 
Ref. Goodridge et al 2007; Xu et al 2009 
 
SENSING MODULE RAF1 
Besides Syk, Dectin-1 induces a second signalling pathway trough the kinase Raf1 that was 
independent of the Syk pathway but integrated with it at the level of NFkB activation. The 
dectin-1 induced Raf-1 signalling. repressed the Syk-induced RelB activity and increased p65 
transcription activityto induce Th1- and Th17-polarizing cytokines in response to both curdlan 
and C. albicans. Moreover, Dectin-1 cross-talk with various TLRs was dependent on Raf-1 
signalling.  
 
The 1,3-β-glucan particles binds to the C-type lectins Dectin-1 in glucan containing phagosome 
(see frustrated phagocytosis comment above). On ligand binding Dectin-1 dimerizes (see 
dimerisation comment above) and becomes tyrosine phosphoryilated. Syk is recruited by a 
tyrosine phosphorylation in the ITAM portion of receptor (Rogers et al 2005; Gantner et al, 
2006).  
Usually, dually phosphorylated ITAM domains recruit tandem SH2 containing kinase of the Syk 
family (Underhill et al, 2005, Rothfuchs et al, 2007). Although Dectin-1 has a dual tyrosine 
motif, only tyrosine 15 is required. This differs from all other ITAMs (Rogers et al 2005). This 
binding triggers autophosphorylation (Turner et al., 2000). The kinase Raf1 is recruited. 
 
Ref: Gantner et al, 2006; Rogers et al, 2005; Underhill et al, 2005, Rothfuchs et al, 2007; 
Futterer et al., 1998; Gruighuis et al., 2009-06-10 
 
TRANSDUCTION MODULE Raf1 
Dectin-1 induced Raf1-signalling repressed Syk-induced RelB activity and increased p65 
transactivation activity to induce cytokine expression. Raf1 signalling phosphorylates RelA/p65 
at Ser276, which regulates cytokine expression at two distinct levels: RelB inactivaition and p65 
acetylation by the HAT CBP and p300.   
The formed p65-RelB complex of the transcription factor NKkB translocates into the nucleus. 
 
OUTCOME MODULE RAF1 
The formed p65-RelB complex of the transcription factor NKkB translocates into the nucleus. 
The formed p65-RelB complex of the transcription factor NKkB activates the transcription of the 
genes IL12A, IL12B, IL1B, !L10, IL6 and represses the transcription of the gene IL23A. 
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Appendix C 
 
 
The following is the gene list of the components involved in Dectin-1 signalling, dissected 
in modules. 
 
 
 
Sensing/Receptor Module - SYK Sensing/Receptor Module - RAF 
       
Gene Symbol Official Name GeneID  
Gene 
Symbol 
Official 
Name GeneID 
DECTIN-1 CLEC7A 64581  DECTIN-1 CLEC7A 64581 
SYK SYK 6850  RAF1 RAF1 5894 
       
Transduction module - NFkB     
    Transduction module - ERK 
Gene Symbol Official Name GeneID     
SYK SYK 6850  
Gene 
Symbol 
Official 
Name GeneID 
CARD9 CARD9 64170  SYK SYK 6850 
BCL10 BCL10 8915  GRB2 GRB2 2885 
MALT1 MALT1 10892  SOS2 SOS2 6655 
TRAF6 TRAF6 7189  PLCγ PLCG1 5335 
TAB1 MAP3K7IP1 10454  ERK MAPK1 5594 
TAB2 MAP3K7IP2 23118     
TAK1 MAP3K7 6885     
IKKg IKBKG 8517  Outcome module - ERK 
IKKa CHUK 1147     
IKKb IKBKB 3551  
Gene 
Symbol 
Official 
Name GeneID 
IkBa NFKBIA 4792  ERK MAPK1 5594 
NF-kB NFKB1 4790  IL2 IL2 3558 
NF-kB RELA 5970  IL10 IL10 3586 
cREL REL 5966     
RELB RELB 5971     
    Transduction module - NFAT 
Outcome module - NFkB RELA     
    
Gene 
Symbol 
Official 
Name GeneID 
Gene Symbol Official Name GeneID  SYK SYK 6850 
NF-κB NFKB1 4790  PLCγ PLCG1 5335 
NF-κB RELA 5972  STIM1 STIM1 6786 
IL2 IL2 3558  STIM2 STIM2 57620 
IL10 IL10 3586  ORAI1 ORAI1 84876 
IL6 IL6 3569  NFATC1 NFATC1 4273 
IL23 IL23A 51561  NFATC2 NFATC2 4772 
TNF TNF 7124  IP3R ITFR1 3708 
MIP2 CXCL2 2920  calcineurin PP3CB 5532 
    calcineurin PP3CA 3330 
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Outcome module - NFkB RELB     
       
Gene Symbol Official Name GeneID  Outcome module - NFAT 
NF-κB p50 NFKB1 4790     
NF-κB p65 RELB 5971  
Gene 
Symbol 
Official 
Name GeneID 
IL1B IL1B 3553  NFAT1 Nfatc2 18019 
CCL17 CCL17 6361  EGR2 EGR2 1959 
CCL22 CCL22 6367  EGR3 EGR3 1960 
IL12A IL12A 3592  COX2 PTGS2 5743 
IL12B IL12B 3593  IL2 IL2 3558 
IL1B IL1B 3553  IL10 IL10 3586 
IL10 IL10 3586     
IL6 IL6 3569     
       
       
Outcome module - RAF  Transduction module - JNK 
       
Gene Symbol Official Name GeneID  
Gene 
Symbol 
Official 
Name GeneID 
NF-κB p50 NFKB1 4790  SYK1 SYK 6850 
NF-κB p65 RELA 5970  CARD9 CARD9 64170 
RELB RELB 5971  BCL10 BCL10 8915 
IL12A IL12A 3592  MALT1 MALT1 10892 
IL12B IL12B 3593  JNK MAPK8 5599 
IL1B IL1B 3553     
IL10 IL10 3586     
IL6 IL6 3569     
IL23 IL23A 51561  Transduction module - p38 
       
    
Gene 
Symbol 
Official 
Name GeneID 
Transduction module - RAF  SYK1 SYK 6850 
    CARD9 CARD9 64170 
Gene Symbol Official Name GeneID  BCL10 BCL10 8915 
NF-κB p50 NFKB1 4790  MALT1 MALT1 10892 
NF-κB p65 RELA 5970  p38 MAPK14 1432 
CBP CREBBP 1387     
p300 EP300 2033     
RELB RELB 5971     
 
 
 
 
 
 
 
 
  
 A 
1 
When your heart speaks, take good notes. 
Judith Campbell 
 
 
 
 
Acknowledgments 
Here is the space to thank everyone who has somehow contributed to this work in the last years. 
Might it have been intellectually, financially, by keeping me focused or by keeping me sane...  
 
First and foremost I would like to thank my supervisors Prof. Iliana Ferrero Fortunati (Univerity of 
Parma) and Dr. Duccio Cavalieri (University of Firenze) for their invaluable assistance, support and 
guidance throughout the last years. I am grateful that they gave me the opportunity to work on this 
exciting project.  
Their expertise, enthusiasm and their suggestions as well as their encouragements and 
persistence helped me at all times. Thanks for always pushing me a wee bit further.  
 
 
Thanks to all the Duccio’s lab member, past and present, for their support, help, encouragement 
and (most important) for the fun time! In particular I want to thank Dr. Irene Stefanini (and her 
cigarette break), Dr. Enrica Calura, Dr. Damariz Rivero Guedez, Dr. Emmanuela Marchi (thank 
you, roommate), Dr. Monica DiPaola (and her unmistakable laughter) and Dr. Roberto Bonaiuti for 
their help whenever it was needed; thanks from the compliance at the coffee break to the smiles 
through the hall. I also want to thank Dr. Luca Beltrame for reading my thesis, giving advice and 
putting the commas at the right spot! I am grateful to them for their sound advice. Their 
suggestions helped to stay focused on the most important things.  
 
I want to thank all the lab members of Genetic, Biology of Microorganism, Antropology and 
Evolution department. To Dr. Paola Goffrini for the friendly distance support. 
 
Thanks also go to Letizia Sgalambro (University of Firenze) for her flawless handling of the funds 
that ultimately permitted this work to be written. 
 
I wish to thank Dr. Alessandra Cambi (NCLMS) for giving me the opportunity to work in her lab. 
She and everyone in her lab helped and taught me how to perform the experiments and I am 
deeply grateful for the great aboard experience in the Dutch world and not only for this reason.  
 
I would like to mention Prof. Mihai Netea (Radboud University) graciously supplied me suggestions 
and insights.  
Dr. Carlotta De Filippo, Dr. Gabriella Torcia, Dr. AnnMaria Di Clemente (University of Firenze), 
prof. Ugo D’Oro (Novartis Vaccine), for helping with the last part of the Results, and in particular 
Dr. Mirela Kuka (Novartis Vaccine) for the useful discussions, help with the experiment and the 
recicprocal encouragement. 
 
I wish to thank Ab, Louise and Yvette who accepted me as a family during my time in Nijmegen. 
Thanks for making it feel like home.  
 
A big, big thank you goes to my family and my friends. To my parents and Andrea, I owe special 
gratitude. Without their support and understanding, it would have been impossible to get this far. 
With their incredible amount of patience and their love they supported me all the way through and 
enabled me to finish this work. 
 
 
